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Abstract 
Individual histone post-translational modifications have been implicated in regulating 
many cellular events.  Modifications can occur at high densities in the N-terminal tail 
domains of core histones, enabling the possibility that combinations of modifications 
regulate chromatin processes differently than modifications occurring individually.  
However, surprisingly little is known about the nature and functions of multi-site histone 
modification.  This study investigates functional interactions between acetylation of 
lysine 16 (K16ac) and methylation of lysine 20 (K20me), two modifications that 
frequently occur together on molecules of histone H4 (H4).  Methylation state-specific 
binding of the P53-binding protein 1 (53BP1) to dimethyl K20 H4 (K20me2) and the 
formation of 53BP1 nuclear foci near double strand breaks are early events in DNA 
damage responses (DDR) that provide a platform for the assembly of downstream 
effectors.  Since global levels of K20me2 are relatively stable and are established 
independently of DNA damage, we propose that reversible changes in the levels of 
K16ac co-modification act like a dynamic switch to modulate DDR responses mediated 
by K20me2.  Analyses of the interaction of the K20me2 binding domain of 53BP1 with 
H4 peptides in vitro reveal that K16ac co-modification attenuates specific recognition of 
K20me1/2 (mono- and di-methylation) by 53BP1.  The possibility that K16ac and 
K20me2 interact functionally in vivo is demonstrated by my finding that K16 
deacetylation accompanies the induction of H2A.X phosphorylation, a well-known 
marker for DDR, following DNA damage by either UV irradiation, hydroxyurea or 
bleocin treatment.  Moreover, the effects of expressing K16 mutants of H4 and inhibition 
of histone deacetylases on 53BP1 foci formation induced by DNA damage support the 
hypothesis that K16ac co-modification negatively regulates the formation of 53BP1 foci.  
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The functional significance of these interactions is underscored by the finding that K16 
hyperacetylation also hindered 53BP1-mediated nonhomologous end-joining as 
demonstrated by treatment of HDACi and overexpression of a H4 mutant mimicking 
acetylation at K16.  DNA damage-induced deacetylation was associated with 
transcriptional repression, but was not linked to chromatin decondensation.  Deregulated 
DDR mechanisms are frequently involved in the development and progression of cancer, 
and interruption of the DDR is used in chemotherapeutic treatments against cancer.  
Further investigation of the role of H4 modifications in DDR will enhance our 
understanding of how genome integrity is maintained in normal cells and may provide 
insights crucial for developing new cancer therapies. 
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Chapter 1 – A brief introduction to the complexity of the histone world 
& DNA damage responses 
1.1 From histones to chromatin 
The repeating subunit of eukaryotic chromatin is the nucleosome.  In general, there 
are four kinds of core histone proteins – H2A, H2B, H3 and H4 and one linker histone, 
H1.  One tetramer made of two histone H3 and two H4 molecules and two dimers of H2A 
and H2B form a single octamer around which 146 base pairs (bp) of DNA are wrapped.  
In addition to core histones, one histone H1 molecules binds nucleosomes near the region 
where the DNA enters and exits the nucleosome, and seals approximately 166 bp of DNA 
around the octamer.  The core histones share a similar tripartite structure, which consists 
of a relatively long amino(N)-terminal tail, a globular domain and a shorter carboxyl(C)-
terminal tail (Luger, et al. 1997).  Among these regions, the N-terminal tail of each 
histone has been intensively investigated due to its highly regulated post-translational 
modifications (Fig. 1.1).  Addition or removal of acetyl, methyl and phosphate groups 
can modulate the functions of histones (Luger, et al. 1997).  The potential regulatory 
complexity afforded by combinatorial modification of histones (i.e. “the histone code”) 
has long been appreciated (Strahl and Allis 2000).  The N-terminal tail domains of 
histones extruding from nucleosomes mediate interactions between adjacent DNA fibers 
in folded chromatin, and serve as sites of interaction for a wide variety of enzymes and 
effectors, including histone acetyltransferases, deacetylases, methyltransferases, 
demethylases, and chromatin remodeling complexes to mediate changes in chromatin 
structure and DNA accessibility. 
1.2 The histone families 
Although the nomenclature H1, H2A, H2B, H3 and H4 implies there are single  
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Fig. 1.1 Nucleosome structure 
The nucleosome was viewed along the superhelical DNA axis (adapted from Wolffe and 
Hayes 1999).  Well-characterized modifiable residues on the extruding N-terminal tails 
are marked.  Acetylation sites on lysines are indicated by asterisks.  Sites of methylation 
(M), the site of phosphorylation (P) and sites of ribosylation (R) and ubiquitination (U) 
are also indicated.  Positions of K16 and K20 of H4 are indicated by arrows. 
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protein forms, the situation is more complicated in terms of diversity in genomic DNA 
and protein sequences.  The first layer of complexity is the diversity of protein sequence.  
For each type of histone (except H4, see later part), there are several variants.  The term 
histone H1 is intentionally non-specific and refers to a variety of closely related proteins 
which vary often by only few amino acids.  In human, for instance, there are 10 H1 
proteins.  In a similar manner,  histone H2A represents 9 variants, H2B 19 variants and 
H3 6 variants (Khare, et al.).  Characterization of the functions of these slightly different 
variants has just begun due to the development of isoform specific antibodies and the 
advance of mass spectrometry analysis.  Using DNA damage responses as an example, 
one of the histone H2A variants, H2A.X, has been identified as an important molecule, 
spreading the signal of DNA damage (Rogakou, et al. 1999). 
The second layer of complexity is the multiple copies of histone genes encoded for a 
given protein sequences.  For example, histone H4 has 15 gene copies among 
chromosome 1, 6 and 12 (ENSEMBL, GRCh37.p3), all of them encoding the same 
protein sequence.  It is worthwhile to note that H4 is the most conserved histone in terms 
of having no variants in protein sequence among these 5 types of histones, implying its 
critical roles in genome organization among the different species.  Multiple copies of 
histone genes have been proposed as a requirement for its critical roles in genome 
organization.  Multiple copies can serve as backup sources for other individual copies, 
allowing the tolerance of mutations in one or a few copies, and/or also allows the burst 
expression of histone proteins during S phase of cell cycle. 
1.3 H2A variants: H2A.X in DNA damage responses 
Here I will briefly describe variation in H2A and then focus on H2A.X, a variant that 
is an important component in DNA damage responses.  In most cell types, the bulk of 
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H2A molecules consist of the H2A1 and H2A2 variants which co-migrate on SDS gels as 
a single band and do not appear to have distinct functions.  The human genome contains 
10 genes encoding for H2A1 variants, six of them are completely identical while four of 
them vary in few residues.  H2A2 differs from H2A1 only at residue 51, where a 
methionine-to-leucine substitution occurs (Redon, et al. 2002). 
There are also five minor H2A variants - H2A.X, H2A.Z (West and Bonner 1980), 
macroH2A1 (Pehrson and Fried 1992), macroH2A2 (Chadwick and Willard 2001, 
Costanzi and Pehrson 2001) and H2A-Bbd (Chadwick and Willard 2001) – which vary 
noticeably from the major isoforms of H2A1 and H2A2.  Among these five variants, 
H2A.X has a longer C-terminal tail compared to H2A1 and H2A2, and the tail contains a 
highly conserved SQ phosphorylation site (serine 139).  In response to DNA damage, 
phosphorylation at this SQ site, referred to as -phosphorylation or H2A.X, is rapidly 
induced and spread (Rogakou, et al. 1998).  By using two dimensional electrophoresis of 
acetic acid-urea-Triton X-100 (AUT) and acetic acid-urea-cetyltrimethylammonium 
bromide (AUC) gel, Bonner and colleagues showed that this phosphorylated form is 
induced in cells treated with ionizing radiation (Rogakou, et al. 1998).  Other treatments 
producing double stranded DNA breaks, including ultraviolet light, bleocin and hydrogen 
peroxide also induced this -component.  32P labeling, site-specific mutation and mass 
spectrum analyses were used to demonstrate that this shifted -component is H2A.X 
phosphorylated at serine 139.  The roles of H2A.X in the DNA damage responses will be 
addressed later in this chapter. 
1.4 Histone H4 lysine 20 methylation 
In the histone H4 N-terminal tail, multiple residues can be modified, including 
arginine 3 and lysines 5, 8, 12, 16 and 20 (Fig. 1.2A).  Among these residues, the  
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Fig. 1.2 The histone H4 N-terminal tail and lysine modification 
(A) A cartoon illustrating the N-terminal tail of histone H4 shows the highly clustered 
modifiable sites for R3, K5, K8, K12, K16 and K20.  (B) Acetylation and possible 
methylation states affecting lysine residues.  Acetylation neutralizes the charge associated 
with the -NH3 group whereas methylation does not. 
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functions and regulations of K20 methylation has generated the most controversy.  
Lysine 20 can be modified by one, two or three methyl groups (Fig. 1.2B) by different 
enzymes.  PR-SET7, also known as SET8, SETD8 or KMT5A, is the only enzyme 
identified so far that mono-methylates K20 in humans (Fang, et al. 2002, Nishioka, et al. 
2002, Rice, et al. 2002).  PR-SET7 regulation has been extensively studied recently 
(Huen, et al. 2008, Liu, et al. 2010, Oda, et al. 2010).  Mono-methylation of K20 begins 
to increase in late G2 and peaks in the M phase (Pesavento, et al. 2008), and is thought to 
play roles in chromatin condensation for mitosis (Houston, et al. 2008, Oda, et al. 2009, 
Sakaguchi and Steward 2007).  Loss of PR-SET7 in Drosophila, mouse and human cells 
causes DNA damage during the S phase and/or improper chromosome compaction in the 
M phase (Houston, et al. 2008, Huen, et al. 2008, Jorgensen, et al. 2007, Karachentsev, et 
al. 2005, Oda, et al. 2009, Sakaguchi and Steward 2007, Tardat, et al. 2007).  The down-
regulation or degradation of PR-SET7 in S phase is mediated via the ubiquitin ligase 
complex CRL4CDT2, which consists of cullin 4, CDT2, DDB1 and RBX1 (Abbas, et al. 
2010, Centore, et al. 2010, Oda, et al. 2010).  The CRL4CDT2 complex also serves in 
nucleotide-excision repair (NER) pathway (Hannah and Zhou 2009), and UV-induced  
DNA damage causes PR-SET7 degradation (Centore, et al. 2010), implicating K20me1 in 
cell cycle regulation during DNA damage responses. 
To understand the functions of K20me1, one approach is to identify its reader 
modules and characterize proteins containing these modules.  It has been reported that 
MBT(malignant brain tumor), Tudor, PWWP(conserved Proline and Tryptophan) and 
chromo-barrel domain-containing proteins share a common fold and can recognize 
methyl lysine residues including methyl K20 of histone H4 (Botuyan, et al. 2006, 
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Maurer-Stroh, et al. 2003, Min, et al. 2007, Moore, et al. 2010, Trojer, et al. 2007, Wang, 
et al. 2009).  One PWWP domain containing protein, pdp1 in fission yeast (S. pombe), 
associates with set9 (Wang, et al. 2009) – the sole methyltransferase responsible for 
mono-, di- and tri-methylation in fission yeast – and is required for establishment of all 
states of K20 methylation, suggesting that positive feedback is used to expand K20 
methylation in fission yeast (Fang, et al. 2002).  In contrast to the notion that K20me1 
may contribute to chromatin compaction in mitosis, however, another PWWP domain-
containing protein, EXPAND1, interacts with the BRCT domain of 53BP1 and 
contributes to DNA damage-induced chromatin decondensation (Huen, et al. 2010), 
suggesting that K20m1 can mediate distinct molecular functions depending on the reader 
module. 
Proteins with MBT domains have also been extensively investigated.  MBT-
containing proteins usually have 2 to 4 MBT repeats – for example, three in L3MBTL1; 
four in both L3MBTL2 and MBTD1 – which form a cage-like cavity that can interact 
with mono- and di-methylated lysine (Eryilmaz, et al. 2009, Guo, et al. 2009, Trojer, et al. 
2007).  L3MBTL1 has been proposed to bind to K20me1 and K20me2 together with 
mono-methylated histone H1b to promote chromatin compaction (Trojer, et al. 2007).  As 
members of the polycomb group (PcG) of proteins, L3MBTL2 and MBTD1 are both 
implicated in transcriptional repression (Guo, et al. 2009, Trojer, et al. 2011).  L3MBTL2 
forms polycomb repressive complexes (PRC) along with ubquitin E3 ligases and is 
essential for H2A lysine 119 monoubiquitination-mediated gene silencing. However, in 
vitro chromatin condensation assay performed with either native or recombinant histones 
demonstrated that L3MBTL2 compacts oligo nucleosomal arrays irrespective of the state 
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of K20 methylation (Trojer, et al. 2011). Thus the role of K20 methylation in this 
suppressive pathway needs further in vivo investigation.  It is notable that H2A lysine 119 
monoubiquitination mentioned above is part of DNA damage responses for suppressing 
transcription proximal to damage sites (Shanbhag, et al. 2010), and this particular issue 
will be addressed in chapter 4. 
Artificial targeting of PR-SET7 to the promoter of a reporter construct also suggests a 
repressive roles for K20me1 in transcriptional regulation (Congdon, et al. 2010).  PR-
SET7 knockdown by shRNA caused increased accessibility to micrococcal nuclease 
(MNase), also supporting a repressive role of K20me1 (Houston, et al. 2008).  However, 
other groups have shown that K20me1 appears to be enriched at active genes (Barski, et 
al. 2007, Talasz, et al. 2005, Vakoc, et al. 2006).  This paradox could arise from the 
following scenario: the presence of K20me1 at active genes may only indicate the 
potential for transcriptional regulation by K20me1, but the presence of K20me1 does not 
always coincide with that of repressive modulators which bind K20me1.  Additionally, 
other K20me1 readers may have different effects on transcription.  This issue thus needs 
further investigation. 
The functions associated with either MBT or PWWP domains appear to be primarily 
involved in transcriptional regulation.  However, Tudor domain-containing proteins have 
more diverse roles.  Similar to MBT-containing proteins, Tudor domain-containing 
proteins usually have multiple tandem repeats of the Tudor domain.  Tudor domains have 
been implicated in binding RNA (Ponting 1997), methyl arginine (Brahms, et al. 2001, 
Cote and Richard 2005, Friesen, et al. 2001, Goulet, et al. 2008, Linder, et al. 2008, 
Sprangers, et al. 2003) and methyl lysine residues (Botuyan, et al. 2006, Huyen, et al. 
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2004).  The RNA binding activity of Tudor domains appears to be involved mostly in the 
regulation of splicing and small RNA processing (Chuma, et al. 2003, Li, et al. 2008, Liu, 
et al. 2011).  Interestingly, many of the arginine-methylated proteins bound by Tudor 
proteins are RNA-binding proteins involved in embryonic development (Brahms, et al. 
2001, Chen, et al. 2009, Goulet, et al. 2008, Linder, et al. 2008, Liu, et al. 2010, Vagin, et 
al. 2009), suggesting there may be a conserved role for the Tudor domain in the 
regulation of RNA metabolism.  The more recently discovered property of methyllysine 
binding was originally reported in human 53BP1 and its ortholog in fission yeast crb2 in 
response to DNA double-stranded breaks (Huyen, et al. 2004, Sanders, et al. 2004).  
There was confusion whether the relevant targets are histone H3 K79 or H4 K20.  Further 
work favored H4 K20, and this was supported by the finding that knockdown of SUV4-
20, the methyltransferase responsible for K20me2/me3, impairs DNA damage-induced 
53BP1 recruitment (Yang, et al. 2008).  To understand the relationship between DNA 
damage and histone H4, one must consider nucleosome structure.  In the crystal structure 
of the nucleosome, the K20 residue is situated within a highly basic patch of sequence 
that follows the major groove of nucleosomal DNA to connect the flexible N-terminal tail 
and the globular histone fold domains of H4 (Lu, et al. 2008).  Thus, K20 is expected to 
be less accessible than other N-terminal sites, but has been suggested to become more 
accessible following DNA double-stranded breakage (Sanders, et al. 2004).  Since 
approximately 80% of histone H4 in animal cells is dimethylated at K20 (Pesavento, et al. 
2008), any change in the exposure of K20 represents largely a change in the exposure of 
K20me2, enabling methylation-dependent interactions with the tandem Tudor domains of 
53BP1. 
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1.5 Histone H4 lysine 16 acetylation and deacetylation 
The functions of K16ac in processes apart from DNA damage responses (DDR) have 
been widely studied in different systems.  Current evidence suggests it is involved in 
multiple molecular processes including defining boundaries to limit the spread of 
heterochromatin (Kimura, et al. 2002, Meijsing and Ehrenhofer-Murray 2001, Suka, et al. 
2002), transcriptional activation (Kapoor-Vazirani, et al. 2008), transcriptional elongation 
(Bell, et al. 2007) and regulation of higher order chromatin structure (Robinson, et al. 
2008, Shogren-Knaak, et al. 2006). 
The evidence regarding regulation of heterochromatin is based primarily on analyses 
in budding yeast (S. cerevisiae).  In budding yeast, Rap1p, a cis-element binding protein 
that recognizes telomeric DNA sequences and recruits the Sir2p, Sir3p and Sir4p 
(silencing information regulator) proteins to form complexes and spread telomeric 
heterochromatin.  The interactions between Sir3p, Sir4p and the N-terminal tail of histone 
H4 probably require hypoacetylation at K16 but not K5, K8 and K12, as shown by amino 
acid replacements at these residues (Johnson, et al. 1990, Megee, et al. 1990).  Sir3p 
facilitates the formation of telomeric heterochromatin by interacting with H4 
hypoacetylated at K16 and preventing acetylation.  On the other hand, Esa1p (essential 
SAS2-related acetyltransferase 1) and Sas2p (something about silencing 2) are the 
histone acetyltransferases contributing most of the H4 K16 acetylation (Smith, et al. 1998) 
and antagonize the effects of Sir proteins.  In esa1, sas2, and/or sir2 mutants, results from 
ChIP assays relative to telomeres demonstrated that in both sas2 mutants and gene-
replacement strains expressing H4-K16R, Sir3p spreads away from telomeres and that 
genes close to telomeres have lower expression, implying that K16 acetylation acts to 
restrict the spreading of Sir3p. 
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Secondly, the K16 acetyltransferases, sas2 and esa1, are orthologs of Tip60 (HIV Tat-
interactive protein 60kDa) and MOF (males-absent on the first), respectively, in human.  
They belong to the MYST histone acetyltransferase (HAT) family, named for the 
founding members MOZ (monocytic leukemia zinc finger protein), Ybf2/Sas3 Sas2, and 
Tip60 (Borrow, et al. 1996).  All members of this family have a MYST homology region 
with an atypical C2HC-type zinc finger motif and a canonical acetyl-CoA-binding site 
(Sterner and Berger 2000).  In addition to the role in regulation of heterochromatin in 
yeast, Tip60 has been implicated as a coactivator for nuclear receptors, myc, NF-kB and 
E2F (Baek, et al. 2002, Frank, et al. 2003, Taubert, et al. 2004).  There is also evidence 
suggesting it can act as a corepressor (Ai, et al. 2007, Xiao, et al. 2003). 
Third, histone H4-K16 acetylation controls chromatin structure and protein 
interactions (Shogren-Knaak, et al. 2006).  By using an in vitro chemical ligation-based 
method, histone H4 bearing K16 acetylation not only abolishes nucleosome folding 
resulting in higher solubility but also impedes ACF-mediated nucleosome sliding. 
Perturbations in K16 acetylation have also been linked to oncogenesis.  Some studies 
have claimed that tumors and immortalized cell lines have higher levels of both K16ac 
and the K16 HAT, MOF (Gupta, et al. 2008, Park, et al. 2008).  However, other studies 
claim that decreased levels of K16ac are a common feature of cancer tissues and cancer 
cell lines (Fraga, et al. 2005, Pfister, et al. 2008).  Further investigations are required to 
elucidate whether these controversies arise from comparing different stages of cancer or 
reflect differences in the assays employed.  Several clinical studies have suggested that 
cancer tissues/cells have elevated DNA damage responses (Blanco, et al. 2007), but how 
this links to K16ac has not been investigated.  
 12
1.6 DNA damage responses 
Cellular responses to DNA damage and the subsequent repair processes are critical 
functions that guard genome integrity and stability.  Mutations of many genes involved in 
DNA damage responses have been reported to cause disorders including cancer.  
Different types of DNA damage are recognized and processed by specific molecular 
pathways to ensure efficient repair—or, if the damage is too severe, to trigger permanent 
cell cycle arrest or cell death by apoptosis.  For example, crosslinking damage, such as 
pyrimidine dimers caused by ultraviolet light (UV), is recognized and processed by the 
nucleotide-excision repair (NER) pathway; base damage mediated by abnormal 
nucleotide modifications—including deamination, oxidation, and methylation—is 
processed by the base-excision repair (BER) pathway.  DNA double-stranded breaks 
(DSBs) caused by ionizing radiation and by transcription/replication stresses are 
processed by two complementary pathways, non-homologous end-joining (NHEJ) and 
homologous recombination (HR), depending on the context in which the DSBs occur 
(Fig. 1.3). 
1.7 Homologous recombination and nonhomologous end-joining 
The extent to which HR and NHEJ are used to repair DSBs in eukaryotes varies 
between species, developmental stages (Serrano, et al. 2011) and during the cell cycle 
(Takata, et al. 1998).  In lower eukaryotes e.g., S. cerevisiae (budding yeast) and S. 
pombe (fission yeast), DSBs are repaired primarily by HR (Jazayeri and Jackson 2002, 
Prudden, et al. 2003), whereas in vertebrates, NHEJ dominates (Takata, et al. 1998).  
Among vertebrates, avian cells tend to use HR more than mammalian cells (Wang, et al. 
2001).  Although data for amphibians and reptiles are lacking, there seems to be a general  
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Fig. 1.3 Two major pathways involved in DSB repair 
A cartoon illustration summarizing crosstalk between the two major DSB repair 
pathways (adapted from Kastan and Lim 2000) .  See details in text. 
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trend that more recently emerged species use NHEJ more extensively.  In another word, 
the NHEJ pathway may have evolved recently compared to HR. 
There are a few possible explanations for why HR is restricted to certain specific 
stage(s) of the cell cycle.  First is the availability of homologous templates: HR requires 
homologues template DNA from unaffected sister chromatids to effect DSB repair and 
thus is limited to late S, G2 and early M phases of the cell cycle.  This notion is supported 
by the evidence from NHEJ-deficient avian cells (which only can do HR) (Takata, et al. 
1998).  For cells in late S, G2 or M phases, no difference exists in response to -
irradiation-induced DSBs.  Conversely, NHEJ-deficient cells display increased mortality 
for DSBs induced in G1 phase, indicating NHEJ is the major pathway in G1 phase.   
Although it is also reported that HR can take place in the G1 phase involving the parental 
and maternal alleles of chromosomes (Fabre 1978); this G1-HR results in the loss of 
heterozygosity (LOH) which is a common cause for the inactivation of tumor suppressor 
genes (e.g., BRCA1 and BRCA2) and plays significant roles in cancer development 
(Yang and Lippman 1999).  Thus understanding how DNA repair pathway choice is 
selected is a critical research goal. 
1.8 Double stranded DNA damage 
Several types of DNA damage can give rise to DSBs if they block replication forks 
during the S phase of the cell cycle.  DSBs are the most dangerous kind of DNA damage, 
since they increase the frequency of chromosome deletion, insertion and translocation.  
Cells have evolved multiple mechanisms to sense and repair various kinds of DNA 
damage.  Therefore, it is not surprising that current evidence suggests that multiple 
distinct and overlapping pathways compete to sense and repair DSBs. 
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1.8.1 Ku and the DNA-dependent protein kinase pathway for DSB repair 
The first one discussed here is the Ku/DNA-dependent protein kinase (DNA-PK) 
mediated pathway (see Fig. 1.3, right branch of pathway).  DNA-dependent protein 
kinase is a heterotrimer containing DNA-PK catalytic subunit (DNA-PKcs), Ku70 and 
the K80 proteins.  This complex has been extensively studied for its role in mediating 
DSB repair by NHEJ.  DNA-PK also has well documented roles in variable (diversity) 
joining [V(D)J] recombination, switch recombination, homologous recombination and 
telomere maintenance, and mutation of DNA-PKcs accounts for the severe combined 
immune deficiency (SCID) syndrome.  The first two processes are indispensable for 
proper development of the immune system in mammals, while the rest and NHEJ are 
essential for any living cell. 
The first step in the response to DSBs is the recognition of DNA free ends.  The Ku 
heterodimer binds to DNA free ends and threads the DNA through its toroidal structure.  
Ku is an ancient protein and its orthologs have been discovered in some bacterial species 
and bacteriophages (d'Adda di Fagagna, et al. 2003).  Ku orthologs in bacteria associate 
with DNA ligase, indicating that its roles in DNA repair is well conserved during 
evolution (Della, et al. 2004).  In humans, Ku was originally identified as an autoantigen 
recognized by sera from patients with autoimmune diseases including systemic lupus 
erythematose, scleroderm, polymyositis, and Sjorgen’s syndrome (Mimori, et al. 1990).  
This antigen was named “Ku” based on the first two letters of a patient’s last name.  The 
eukaryotic Ku proteins, Ku80 (a.k.a. Ku86 or Ku83) and Ku70, were named after their 
molecular weights on gel.  However discrepancies between labs have led to different 
names for the larger one, Ku80, Ku83 or Ku86.  Since Ku80 is used the most in the 
literature; the larger subunit is referred to as Ku80 here.  Why Ku proteins are involved in 
 16
autoimmune diseases is not completely understood, but seems likely to result from the 
abundance of these proteins in cells (approximately half million molecules per cell) 
(Mimori, et al. 1986, Tuteja, et al. 1994).  Similarly, there are also reports indicating that 
histone proteins are also autoantigens (Fritzler, et al. 1982, Hannestad and Stollar 1978, 
Stollar 1971, Tan and Portanova 1981).  Ku proteins bind to DNA ends irrespective of 
DNA sequence (Mimori and Hardin 1986). 
The second step is to resect the DNA ends to promote the efficiency of NHEJ.  DSBs 
can contain 5’ or 3’ overhangs of varying lengths and may also contain various adducts 
on the sugar and base moieties.  Thus, it is likely that multiple nuclease activities are 
required for different repair machineries and multiple nucleases have been reported to be 
involved in this process.  One good example is Artemis, a native 5’ to 3’ exonuclease 
which is recruited to DNA-PKcs along with the Ku70/Ku80 complex to DNA ends (Ma, 
et al. 2002).  WRN is another nuclease/helicase recruited to Ku proteins (Li and Comai 
2000, Li, et al. 2004).  Both Artemis and WRN show enhanced nuclease activity when 
they are associated with their partners, DNA-PKcs and Ku proteins, respectively.  Since 
Ku proteins are responsible for the DNA-binding property of DNA-PK complexes, it 
resolves the puzzle why Ku70, Ku80 and Artemis are implicated in SCID phenotype, but 
none of them is encoded from the SCID locus.  Once the Ku/DNA-PK complexes bind to 
DNA ends, DNA-PKcs is activated and phosphorylates itself, Artemis and WRN 
(Goodarzi, et al. 2006, Karmakar, et al. 2002, Niewolik, et al. 2006), allowing whole 
DNA-PK complexes to harbor endonuclease activity.  Via the association with 
Ku70/Ku80, DNA-PK is able to slide along the DNA strand and position Artemis and/or 
WRN to cleave both 5’ and 3’ overhangs of any length.  The final step, carried out by 
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XRCC4/DNA ligase IV complexes, is to rejoin the broken ends once proper ends have 
been made via resection and gap fill-in synthesis. 
Although we now know the basics of how Ku/DNA-PKcs contributes to NHEJ, it 
remains unclear how broken ends are held proximal to each other prior to repair.  The 
following section provides some clues about this. 
1.8.2 The Mre11-Rad50-NBS1 pathway 
Genes involved in DSB repair were identified in mutants of S. cerevisiae sensitive to 
radiation (Rad for radiation-sensitive, Xrs for X-ray-sensitive) or deficient in meiotic 
recombination (Mre).  Three of these mutants, Mre11, Rad50 and Xrs2, are all deficient 
in meiosis and sensitive to methyl methanesulfonate (MMS, a compound indirectly 
inducing DSB) (Ivanov, et al. 1992, Kupiec and Simchen 1984, Niewolik, et al. 2006), 
and belong to an epistasis group related to HR (Johzuka and Ogawa 1995).  Most 
importantly, these three proteins are identified in the same protein complex (Hopfner, et 
al. 2001, Johzuka and Ogawa 1995).  Like the example of Ku proteins, Mre11 and Rad50 
are conserved among their orthologs from other species; suggesting they serve vital 
functions in cellular physiology.  However, a human ortholog of Xrs2 was not identified 
until Petrini and colleagues showed that Nbs1 fulfills this role in the human Mre11 and 
Rad50 complex (Carney, et al. 1998).  Nbs1 was originally implicated in Nijmegen 
breakage syndrome (NBS), a variant of ataxia-telangiectasia (AT) that is an autosomal 
recessive disorder characterized by microcephaly, growth retardation, severe combined 
immunodeficiency and a high incidence of lymphoid cancers (Matsuura, et al. 1998, 
Varon, et al. 1998). 
Rad50 contains a bipartite ATP-binding cassette(ABC)-type ATPase and a long 
heptad repeat sequence that is folded into an anti-parallel coiled-coil domain.  The Rad50 
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coiled-coil domains protrude from the globular head of the protein and can associate with 
another Mre11/Rad50 complex via a conserved apical Cys-X-X-Cys motif for metal ion-
dependent dimerization.  Mre11 possesses a phosphodiesterase domain in its N-terminal 
region which is also responsible for NBS1 interaction.  The function of the Mre11 C-
terminal domain is less understood, but may be involved in Mre11 dimerization and DNA 
interaction.  Among these three components, NBS1 is the least conserved during 
evolution and is only found in eukaryotes.  Interestingly, NBS1 has been shown to 
facilitate the nuclear accumulation of Mre11/Rad50 (Difilippantonio, et al. 2005), which 
is obviously unnecessary for prokaryotes.  The N-terminal region of NBS1 has two 
common phosphopeptide-recognition domains – fork-headed associated (FHA) domain 
and breast cancer associated C-terminus (BRCT) domain.  It has been shown that these 
two domains can bind CK2-dependent phosphorylated MDC1 and recruit MDC1 to DSB 
sites (Chapman and Jackson 2008).  NBS1 also bridges ATM to Mre11/Rad50 complexes 
through its ATM- and Mre11-interaction regions (AIR and MIR) (Falck, et al. 2005), 
further supporting the observation that ATM activation requires both MRN complexes 
and DNA free ends (Lee and Paull 2005).  Remarkably, MRN complexes also have the 
ability to resolve blocked and misfolded DNA ends using an ATP-driven nuclease 
activity, and to tether broken DNA ends in contrast to Ku protein complexes (Walker, et 
al. 2001).  With the assistance of atomic force microscopy, Moreno-Herrero et al 
demonstrated that in the absence of DNA free ends, the coiled-coil arms of Rad50 favor 
intramolecular interaction, while in the presence of DNA ends, the Rad50 arms favor 
intermolecular interactions, which are proposed to tether broken ends together (Moreno-
Herrero, et al. 2005).  Nevertheless, the binding of ATP to Rad50 induces conformational 
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changes in Mre11, providing a mechanistic role for Rad50 in controlling DNA processing 
by Mre11 (Lammens, et al. 2011).  Growing evidence suggests that MRN travels along 
chromatin and scans for DNA breaks (Lee and Paull 2005, Moreno-Herrero, et al. 2005).  
Once MRN binds to DSBs, ataxia telangiectasia mutated (ATM) kinase is recruited by 
the MRN complex via NBS1 and becomes activated (Cerosaletti, et al. 2006, 
Difilippantonio, et al. 2005, Falck, et al. 2005).  Then ATM phosphorylates multiple 
substrates involved in DDR or cell cycle checkpoints, such as H2A.X (Burma, et al. 
2001), 53BP1 (Anderson, et al. 2001, Rappold, et al. 2001), NBS1 (Gatei, et al. 2000) 
and chk2 (Matsuoka, et al. 1998), stimulating the accumulation of more MRN complexes 
in a positive feedback loop to amplify the DSB signals.  MDC1 can recognize the 
phosphorylated serine 139 of histone H2A.X (Rodriguez, et al. 2003, Stewart, et al. 2003) 
and subsequently MDC1 recruits RNF8, a ubiquitin E3 ligase for H2A.X (Huen, et al. 
2007, Kolas, et al. 2007, Mailand, et al. 2007).  RNF168, another ubiquitin E3 ligase, is 
subsequently recruited by ubiquitinated H2A.X to modify a larger population of H2A 
molecules (Stewart, et al. 2009).  Since H2A.X represents approximately 25% of the 
H2A pool, this ubiquitination of other H2A variants ensures augmentation of DNA 
damage signaling and changes in local chromatin conformation that presumably facilitate 
the exposure of K20 residues of histone H4. 
1.9 Molecular and physiological functions of 53BP1 
53BP1 was originally identified as a p53 binding protein in yeast two-hybrid 
screening (Iwabuchi, et al. 1994).  Subsequently, the fission yeast ortholog of 53BP1, 
crb2, was implicated in cell cycle checkpoint signaling and DDR-related cell cycle arrest 
(Saka, et al. 1997).  Analyses of the Xenopus ortholog of 53BP1 expressed in human cells 
revealed that it becomes phosphorylated and re-localizes rapidly to the nucleus upon 
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irradiation (Anderson, et al. 2001).  53BP1 contains two tandem repeats of the BRCT 
domain, named after the C-terminal domain of a breast cancer susceptibility protein.  
BRCT domains are found in many proteins involved in cell cycle regulation and DNA 
repair (Bork, et al. 1997).  53BP1 also contains two tandem repeats of the Tudor domain 
(Charier, et al. 2004).  The BRCT domain has been shown to serve as a phosphoprotein 
recognition module (Rodriguez, et al. 2003, Yu, et al. 2003).  Initially, Ward et al 
suggested that 53BP1 foci formation depends on C-terminal phosphorylation of H2A.X 
(i.e. as H2A.X), but that the BRCT domains are not involved in 53BP1 foci formation 
(Ward, et al. 2006).  Instead, the interactions required for foci formation mapped to a 
region upstream of the BRCT domains that includes the Tudor domains.  In 2004, two 
groups implicated different histone modifications in 53BP1 recruitment.  Huyen  et al. 
showed that the tandem Tudor domains of 53BP1 are required for 53BP1 recruitment and 
suggested that they recognized methylated lysine 79 of histone H3 (Huyen, et al. 2004).  
In contrast, Sanders et al. show that set9-mediated methylation of H4K20 is necessary for 
crb2 recruitment (Sanders, et al. 2004).  Subsequently, Botuyan et al. determined the 
structure of the tandem Tudor domains co-crystallized with a H4K20me2 peptide 
(Botuyan, et al. 2006), and demonstrated the basis for specific recognition of H4K20me2 
by this domain.  It is interesting to note that while fission yeast have the 53BP1 ortholog, 
crb2, involved in DDR and a single H4 K20 methyltransferase, set9, budding yeast do not 
have detectable K20 methylation or an apparent 53BP1 ortholog.  Recently, our lab has 
shown that depletion of SUV4-20, the enzyme which produces most H4K20me2/3 in vivo, 
attenuates 53BP1 foci formation (Yang, et al. 2008), demonstrating the importance of 
K20me2 for 53BP1 recruitment.  Therefore, 53BP1 functions in an alternative DDR 
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pathway independent of the MRN complex.  The initial recruitment of 53BP1 does not 
depend on other proteins like NBS1, ATM or DNA-PK (Schultz, et al. 2000), although 
further accumulation is dependent on H2A.X and MDC1 (Adams and Carpenter 2006, 
Celeste, et al. 2003, Ward, et al. 2003).  53BP1 is able to induce autophosphorylation and 
activation of ATM and ATR (DiTullio, et al. 2002), and thus may promote the activity 
and accumulation of the MRN complex. 
What is the function of 53BP1 aside from its methyl lysine binding property?  It has 
been reported that 53BP1 can promote NHEJ (Dimitrova, et al. 2008), and relax and 
mobilize chromatin via the recruitment of EXPAND1 (Huen, et al. 2010).  NHEJ plays 
an important role in V(D)J recombination and class switch recombination (CSR).  V(D)J 
recombination is critical for the early development of B and T lymphocytes, whereas 
CSR is induced to further modify diversity of antibody in B cells in response to antigen 
(Dudley, et al. 2005, Stavnezer, et al. 2008).  Both processes involve the induction of 
double-strand breaks and their repair by nonhomologous end-joining.  CSR and V(D)J 
recombination lead to diversification of immunoglobulin (Ig) genes and take place in G1 
phase of cell cycle when canonical HR is not available.  While CSR alters the Ig effector 
function (fragment-crystallizable region, Fc), V(D)J recombination alters antibody 
specificity (fragment-antigen binding region, Fab).  In CSR, this process in initiated by the 
activation-induced cytidine deaminase (AID), an enzyme which deaminates cytidines in 
single-stranded DNA of the switch region of Ig genes that are exposed during 
transcription.  V(D)J recombination is initiated by recombination activating gene-1/2 
(RAG-1/2), enzymes to generate DSBs.  The AID-induced deamination of cytidine 
causes a U/G mismatch, which is processed further to DSB through base excision and 
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mismatch repair pathways.  Switch region DSBs are acquired in G1 phase of the cell 
cycle and are repaired by either classical NHEJ (C-NHEJ) or alternative NHEJ (A-NHEJ).  
A-NHEJ is a poorly characterized EJ pathway(s) that includes backup-NHEJ (B-NHEJ) 
(Wang, et al. 2003), microhomology-mediated EJ (MMEJ) and single strand annealing 
(SSA) (McVey and Lee 2008) and is independent of the core components of C-NHEJ.  I 
focus on C-NHEJ hereafter in my thesis.  C-NHEJ is mediated by the Ku70/Ku80/DNA-
PKcs and ligase IV/XRCC4 pathway discussed above.  Deficiency of any of these factors 
impairs CSR or V(D)J recombination, causing severe combined immunodeficiency.  
Cells with 53BP1 deletion show increased DNA resection, which in turn favors repair by 
the microhomology-mediated A-NHEJ pathway, indicating that 53BP1 limits resection 
activity at DNA free ends (Bothmer, et al. 2010).  Intriguingly, 53BP1 has also been 
implicated in the decision for HR versus NHEJ pathways (Xie, et al. 2007), and resected 
DNA also favors HR pathway selection.  Although, it is still unknown how 53BP1 limits 
the nuclease(s) responsible for resection, these studies indicate that 53BP1 favors C-
NHEJ.  Although some evidence places 53BP1 downstream of MRN/ATM, other studies 
indicate that the initial recruitment of 53BP1 may be independent of ATM, NBS1 and 
DNA-PK (Haince, et al. 2007, Schultz, et al. 2000), even though accumulation of 53BP1 
at DSBs depends on H2A.X and MDC1 (Celeste, et al. 2003, Ward, et al. 2003). 
1.10 Classification of histone deacetylases 
In humans, at least 18 members of histone deacetylases (HDACs) have been 
identified and classified into four classes based on their homology to yeast orthologs 
(Haigis and Guarente 2006, Yang and Seto 2008). 
Class I HDACs are orthologs of Rpd3 in S. cerevisiae and Clr6 in S. pombe, and 
include HDAC1, 2, 3 and 8.  They are relatively small nuclear HDACs (~50 KDa), 
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except for HDAC3, which is a unique member among class I HDACs due to its ability to 
shuttle between nucleus and cytoplasm (Yang, et al. 2002). 
Class II HDACs are orthologs of hda-1 in S. cerevisiae and Clr3 in S. pombe, and 
include HDAC4, 5, 6, 7, 9 and 10, which can be further classified to class IIa (HDAC4, 5, 
7 & 9) and IIb (HDAC6 & 10).  Compared to class I HDACs, they are larger in size (> 
100 KDa).  Class IIa HDACs have a longer N-terminal extension containing binding 
domains for myocyte enhancer factor-2 (MEF2) and 14‑3‑3 proteins; unlike class IIa 
HDACs, HDAC6 has tandem deacetylase domain and a zinc finger in the C-terminus, 
and is a major cytoplasmic deacetylase.  HDAC10, the other class IIb HDAC, contains 
the deacetylase domain, which is similar to the first one in tandem deacetylase domain of 
HDAC6. 
Class III HDACs (Sirtuin, SIRT1-7) are homologues to SIR2 in S. cerevisiae.  
Among these members, SIRT1, 2, 3 and 5 have a NAD+-dependent deacetylase domain 
and catalyze the deacetylation of histone and non-histone proteins while SIRT4 and 6 
have a NAD+-dependent ADP-ribosylation domain and catalyze protein ribosylation.  
Enzymatic activity of SIRT7 remains unclear to date.  SIRT1, 6 and 7 are nuclear 
proteins; SIRT2 resides in cytoplasm whereas SIRT3, 4 and 5 are found in mitochondria. 
The only member of class IV HDACs, HDAC11, shows certain sequence similarity to 
both class I and II HDACs; however, phylogenetic analysis indicates that this deacetylase 
and its homologues belong to a separate class (Gregoretti, et al. 2004).  Although it is 
highly conserved from C. elegans and D. melanogaster to humans, there is not much 
known about its regulations and functions. 
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1.11 Histone deacetylases and acetyltransferases involved in DDR 
Several lines of evidence suggest that histone acetylation plays roles in DDR.  
Histone deacetylase inhibitors (HDACi) have been widely used as sensitizing agents for 
treatments involving DNA damage (Dos Santos, et al. 2008, Hajji, et al. 2010, 
Sankaranarayanan, et al. 1990, Smith 1986, Smith, et al. 1985, Stoilov, et al. 2000) and 
multiple histone acetyltransferases and deacetylases have been implicated in the DDR. 
MOF and Tip60, two major HATs responsible for K16 acetylation, have been linked 
to multiple aspects of the DDR including phosphoinositide 3-kinase-like kinase (PI3KK) 
activation, apoptosis and signal turnover.  siRNA knockdown of MOF or expression of 
dominant-negative forms of MOF suppresses ATM autophosphorylation and decreases 
levels of p53 and Chk2 phosphorylation after IR treatment (Gupta, et al. 2005).  However, 
these finding are contradicted by another study which indicates that MOF-depleted cells 
show higher basal ATM autophosphorylation, a sign of checkpoint activation, and 
delayed formation of phosphorylated ATM foci, possibly indicating delayed repair 
kinetics after IR-induced DNA damage (Taipale, et al. 2005).  In contrast, exogenous 
expression of a catalytically inactive mutant of the Tip60 acetyltransferase impairs DDR 
and the regulation of apoptosis (Ikura, et al. 2000).  The role of Tip60 in DDR is further 
supported by the evidence that knockout of one of proteins complexed with Tip60, 
TRRAP, impairs 53BP1 foci formation, but not MDC1 foci (Murr, et al. 2006).  Tip60 
along with TRRAP is also associated with ATM and DNA-PKcs, and is required for 
DNA-PKcs autophosphorylation (Jiang, et al. 2006).  Similarly, MOF interacts with 
ATM (Gupta, et al. 2005) and DNA-PK (Sharma, et al. 2010).  Interaction between Tip60 
and PI3KK affects their respective activities; HAT activity of Tip60 can be promoted by 
interaction with the FACT domain of ATM, and in turn acetylation of ATM by Tip60 
 25
promotes ATM activation (Sun, et al. 2005, Sun, et al. 2007).  Besides direct interactions 
between ATM and Tip60, recognition of histone H3 K9 methylation via the chromo 
domain of Tip60 also are involved, as suggested by evidence that ATM 
autophosphorylation is suppressed in suv39h1/2-knockout cells (Sun, et al. 2009).  In 
addition to trigger activation of the DDR, Tip60-mediated acetylation promotes H2A.X 
turnover after DNA damage (Ikura, et al. 2007, Jha, et al. 2008, Kusch, et al. 2004), 
suggesting the possibility that K16ac may negatively regulate DNA damage responses by 
promoting turnover of 53BP1. 
Multiple HDACs have been implicated in the DDR.  An increase of global HDAC 
activity is rapidly induced after IR (Kim, et al. 1999).  Knockdown of members of the 
sirtuin family of HDACs reduces survival after DNA damage (Matsushita, et al. 2005).  
SIRT1 activity increases upon ionizing radiation (IR) treatment in a CK kinase-dependent 
manner (Kang, et al. 2009) and SIRT1 is also able to activate the NBS1, a component of 
the MRN complex, by deacetylation (Yuan, et al. 2007).  Upon IR-induced DNA damage, 
protein phosphatase 1 (PP1) is activated via an ATM-dependent dephosphorylation (Guo, 
et al. 2002), and subsequently dephosphorylates HDAC1 to facilitate its release from 
inhibitory complexes of PP1-Rb (Guo, et al. 2007).  Direct association between HDAC1 
and ATM has also been reported (Kim, et al. 1999), while HDAC2 associates with ATR 
(Schmidt and Schreiber 1999).  The biological significance of these associations 
remained unknown for the past decade.  Recently, it has been reported that both HDAC1 
and HDAC2 facilitate the end-joining (Miller, et al. 2010).  The DDR is also involved in 
telomere maintenance and one telomere binding protein, TRF2, also forms complexes 
with HDAC1 and HDAC2 (Zhou, et al. 2009), supporting the notion that 
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HDAC1/HDAC2 are involved in DDR pathways.  Moreover, deletion of HDAC3 causes 
delayed cell cycle progression and cell cycle-dependent accumulation of DNA damage 
(Bhaskara, et al. 2008).  DNA damage induces HDAC4 nuclear translocation (Basile, et 
al. 2006) and also ATM-dependent association with 53BP1, events which are implicated 
in G2 checkpoint signaling and preserving cell viability (Kao, et al. 2003).  How DNA 
damage-induced HDAC4 nuclear translocation is regulated is still unclear; however, it 
has been reported that protein phosphatase 2A (PP2A) dephosphorylates serine 298 of 
HDAC4 and promotes HDAC4 nuclear import (Paroni, et al. 2008).  Given that HDAC1 
is dephosphorylated and activated by PP1 following DNA damage, it is possible that 
HDAC4 may be activated by dephosphorylation mediated by PP2A.  Inhibition of 
HDAC6 is associated with the accumulation of topoisomerase inhibitor-induced H2A.X 
phosphorylation and Chk2 phosphorylation (Namdar, et al. 2010), although the biological 
significance of these events is unknown.  Furthermore, it has recently been demonstrated 
that HDAC9 and HDAC10 are required for HR using a plasmid-based assay (Kotian, et 
al. 2011), but little is known about the substrates of these enzymes in this context.  Taken 
together, the regulation and roles of acetylation/deacetylation share similarities with those 
of the temporal and spatial aspects of regulation by phosphorylation/dephosphorylation.  
Of special note, among the studies mentioned above, histone H4 K16 has been reported 
to be a preferred substrate for MOF, Tip60 and SIRT1/2 (Kimura and Horikoshi 1998, 
Taipale, et al. 2005, Vaquero, et al. 2004, Vaquero, et al. 2006).  Together, the data 
discussed above prompted me to investigate the role of K16ac during DNA damage 
responses, since little was known about whether K16ac mediates any specific functions in 
the DDR.  Recent evidence suggests that both proper assembly and disassembly of 
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damage-associated foci are required for normal repair (Chowdhury, et al. 2005, Ikura, et 
al. 2007, Kusch, et al. 2004, Shi, et al. 2008), suggesting the possibility that K16ac could 
function at multiple stages to regulate the progress of DDR rather than serving only to 
terminate damage-induced signaling.  Given the roles suggested for 53BP1 studies in 
end-joining (Bothmer, et al. 2010, Xie, et al. 2007) and evidence that the chromatin 
association of 53BP1 is regulated by H4 K20 methylation (Sanders, et al. 2004, Yang, et 
al. 2008), and that NHEJ is repressed by hyperacetylation (Murr, et al. 2006), I focused 
on investigating whether links existed between H4 K16 acetylation & K20 methylation 
that were relevant for the regulation of NHEJ. 
1.12 Potential significance for human health 
It is reasonable to propose that the magnitude, and possibly even the nature, of the 
effects of K16ac on DDR or other processes may differ between cell types or 
chromosomal regions, due to differences in K16ac levels and the expression and 
functionality of H4-interacting regulatory factors in these contexts.  By completing this 
study, I propose to enhance our understanding of both the physiological and pathological 
aspects of how K16ac affects or regulates DNA damage responses.  Because these 
mechanisms are likely to affect oncogenesis and tumor progression, understanding them 
could inform efforts to develop novel therapeutic strategies. 
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Chapter 2 – Histone H4 Lysine 16 deacetylation in DNA damage 
responses 
2.1 Introduction 
Genome integrity is susceptible to DNA damage, which is attributable to spontaneous 
reactions (especially hydrolysis), specialized cellular processes [V(D)J recombination 
and class-switch recombination], reactive oxygen/nitrogen species generated by 
metabolism and exogenous physical and chemical agents.  DNA lesions can be the 
primary cause of cell death, or the cause of mutations that subsequently affect cell cycle 
control, cell death, or senescence. Therefore, molecular and cellular responses to DNA 
damage are critical for maintaining genome integrity and stability.  Mutations of many 
genes involved in DNA damage responses have been implicated as causes for human 
diseases and for predisposition to cancer (Shiloh 2003, Taylor 2001).  Improper repair 
processes may cause mutations, and a crucial consequence of mutations can be 
inactivation of tumor-suppressor genes and/or activation of oncogenes, either of which 
can lead to uncontrolled cell proliferation. 
Various kinds of damage can occur to DNA, including base modifications, single-
strand break, and double-strand breaks (DSBs); and cells have developed different 
machineries to tackle them.  The consequences and repair of DSBs have been 
investigated extensively, but much remains to be elucidated.  Failure to completely repair 
DSBs can cause cell death or chromosomal rearrangements, including translocations or 
deletions.  In yeast and mammalian cells, recognition of DSBs occurs via Mre11-Rad50-
NBS1 (MRN) complexes.  MRN complexes tether the two free DNA ends at DSBs, and 
initiate signaling that facilitates downstream processes such as cell cycle arrest and 
apoptosis.  Following recognition of DSBs, MRN recruits inactive ATM dimers; ATM is 
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then autophosphorylated and the active monomers released to phosphorylate a variety of 
downstream mediators and effectors—including H2A.X, MDC1, RNF8, RNF168 and 
53BP1.  These recruitments are highly regulated spatially — discrete nuclear foci 
containing high concentration of these proteins form at DSB sites.  Successively, MDC1 
is recruited by H2A.X, followed by recruitment of RNF8 by phosphorylated MDC1.  
RNF8, a ubiquitin E3 ligase, ubiquitinates H2A.X, which later recruits RNF168.  These 
mediators are recruited in a regulated temporal manner and act successively through 
phosphorylation and ubiquitination to cause the local conformational change of 
chromatin.  Currently, it is still unclear what causes the recruitment of 53BP1.  In contrast 
to the recruitment of MDC1, RNF8 or RNF168 by de novo modification (e.g. H2A.X, 
phospho-MDC1 and ubiquitinated H2A.X), it has been proposed that a chromatin 
conformational change is necessary to render H4 K20 accessibility for interaction with 
Crb2/53BP1 (Sanders, et al. 2004).  It has also been reported that the initial recruitment 
of 53BP1 is independent of MRN complexes and PI3KK (Haince, et al. 2007, Schultz, et 
al. 2000), but that further accumulation of 53BP1 at DSBs depends on H2A.X and 
MDC1 (Celeste, et al. 2003, Ward, et al. 2003).  Thus, better understanding of how 
53BP1 recruitment to foci is regulated may shed light on novel mechanisms for sensing 
genotoxic stress in cells.  A recent report suggested that MMSET (NSD2, WHSC1), 
another methyltransferase for histone H4 K20 dimethylation, localizes to DSB sites and 
may contribute to the 53BP1 recruitment (Pei, et al. 2011), suggesting that there may be 
several independent and/or compensatory pathways for 53BP1 recruitment. 
The function of 53BP1 is yet another mystery, although it has been implicated in the 
G2/M checkpoint (Fernandez-Capetillo, et al. 2002, Wang, et al. 2002, Ward, et al. 2003).  
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Other than the cell cycle regulation, two independent groups demonstrated its potential 
role in fine-tuning DNA repair pathways.  Xie et al. demonstrated that 53BP1 
preferentially suppresses the homologous recombination (HR) pathway (Xie, et al. 2007), 
while Bothmer et al. showed that 53BP1 down-regulates resection activity, favoring 
microhomology-mediated end-joining (Bothmer, et al. 2011, Bothmer, et al. 2010).  More 
recently a study indicated that, by increasing the mobility of DNA free ends 53BP1 can 
promote nonhomologous end-joining (Dimitrova, et al. 2008).  The extent to which these 
effects on resection and chromatin mobility represent independent or linked functions of 
53BP1 is not known.  HR also requires resection, but whether 53BP1 represses the HR 
pathway through inhibition of resection activity needs further investigation.   
Posttranslational modifications can occur with high frequency in the N-terminal tail 
of core histones, suggesting that combinations of adjacent modifications may mediate 
molecular events differently than modifications occurring individually.  Early analyses of 
K20 methylation suggested antagonism could occur between K16 acetylation and K20 
methylation.  Assaying enzyme activities in vitro, Nishioka et al. claimed that p300 
preferentially acetylated an unmodified histone H4 peptide compared to K20-
dimethylated H4 peptide and that PR-SET7 (SET8) preferred unmodified H4 compared 
to the K16-actylated H4 peptides (Nishioka, et al. 2002).  Suv4-20h2-mediated K20me3 
also blocks MOF-dependent K16 acetylation (Kapoor-Vazirani, et al. 2011).  In contrast, 
Fang et al. observed synergism, with SET8 preferring to methylate hyperacetylated 
histone H4 (Fang, et al. 2002).  Furthermore, our recent work revealed that K16ac and 
K20me(s) were able to co-occupy in same histone H4 molecule in vivo (Pesavento, et al. 
2008).  Eighty percent of histone H4 was dimethylated on K20; 20% of histone H4 had 
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both acetyl K16 and dimethyl K20, while less than 3% had acetyl K16 alone.  The co-
occupancy of K16ac and K20me2 we observed implied that no antagonistic relationship 
existed between methylases and K16 acetylases.  However, our analyses did not address 
the issue that these sites may intersect at the level of factor "reading" the respective 
modifications.  Since K20 dimethylation is more abundant and stable, I hypothesized that 
K16 acetylation may play a role in regulating K20 accessibility to 53BP1 or other H4-
interaction proteins. 
In the current model of 53BP1 recruitment, K20 methylation plays crucial roles 
during DDR (Sanders, et al. 2004, Yang, et al. 2008).  In this study, I explored potential 
roles of adjacent acetyl K16 on dimethyl K20 recognition by the tandem Tudor domain of 
53BP1, aiming to resolve the paradox of how 53BP1 foci can form transiently given the 
stable and ubiquitous nature of dimethyl K20.  After using bleocin, ultraviolet light or 
hydroxyurea to induce DNA damage, I observed global K16 deacetylation using 
acetylation-specific antisera in both immunofluorescence staining and immunoblotting.  
Comparing multiple cell lines that differ in the basal levels of K16 acetylation revealed 
that these levels were negatively correlated with 53BP1 foci formation after DNA 
damage, implying that K16ac suppresses foci formation by 53BP1.  These results provide 
an alternative model of antagonism in the histone code.  Moreover, the novel modulation 
of 53BP1 by acetyl K16 may also provide a new avenue to inhibit oncogenesis by 
attenuating 53BP1 functions. 
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2.2 Material and Methods 
Reagents 
All reagents used in this study are listed as "(manufacturer, Cat.#)".  Details of 
preparations of buffers and protocols are listed in appendix. 
Cell culture and treatments 
Human tissue-derived cell lines, including HeLa (cervical carcinoma), U2OS 
(osteosarcoma), MCF-7 (breast adenocarcinoma) and HL-60 (promyelocytic leukemia) 
were obtained from the American Type Culture Collection.  The first three cell lines were 
maintained in Dulbecco's Modified Eagle's Medium (DMEM) with 10% fetal bovine 
serum in a humidified atmosphere of 5% CO2 and 95% air at 37°C.  All media used were 
pre-warmed to 37°C.  HL-60 cells were maintained in RPMI-1640.  Cells were cultured 
in T-75 flasks with 20 ml medium.  Medium was changed every 2 days until confluence 
was reached.  For adherent cells, subculture was performed with 0.25% trypsin and cells 
were seeded in 40%-50% confluence.  After 48 h, the confluence reached 80%-90%, and 
desired treatments were performed.  Suspension cells were subcultured by dilution with 
fresh medium.  To induce DNA damage, typically 10 g/ml bleocin (Calbiochem, Cat# 
203408) was applied to cells for 1 h.  For pulse treatment, 10 g/ml bleocin was 
administered for 10 min, after which cells were transferred to a bleocin-free conditioned 
medium and then harvested at the desired time.  Like bleocin treatment, hydroxyurea 
(HU; Avocado Research Chemicals, 10831) was added directly to medium at 5 mM final 
concentration.  Cells received UV irradiation in a UV crosslinker (Spectronics Corp., 
Spectrolinker XL-1500) with desired energy ranging 5-125 J/m2, and then harvested 2 h 
later. 
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SDS-PAGE and Immunoblot 
Cells were harvested by scraping in 1X TBS with protease inhibitor (1 mM AEBSF), 
protein phosphatase inhibitors (1 mM NaF, 1 mM Na3VO4, and 5 nM microcystin LR), 
and histone deacetylase inhibitors (10 mM sodium butyrate and 10 mM nicotinamide) 
using short spins to collect cell pellets.  The pellets were then lyzed in hot 2X sample 
buffer (20 mM Tris-Cl, 20 mM EDTA, 2% SDS, 20% glycerol(v/v), 0.004% 
bromophenol blue and 200 mM DTT, heated at 95°C for 3 min before using) with the 
abovementioned inhibitors.  Typically sonication was required to shear the viscous 
genomic DNA.  Roughly 10-20 g of proteins were loaded on 5% or 15% gels and 
analyzed by SDS-PAGE, and then transferred to a polyvinylidene fluoride (PVDF) 
membrane.  Ponceau S staining (0.4% Ponceau S, 8% TCA and 2% acetic acid) was also 
conducted to verify even sample loading and transfer efficiency.  After blocking in 1X 
TBST with 5% nonfat milk, the membrane was probed with the desired antisera diluted 
in 1X TBST with 0.1% BSA (Table 2.1).  Secondary antibodies were diluted from 1:2000 
to 1:10000 and then subjected to enhanced chemiluminescence (ECL). 
Immunofluorescence staining and image processing 
Protocols were adapted from a previous study (Yang, et al. 2008) with slight 
modifications.  Briefly cells growing on a coverslip were fixed and permeabilized at 
room temperature for 15 min with 4% paraformaldehyde, 4% sucrose, and 0.2% Triton 
X-100 in phosphate-buffered saline, followed by blocking at RT for 1h with 
immunofluorescent blocking buffer (IF blocking buffer; 2% bovine serum album, 2% 
fetal bovine serum and 0.1% Tween-20 in TBS).  Antibodies were prepared in IF 
blocking buffer in the desired dilution (Table 2.1) and applied to coverslips at room 
temperature for 2 h.  Then coverslips were incubated with fluorochrome-conjugated 
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antibody and TO-PRO-3 (1:1000) at room temperature for 1 hour.  Images were acquired 
with Zeiss LSM 710 confocal microscope and processed with ZEN 2009 (Zessie) and 
Cell Profiler 1.0 (Carpenter, et al. 2006).  Quantification of 53BP1 foci number and 
histone H4 acetyl K16 were analyzed from at least 100 cells randomly selected from 
multiple fields. 
Statistical analyses 
All data are expressed as the mean ± S.E.M. and were analyzed by one-way ANOVA, 
followed by Tukey’s test if significant differences were found.  Differences were 
classified as significant when two-tailed analysis gave p < 0.05. 
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Table 2.1 Antibodies used in this study 
Primary antibodies 
Antibody dilution (application) Source Cat. # (Lot #) 
mouse  ATM pS1981 1:1000(IB)  Upstate 05-740 (DAM1493342) 
 1:250(IF)   
mouse  53BP1 1:250(IF) Upstate 05-726 (24568) 
rabbit  53BP1 1:500(IF) Santa Cruz sc-22760 (F0704) 
mouse histone H2A.X pS139 1:2000(IB)  Upstate 05-636 (JBC1353261) 
rabbit histone H3 1:20000(IB)  Abcam ab1791 (624409) 
rabbit  histone H4 K16ac 1:2000(IB)  Upstate 06-762 (31884) 
 1:100(IF) 
rabbit  histone H4 K20me2 1:100(IF)  Abcam ab9052 (482388) 
rabbit  His-tag 1:3000(IB/ELISA) Santa Cruz sc-803 (c2604) 
mouse  FLAG-tag (M2) 1:5000(IB) Sigma F1804 (035K6196) 
 1:500(IF) 
rabbit  FLAG-tag (OctA probe) 1:5000(IB) Santa Cruz sc-807 (J1608) 
 1:500(IF) 
mouse  BrdU 1:100(IF) Thermo Sci MS-1058-P (1058P705A) 
Secondary antibodies 
goat mouse IgG-Alexa 405  Invitrogen A-31553 
goat rabbit IgG-Alexa 405  Invitrogen A-31556 
goat mouse IgG-FITC  Jackson 715-095-150 
goat  mouse IgG-Alexa 488  Invitrogen A-11029 
goat  rabbit IgG-Alexa 488  Invitrogen A-11034 
goat  rabbit IgG-Cy3  Jackson 715-165-152 
goat mouse IgG-Alexa 568  Invitrogen A-11031 
goat rabbit IgG-Alexa 568  Invitrogen A-11036 
goat mouse IgG-Alexa 647  Invitrogen A-54415A 
goat rabbit IgG-Alexa 647  Invitrogen A-21245 
sheep  mouse IgG-HRP  GE Healthcare NA931 
donkey  rabbit IgG-HRP  GE Healthcare NA934 
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2.3 Results 
DNA damage-induced histone H4 K16 deacetylation 
DNA damage responses were evaluated for bleocin treatment in HeLa, U2OS, and 
MCF-7 cell lines.  Bleocin, a member of the bleomycin family of antibiotics, is capable 
of cleaving DNA by being complexed with metal ions such as copper and iron, and by 
generating free radicals (Chen and Stubbe 2005).  Due to the radiomimetic property of 
bleocin, it has been applied as a model for studying DNA double stranded breaks (DSBs) 
(Jackson and Bartek 2009).  The effect of bleocin in this study was initially characterized 
in immunofluorescence microscopy.  One hour post bleocin treatment, 53BP1 
recruitment to DSB sites was evident as a focal staining pattern (Fig. 2.1).  This foci 
pattern is termed ionizing radiation-induced foci (IRIF), which originally described the 
accumulation or recruitment of proteins responding to DNA damage on DNA break ends 
(Carney, et al. 1998).  These foci can occasionally be observed even in cells without 
bleocin treatment, presumably caused by replication-associated DNA damage (Fig. 2.1 
and 2.6B).  Accompanying 53BP1 foci formation, the intensity of K16ac staining 
decreases in both U2OS and MCF-7 cell lines, suggesting that either chromatin 
accessibility changed or that deacetylation had occurred (Fig. 2.1).  To distinguish 
between possibilities, total cell lysates were harvested for SDS-PAGE and 
immunoblotted using K16ac specific antisera.  The result demonstrated that the total 
K16ac level went down, indicating that it was unlikely the change in K16 intensity in 
immunofluorescence staining was caused by a change in K16 accessibility.  In addition, 
phosphorylation of H2A.X, a major ATM substrate, was monitored to provide proof of 
the efficacy of bleocin treatment (Fig. 2.2).  ATM is the master kinase of the DNA  
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Fig. 2.1 Histone H4 K16 deacetylation and 53BP1 foci formation after DNA damage 
U2OS (left panel) and MCF-7 (right panel) cells treated with 10 g/ml bleocin for 1 h 
were stained with antisera against 53BP1 and K16ac.  DNA stained with TO-PRO-3 
served as counterstaining. 
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Fig. 2.2 DNA damage-induced global K16 deacetylation 
U2OS cells were treated with 10 g/ml bleocin for 1 hour and harvested for immunoblot.  
H2A.X and histone H4 K16 acetylation were probed and Ponceau S staining served as 
loading control. 
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sensing  pathway, and it has been reported that 53BP1 is downstream of ATM.  Double 
staining for 53BP1 and pATM showed that both molecules colocalized to adjacent sites 
in nuclei, suggesting they are in the same pathway (Fig. 2.3). 
In addition to bleocin treatment, ultraviolet light (UV) and hydroxyurea (HU) are 
commonly used to induce DNA damage.  Bleocin, UV and HU use different mechanisms 
to induce DNA damage.  Bleocin mediates metal ion-dependent cleavage of DNA, UV 
energy can cause DNA breaks directly together with crosslinking and base modification, 
while HU inhibits ribonucleotide reductase, leading to depletion of dNTPs and replication 
fork collapse.  Potency to induce DNA damage responses were monitored and confirmed 
by ATM phosphorylation and 53BP1 foci formation in immunofluorescence staining and 
H2A.X phosphorylation in immunoblotting (Fig. 2.4 and 2.5).  As observed for bleocin 
treatment, each of these agents induced decreases in the K16 acetylation signal in 
immunofluorescence microscopy and immunoblots of whole cell lysates, suggesting that 
decreased K16 acetylation may be an early event for DNA damage responses in general. 
Histone H4 K16 acetylation suppresses DNA damaged-induced 53BP1 foci 
formation 
Objective and high throughput quantification of 53BP1 foci number was required to 
evaluate how 53BP1 recruitment is regulated.  A few problems that complicated 
achieving this goal were encountered at beginning of this study.  Smaller foci and/or high 
background in the nucleoplasm complicated software recognition of foci.  Similarly, 
proper counting of multiple foci when they tend to fuse with each other was also a 
problem.  To solve the first problem, three common protocols for immunofluorescence 
staining that differ in the order of fixation and permeabilization were compared.  Most 
protocols do fixation and then permeabilization/extraction (F→P) (Fig. 2.6A, right panel).   
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Fig. 2.3 Colocalization of 53BP1 and phosphorylated ATM 
Bleocin-treated (10 g/ml for 1 hour) U2OS cells were co-stained with antisera for 
phosphorylated Ser 1981 of ATM (pATM) and 53BP1.  TO-PRO-3 was used for DNA 
counterstaining.  Signals from individual channels were merged: green for pATM, red for 
53BP1 and blue for DNA. 
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Fig. 2.4 UV-induced histone H4 K16 deacetylation 
(A) U2OS cells exposed to UV at 125 J/m2 were harvested 2 hours later for 
immunofluorescence staining.  Antibody staining for Acetyl K16 and phosphorylated 
ATM were detected by Cy3- and FITC-conjugated secondary antibody, respectively, and 
DNA was counterstained with TO-PRO-3.  (B) U2OS cells were treated with UV-
irradiation as indicated, harvested 2 h later, and immunoblotted for H2A.X-pS139 
(H2A.X) and H4-K16ac.  Bar graphs show the relative intensity of specific band for 
each modification after normalization to the Ponceau S (Ponceau) staining of the H4 band.  
All values represent mean ± SEM.  Asterisks indicate values significantly different from 
the respective control (p<0.05). 
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A. B. 
 
 
 
Fig. 2.5 HU-induced histone H4 K16 deacetylation 
(A) U2OS cells were treated with 2 mM hydroxyurea (HU) for 4 hours and then 
harvested for immunofluorescence staining.  Antibody staining for Acetyl K16 and 
53BP1 were detected by Cy3- and FITC-conjugated secondary antibody, respectively.  
DNA counterstained by TO-PRO-3.  (B) U2OS cells treated with HU as indicated, 
harvested at 4 h, and immunoblotted for H2A.X-pS139 (H2A.X) and H4-K16ac.  Bar 
graphs show the relative intensity of specific band for each modification after 
normalization to the Ponceau S (Ponceau) staining of the H4 band.  All values represent 
mean ± SEM.  Asterisks indicate values significantly different from the respective control 
(p<0.05). 
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Fig. 2.6 Optimization of quantification for 53BP1 foci 
(Continued on next page) 
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Fig. 2.6 Optimization of quantification for 53BP1 foci (continued) 
(A) Diagram to illustrate and compare three different fluorescence staining protocols.  (B) 
Staining results from three protocols.  (C) Demonstration of the transit analyzing process 
from Cell profiler v1.0.  Typical staining patterns were selected to show the efficiency to 
recognize individual objectives.  Two channels were separated for 53BP1 (for identifying 
foci) and DNA counter-staining (for identifying nuclei).  Distinct objectives were 
identified in different colors. 
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However, this protocol causes an extremely low signal for 53BP1 (Fig. 2.6B, right panel), 
possibly due to masking of the epitope by other proteins.  To resolve this problem, 
another protocol, which does permeabilization and then fixation (P→F) was performed 
(Fig. 2.6A, central panel), and high signal-to-noise (foci-to-nucleoplasm) ratio was 
achieved.  However, the P→F protocol caused more cell detachment (lower cell density) 
and also cell retraction (smaller nuclei) (Fig. 2.6B, central panel).  Thus a protocol 
compromising between these two, which does fixation and permeabilization 
simultaneously (Fig. 2.6A, left panel), was used to improve this issue.  This F/P protocol 
kept the advantages from both F→P and P→F protocols, having overall high signal for 
53BP1, high foci-to-nucleoplasm ratio without affecting cell morphology (Fig. 2.6B, left 
panel). 
The second problem encountered for foci identification was the fusion of foci.  In the 
software tested, ImageJ (Abramoff, et al. 2004) and Image-Pro Plus (Media Cybernetics), 
the foci were identified by highlighting pixels that exceeded a specific threshold signal, a 
measure which does not distinguish foci that are linked/fused from each other.  Although 
manual counting can be used within these software, this has two major disadvantages: 1) 
it is time consuming and makes it impossible to perform batch analyses; 2) bias can be 
generated from one observer to another.  However, a third software, Cell Profiler, 
successfully solved these problems through the use of a shape-dependent recognition 
algorithm (Fig. 2.6C) and pipelined commands.  Of note, only a few tiny foci were not 
recognized as most foci by this program could be quantitated reliably.  After determining 
the 53BP1 foci number, I sought to determine the nature of the relationship between 
K16ac and 53BP1 recruitment.  To address this question, I correlated 53BP1 foci 
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numbers and the K16ac levels across large numbers of cells treated with bleocin.  I 
assumed that if K16ac affects 53BP1 recruitment, there would be a correlation between 
K16ac levels and 53BP1 foci numbers existed in cells after bleocin treatment.  
Intriguingly, the result showed that cells with higher K16ac levels formed fewer 53BP1 
foci (Fig. 2.7), implying that K16ac might play a suppressive role in the bleocin-induced 
recruitment of 53BP1 to DNA damage sites.  In our previous study (Pesavento, et al. 
2008), it was demonstrated that different cell lines vary considerably in K16ac levels.  
This prompted me to ask if the levels of K16ac prior to bleocin treatment would influence 
the recruitment of 53BP1 to DNA damage sites.  Three cell lines were chosen, HeLa, 
U2OS and HL-60, representing low, mediun, and high levels of K16ac, respectively, as 
shown by immunoblots (Fig. 2.8A and B).  The numbers of bleocin-induced 53BP1 foci 
were again inversely correlated to the K16ac levels (Fig. 2.8C and D), supporting the 
hypothesis that K16ac antagonizes DNA damage-induced 53BP1 recruitment.  I also 
performed channel profile analyses for bleocin-treated cells to compare the signals 
corresponding to 53BP1 and K16ac along the selected line regions (Fig. 2.9A and B).  
The peaks in the 53BP1 channels are 53BP1 foci, and it is evident that these foci are 
localized to regions with lower K16ac levels.  Since 53BP1 binds to K20me2, similar 
analyses were done to compare 53BP1 localization with K20me2.  Consistent with our 
previous evidence that K20me2 is highly abundant, K20me2 signal was present across 
the whole nucleus.  Significantly, there was no sign of increased 20me2 at the DNA 
damage sites, implying that localized changes in the abundance of K20me2 levels are not 
a significant factor in the recruitment of 53BP1 (Fig. 2.9C and D). 
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Fig. 2.7 Negative correlation between histone H4 K16 acetylation levels and 53BP1 
foci number 
(A) Bleocin-treated U2OS cells were co-stained with 53BP1 and K16ac for correlation 
analysis.  (B) K16ac intensity and 53BP1 foci number were acquired from multiple fields 
equivalent to (A) using Cell Profiler software.  Approximately 150 cells were analyzed 
from 3 randomly selected regions.  Cells were grouped according to K16ac level as 
indicated on horizontal axis.  The vertical axis represents the number of 53BP1 foci 
formed.  All numbers are expressed as mean ± SEM.  Lettering in the bar graphs in 
panels designates values not significantly different (identical letters) versus those which 
are significantly different (p<0.05) (different letters). 
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Fig. 2.8 K16 acetylation levels determine the strength of DDR 
(Continued on next page) 
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Fig. 2.8 K16 acetylation levels determine the strength of DDR (continued) 
(A) HeLa, U2OS and HL-60 cells were treated with bleocin (10 g/ml) for 1 h and 
harvested for immunoblotting with antisera to H2A.X and K16ac.  Relative 
quantification of the levels of H2A.X and K16ac detected in three independent 
experiments are shown in (B).  (C) HeLa, U2OS and HL-60 cells were treated with 
bleocin (10 g/ml) for 1 h and then stained with antisera to 53BP1.  The mean number of 
53BP1 foci (± S.E.M.) determined by analyzing more than 50 cells for each sample are 
shown in (D).  Lettering in the bar graphs in panels designates values not significantly 
different (identical letters) versus those which are significantly different (p<0.05) 
(different letters). 
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Fig. 2.9 Colocalization profile of 53BP1, acetyl K16, and dimethyl K20 of histone H4 
(Continued on next page) 
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Fig. 2.9 Colocalization profile of 53BP1, acetyl K16, and dimethyl K20 of histone H4 
(Continued on next page) 
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Fig. 2.9 Colocalization profile of 53BP1, acetyl K16, and dimethyl K20 of histone H4 
(continued) 
Bleocin-treated U2OS cells were co-stained for 53BP1 and K16ac (A) or 53BP1 and 
K20me2 (C).  (B) Channel profiles for 53BP1, K16ac, and DNA are shown for the lines 
drawn in (A).  Horizontal axis represents the distance (m), and vertical axis presents the 
relative signal intensity for 53BP1, K16ac, and DNA.  (D) Channel profiles for 53BP1, 
K20me2, and DNA are shown for the lines drawn in (C). 
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2.4 Discussion 
In this study, I demonstrated that K16 deacetylation occurs shortly after DNA damage 
responses induced by bleocin, ultraviolet light and hydroxyurea.  A reliable and unbiased 
analysis pipeline was also established to quantify 53BP1 foci formation induced by DNA 
damage.  This revealed a negative correlation between K16ac levels and 53BP1 
recruitment.  This correlation was evident at level of single cells and when cell types 
differing in K16ac levels were compared.  Together, the data provide strong evidence for 
the hypothesis that K16ac antagonizes 53BP1 foci formation. 
K16 acetylation dynamics during the DDR 
Whether K16 acetylation is up or down-regulated following DNA damage is 
controversial.  Due to the notion that K16 acetylation plays roles in up-regulation of 
transcription and chromatin decondensation, K16 acetylation is generally thought to 
increase the accessibility of damaged DNA to repair machinery.  The notion that K16 
acetylation has a specific role in DNA damage responses has not been extensively 
investigated.  In S. cerevisiae, both H3-K9/14 and H4 (multiple residues) acetylation 
increase after DNA damage within 1 hour (Yu, et al. 2005).  Similarly, K8ac is higher 
around HO endonuclease digestion sites (Downs, et al. 2004).  Downstream effectors or 
functions of these acetylations have not been described.  However, it is reasonable to 
argue that the functions of histone K16 acetylation are different in S. cerevisiae than in 
other eukaryotes since S. cerevisiae lacks methyltransferases for K20, K20 methylation is 
not detectable (Fang, et al. 2002, Nishioka, et al. 2002, Schotta, et al. 2004), and a 53BP1 
ortholog for recognizing methyl K20 is also not apparent (Lancelot, et al. 2007).  In other 
eukaryotes, which have K20 methylation and 53BP1 orthologs, the module of acetyl K16 
may provide specific regulation in the DDR.  Intriguingly, two groups demonstrated that 
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Tip60 (Murr, et al. 2006) and CBP/p300 (Ogiwara, et al. 2011) mediated H4 acetylation 
(residues not specified) increases after I-SceI induced DNA damage in a relative long 
time course (> 10 hours).  In other studies, H2A.X and/or H4 acetylation by Tip60 in the 
late stages of the DDR facilitated H2A.X turnover on the DSB sites, implying a role for 
H4 acetylation in termination of the DDR (Ikura, et al. 2007, Jha, et al. 2008, Kusch, et al. 
2004).  Although these data are consistent with the notion that histone acetylation 
enhances chromatin dynamics, they also provide support for a new role for acetylation in 
DDR, which is to terminate the DDR signal by removing H2A.X from damage sites.  
These observations are actually consistent with my working hypothesis, in which early 
deacetylation promotes the DDR and restored histone H4 acetylation at later times 
terminates the DDR.  Several lines of evidence support this model.  In an early study, 
global HDAC activity was detected within 30 minutes after IR, and histone H4 
acetylation was diminished, although the sites of acetylation were not specified (Kim, et 
al. 1999).  It has been reported that HDAC1 associates with ATM in an IR-dependent 
manner and its activity can be up-regulated by ATM (Guo, et al. 2007, Kim, et al. 1999).  
The functional significance of these observations has only recently been described.  
Using micro-irradiation, Jackson and colleagues demonstrated that K16ac decreases on 
the track of laser-induced DNA damage, and that HDAC1 and HDAC2 are required for 
NHEJ processes (Miller, et al. 2010).  Consistent with this observation, Jazayeri et al. 
showed histone H4 K16 deacetylated around HO endonuclease-induced DNA damage 
sites in budding yeast (Jazayeri, et al. 2004).  Another acetylation site on histone H3, 
lysine K56, which was originally described for its importance in DNA damage responses, 
has recently been shown to be deacetylated upon DNA damage (Battu, et al. 2011).  Thus 
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deacetylation of histones and possibly other proteins may be a general feature of the 
initial stages of DNA damage responses. 
Structural basis for the suppressive role of K16ac 
Clues to the function of K16ac in the DNA damage pathway come from considering the 
interactions of the reader module for dimethylation at the neighboring K20 residue.  The 
structural basis for recognition of dimethyl K20 of histone H4 by the tandem Tudor 
domain of 53BP1 and Crb2 has been determined (Botuyan, et al. 2006).  Recognition of 
dimethyl K20 is basically achieved by the first Tudor domain.  It is not apparent how 
K16 is involved in the interaction between the histone H4 tail and 53BP1 since this 
residue was not visualized in the co-crystal structure.  Only Arg19 and Lys20 can be 
modeled with the first Tudor domain (Fig. 2.10), the region spanning His18 to Lys12 can 
potentially be involved in the interaction through the second Tudor domain.  It has been 
shown that tandem Tudor domains have flexibility to accommodate different methyl 
statuses (Botuyan, et al. 2006, Huang, et al. 2006).  Unlike canonical Tudor domains of 
53BP1, JMJD2A has hybrid Tudor domains, which use both Tudor domains to recognize 
trimethyl lysine (Huang, et al. 2006), implying the second Tudor domain is also involved 
in the interactions.  The second Tudor domain of 53BP1 contains several residues 
including E1543, T1545, S1589, E1591 and Q1592 that potentially are able to form 
hydrogen bonds with K16 of histone H4 (Fig. 2.10).  Acetylation increases the size and 
hydrophobicity of lysine, which together may disturb the original interactions between 
lysine 16 and the Tudor domain.  Further investigations, such as crystallography or NMR 
spectroscopy to compare the interactions of histone H4 dimethyl K20 peptides with and 
without acetyl K16 and the 53BP1 Tudor domain, or site-directed mutagenesis of 
residues on the surface of 53BP1, will be necessary to resolve this issue. 
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Fig. 2.10 Residues of 53BP1 involved in the interaction with acetyl K16 
The structure of the co-crystal of a histone H4 tail and tandem Tudor domain of 53BP1 
(PDB: 2IG0) (Botuyan, et al. 2006) was visualized in UCSF Chimera software (Pettersen, 
et al. 2004).  The molecular surface was plotted and colored according to surface 
hydrophobicity.  Two residues from the histone H4 tail (R19 and K20) are shown at the 
bottom of structure.  Surfaces which may interact with the K16 residue are indicated in 
yellow frames, and the corresponding residues are listed on the left. 
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 Functions of K16ac in DNA damage 
The involvement of epigenetic modifications in the DNA damage response has been 
shown to be of great importance.  One of the best well-known examples is that of histone 
H2A.X serine 139 phosphorylation, which provides an anchor site for MDC1 at an early 
stage of the DDR (Rodriguez, et al. 2003, Stewart, et al. 2003). This allows MDC1 to be 
phosphorylated by ATM in a spatially regulated manner and in turn recruits RNF8, which 
ubiquitinates H2A.X (Huen, et al. 2007, Kolas, et al. 2007, Mailand, et al. 2007).  
Consequently, ubiquitinated H2A.X recruits RNF168, another ubiquitin E3 ligase, to 
ubiquitinate H2A (Stewart, et al. 2009).  These modifications (H2A.X phosphorylation 
and H2A ubiquitination) have been proposed to facilitate a change of chromatin 
conformation that enhances the exposure of the K20 residue and facilitates 53BP1 
recruitment.  These successive steps guarantee that DNA damage signals can be properly 
augmented and activate downstream effectors. 
How do the possible roles of K16ac in the DDR compare to those of H2A.X 
phosphorylation and H2A ubiquitination mentioned above and how do we integrate this 
into the current model for DNA damage responses?  Other proteins involved in the DNA 
damage response may provide some clues.  Cells have multiple options in response to 
DNA damage, including cell cycle arrest, DNA repair, and apoptosis.  These processes 
cooperate (as well as compete) with each other at the cellular and organismic levels to 
maintain genome integrity.  Acetylation of certain proteins can fine-tune these processes.  
Un-acetylated Ku70 favors DNA repair and promotes cell survival, while acetylated 
Ku70 favors apoptosis (Jeong, et al. 2007).  In another example, PCAF- and p300-
mediated p53 acetylation promotes the apoptosis pathway (Liu, et al. 1999), while 
Sir2(SIRT1) can reverse this process (Luo, et al. 2001).  Cells with severe DNA damage 
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can undergo permanent cell cycle arrest or apoptosis, with the repair pathway suppressed.  
When things go wrong, cells with faulty repair may survive and even proliferate despite 
extensive DNA damage, leading to uncontrolled growth and the development of cancer.  
In S. cerevisiae, enhanced histone H4 acetylation was implicated in promoting 
homologous recombination (HR) during HO endonuclease-induced DSBs (Tamburini 
and Tyler 2005).  Given the evidence that 53BP1 promotes NHEJ (Dimitrova, et al. 2008, 
Iwabuchi, et al. 2003), it is reasonable to argue that K16ac may contribute to the selection 
of either HR or NHEJ for DSB repair.  HR occurs only when a homologous sequence is 
available and that is restricted to late S, G2 and M phases of the cell cyle, while NHEJ is 
responsible for repair the majority of DSB.  Although NHEJ is an error-prone repair 
mechanism, it is the key mechanism to help cells survive from the stress of DNA damage.  
Thus the role of deacetylation of K16 is reasonably placed in the same or similar pathway 
to favor cell survival. 
Indirect evidence, such as expression of H4 K16Q to mimic constitutive acetylation 
in S. cerevisiae, also supported the concept that deacetylation of lysine in the histone H4 
N-terminal tail is important for cell survival after ultraviolet light-induced DNA damage 
(Bird, et al. 2002, Megee, et al. 1995).  However, it should be noted that some authors 
have claimed that, instead of mimicking acetylated lysine residues, the K16Q mutant 
resembles an un-acetylated lysine (Bird, et al. 2002).  Since it has been shown that the 
GCN5-knockout phenotype can be rescued by K8Q/K16Q mutants (Zhang, et al. 1998) 
and more recently, the comparison between histone H4 tails with site-specific acetylation 
or K-to-Q mutant shows no significant difference in their capability of weakening the 
nucleosome-nucleosome interaction (Liu, et al. 2011), I prefer the explanation that K16Q 
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mimicks acetylation and thus the deficiency of K16Q observed in ultraviolet light-
induced DNA damage may be interpreted as lacking deacetylation instead of lacking 
acetylation. 
Both hyperacetylation and hypoacetylation have been linked to cancer development.  
Lower K16 acetylation has been implicated in cancer (Fraga, et al. 2005).  Either case can 
significantly affect 53BP1 functions.  Lower levels of K16ac can facilitate 53BP1 
functions such as non-homologous end-joining and cell survival with the associated rich 
of faulty repair — potentially boosting survival of pre-cancerous or cancer cells.  On the 
other hand, K16 hyperacetylation presumably would impair 53BP1 pathway. 
2.5 Conclusion 
In summary, this study shows that K16 deacetylation is a feature of DNA damage 
responses and that the level of K16ac is negatively correlated with the recruitment of 
53BP1 that are formed.  Based on these observations, an appealing hypothesis is that 
acetyl K16 acts a molecular switch to regulate the interaction of H4 K20me2 with 53BP1.  
To further prove or dispute this hypothesis, several issues must be addressed.  First, a 
direct measurement of the interaction between the acetylated histone H4 tail and the 
Tudor domain of 53BP1 should be performed.  In vitro assays – protein pull-down and 
isothermal titration calorimetry (ITC) – and in vivo assays – co-immunoprecipitation and 
FRET – are feasible candidates.  Secondly, evidence is needed which supports a cause-
effect relationship between K16ac and 53BP1.  To this end, treatments which can 
increase or decrease K16 levels can be used to determine if they affect 53BP1 foci.  
Thirdly, functional assays like DNA repair efficiency and/or cell cycle analysis need to 
be performed to assess the significance of K16 deacetylation in the DDR.  Fourth but not 
last, the proteins mediating this K16 deacetylation should be identified.  Knowing the 
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molecular mechanism underlying this deacetylation and how it affects DNA damage 
responses may ultimately allow us to manipulate pathways involved in tumorigenesis.  
The following two chapters will focus on the interaction between 53BP1 and the histone 
H4 tail and the molecular functions of K16 deacetylation, respectively. 
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Chapter 3 – Characterization of the influence of DNA damage-induced 
K16 deacetylation of histone H4 on 53BP1 recruitment 
3.1 Introduction 
In eukaryotes, DNA together with core histones, linker histone and nonhistone 
chromosomal proteins forms multiple levels of chromatin structure.  Many cellular 
processes, including transcription, DNA replication, mitosis and DNA damage repair, are 
modulated in the context of chromatin.  Modulation of chromatin is mediated in part 
through the histone code (Strahl and Allis 2000) — i.e. the usage of different histone 
modifications to specify different functional outcomes.  Recent studies have shown that 
histone modifications (e.g., H2A.X phosphorylation and ubiquitination) facilitate the 
recruitment and accumulation of DNA repair proteins at the DNA damage sites forming 
nuclear foci.  In histone molecules, sites of post-translational modifications are often 
densely clustered, but little is known about the biological functions of histones modified 
at multiple sites. 
The previous chapter focused on characterizing K16 deacetylation during DNA 
damage responses and the negative correlation between 53BP1 foci formation and K16ac 
levels.  53BP1 recognizes dimethyl K20 of histone H4 during DNA damage responses 
(Sanders, et al. 2004, Yang, et al. 2008) and facilitates the nonhomologous end joining 
process (Dimitrova, et al. 2008).  However, the inducible and dynamic nature of these 
foci are not consistent with the evidence that K20me2 is established in the absence of 
DNA damage and is both highly abundant and stable (Pesavento, et al. 2008, Yang, et al. 
2008).  However, based on our observation of DNA damage-induced K16 deacetylation, 
this chapter asks whether it is possible that the binding of 53BP1 to dimethyl K20 is 
regulated by this adjacent K16 deacetylation.  It has been demonstrated that post-
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translational modifications (PTMs) play vital roles in many cellular and molecular 
regulations.  Different PTMs can be cooperative (i.e., additive or synergistic) or 
competitive (i.e., antagonistic) with each other at the same site or at topologically close 
sites.  These characteristics can reflects the properties of the respective modifying 
enzymes and/or those of reader modules.  For interaction at the enzyme level, one of the 
simplest cases is when more than one modification is targeted to the same residue.  For 
example, acetylation, methylation, and ubiquitination can all compete for K382 of p53 
(Dai and Gu 2010).  However, the situation can be more complicated when PTMs at two 
sites are involved since the relationship can be synergistic or antagonistic.  In the case of 
histone H3, prior phosphorylation of serine 10 blocks SUV39H1-mediated methylation at 
K9 and dimethylated K9 suppresses Aurora kinase-mediated serine 10 phosphorylation 
(Rea, et al. 2000).  In the case of p53, K372me inhibits K370me by preventing SMYD2 
binding to p53 (Huang, et al. 2006).  Histone H4 modification sites are closely spaced.  It 
has been reported that acetyl-K8/K16ac hinders HAT-B-mediated K5/K12 acetylation in 
vitro (Makowski, et al. 2001).  R3me facilitates p300-mediated K5/K8 acetylation while 
K5/K8/K12/K16 acetylation suppresses PRMT1-mediated R3 methylation (Wang, et al. 
2001).  These studies illustrate the potential complexity of PTM interactions and 
regulation.  In contrast to these examples involving competition between modifying 
enzymes, my working model proposes an effect involving a PTM reader: K16 serves as a 
switch to control the accessibility of K20me2 to 53BP1.  Thus, this situation differs 
conceptually from previously described examples of histone code. 
Both acetylation and deacetylation are implicated in DNA damage responses.  MOF 
(MYST1) is a major acetyltransferase for K16.  Knockdown of MOF by siRNA results in 
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enhanced formation of phosphorylated ATM nuclear foci and these are retained for 
longer times at DNA damage sites (Taipale, et al. 2005), implying that proper K16 
acetylation is necessary for the disassembly of ATM from foci at DSB sites.  However, 
Pandita and colleagues reported that siRNA knockdown and expression of dominant-
negative MOF suppressed the global levels of ATM autophosphorylation and influenced 
its downstream pathways (Gupta, et al. 2005).  Despite the contradiction between these 
reports, they demonstrate the importance of MOF in the DDR; however, little is known 
about the specific roles of K16 acetylation played in these studies. 
To directly bridge the gap between K16 configuration and 53BP1-mediated events in 
the DDR, I developed an in vitro binding assay to show that the affinity of the 53BP1 
tandem Tudor domain differs for H4 peptides harboring methyl K20 depends on whether 
acetyl K16 is present or not.  Then I used metabolic and drug treatments to elevate K16ac 
levels and observed that 53BP1 foci formation was hindered, indicating antagonism 
between acetyl K16 and dimethyl K20.  Furthermore, siRNA knockdown of MOF and 
replacement of K16 with residues mimicking constitutive acetylation also suppressed 
53BP1 foci formation, supporting the notion that acetyl K16 inhibits dimethyl K20 
recognition by the tandem Tudor domain of 53BP1. 
3.2 Material and Methods 
Total RNA isolation 
Total RNA was isolated with Trizol reagent (Invitrogen, 15596-018) according to the 
manufacturer's instruction.  In brief, culture media was discarded and cells from 3.5 cm 
dishes were lyzed in 350 l Trizol.  Then 175 l of chloroform were added to separate 
the aqueous phase (RNA), interphase (DNA) and organic phase (protein).  The aqueous 
phase was transferred to a new Eppendorf tube to avoid contamination with the DNA and 
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protein fractions.  The RNA was then precipitated by adding 175 l isopropanol and 
incubated at room temperature for 5-10 min.  After pelleting the RNA by centrifugation 
and washing the pellet with ethanol, potential DNA contamination was digested using a 
mixture containing 0.1 U/l RNase-free DNase I (Roche, 776 785), 0.04 U/l RNasin 
(Promega, N2515), 1 mM dithiothreitol (DTT) and 20 mM Tris-HCl pH 8.0 and 
incubation at 37°C for 30 min.  RNA was then recovered using a Qiagen RNeasy column 
(Qiagen 74104).  The RNA was eluted in 50 l of DEPC-treated milli-Q water and the 
concentration estimated from the OD260 value obtained with a NanoDrop 
spectrophotometer (ND-1000, Thermo Scientific). 
Molecular cloning of tandem Tudor domains and human histone H4 
The Tudor domains of 53BP1 (1483-1604 a.a.), JMJD2A (896-1011 a.a.) and  PHF20 
(11-141 a.a.) and full length human histone H4, were cloned from HeLa cell cDNA into 
pCRII (Invitrogen) using primers listed in Table 3.1.  These were then subcloned into the 
pET3 vector (EMD Chemicals) for bacterial expression and pcDNA3 (Invitrogen) for 
mammalian expression.  A FLAG-tag was added and fused to histone H4 N-terminus 
using PCR.  Site-directed mutagenesis was performed using the QuikChange kit 
according to the manufacturer's instruction (Stratagene). 
Plasmid preparation and linearization 
Plasmid preparation was done by following the manufacturer’s instructions 
(QIAprep® Spin Miniprep, Cat# 27106, Qiagen) with minor modifications.  Briefly, 
bacterial lysate, made using buffers P1, P2 and N3, was treated with RNase (50 ng/l) at 
37°C for 20 min before loading on the spin column. 
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Restriction enzyme digestion 
To linearize plasmid DNA, ten to twenty g of eluted plasmid was digested by 10-20 
units of desired restriction enzyme (NEB) in a 10 l of reaction volume at 37°C for 16-18 
hours, and then purified by QIAquick Gel Extraction kit (Qiagen, Cat# 28704). 
Site-directed mutagenesis 
Reactions were set up according to the manufacturer's instruction (Stratagene, 
QuikChange).  Typically 100 ng of template DNA were used for each PCR reaction (20 
l) and the primers used can be found in Table 3.1.  Dpn I treatment (adding 20 units for 
each PCR reaction) at 37°C for 16-18 hours was used to remove methylated templates.  
Five l of the resulting reaction was used for transformation in E.coli strain of DH5.  
Single colonies were picked up and the sequence flanking the target coding region was 
always sequenced bi-directionally. 
Protein expression in E. coli 
The induction protocol was adapted from the study by Botuyan et al. (Botuyan, et al. 
2006).  E.coli strain BL21(DE3) was transformed with the desired constructs.  E. coli 
were then grown in 3 ml of Luria-Bertani (LB) broth at 37 ° C until reaching 
approximately O.D.600 of 0.6.  The cultures were then transferred to 150 ml of 2x YT and 
1 mM isopropyl β-D-thiogalactoside was applied after reaching O.D.600 of 0.6.  Cultures 
were then incubated at 18°C with agitation at 225 rpm for 16-18 h.  After centrifuging at 
1000 xg, the bacterial pellet was collected and resuspended in His-binding buffer (50 mM 
phosphate, 300 mM NaCl, and 500 mM imidazole).  After 25-30 pulses of sonication, the 
lysates were stored at -80°C for further processes. 
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Immobilized metal ion affinity chromatography (IMAC) for 6X His-tagged 
protein purification 
Based on the manufacturer’s instruction (Chelating Sepharose Fast Flow, 17-0575-01, 
GE), the desired amount of beads was washed with 2 bed volumes (BV) of water, and 
then incubated with 0.2 BV of 0.2 M nickel chloride for 30-60 minutes at room 
temperature.  Excess/unbound nickel ion then was washed from the beads using at least 5 
BV of water.  At least 5 BV of acid buffer (0.02 M sodium acetate, pH 4.0, 0.5 M sodium 
chloride) was then applied to remove loosely bound nickel ions, ensuring that the pH of 
the consequent effluent was pH 4.0.  After equilibration in 2 BV of His-binding buffer 
(50 mM sodium phosphate, pH 7.5, 300 mM NaCl and 5 mM imidazole), sonicated 
bacterial lysates containing soluble Tudor protein were loaded on the beads.  Typically, 
bacterial lysate was prepared by sonication and stored in His-binding buffer at -80°C 
(concentration approximately 50 O.D. per ml).  The ratio of lysate volume (LV)-to-BV 
depends on the expression level of the proteins of interest, and was adjusted empirically.  
With rotation, the beads were incubated with lysates at room temperature for 1 hour.  The 
resulting supernatant was collected for the unbound control.  One LV of washing buffer 
(50 mM sodium phosphate, pH 7.5, 300 mM NaCl and 20 mM imidazole) was applied to 
wash the beads, and again the resulting supernatant was collected as wash control.  After 
one more wash with washing buffer, the 6x His-tagged Tudor protein was eluted in 1 LV 
(or less) of elution buffer (50 mM sodium phosphate, pH 7.5, 300 mM NaCl and 500 mM 
imidazole).  The purified Tudor proteins were stored at 4°C since it was found that 
freezing caused the 53BP1-TT to become insoluble. 
ELISA 
Peptides corresponding to 15-22 residues of histone H4 were synthesized with desired 
modifications (Biomer Tech) (Table 3.2).  Sequences and purities of these peptides were 
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verified by mass spectrometry and reverse phase chromatography.  Typically, bacteria-
expressed IMAC-purified Tudor protein (50 l of 50 M protein) was incubated at room 
temperature for 1 hour in microplate (Costar, 3590) wells with 100 pmol histone H4 
which were coated in 50 l of coating buffer (0.05 M NaHCO3, pH 9.6) at least one night 
prior to the incubation.  Following incubation with anti-His tag antibody (1:2000, Santa 
Cruz, sc-803) and HRP-conjugated donkey anti-rabbit IgG antisera, a chromogenic HRP 
substrate, OPD (Sigma-Aldrich, P9187) was used to measure the binding of Tudor 
protein to histone H4 peptide at wavelength of 492 nm using a microplate reader. 
Pull-down assay 
Histone H4 peptides were first reduced in 100 mM dithiothreitol (DTT) overnight, 
followed by purification and quantification by reverse phase chromatography.  Then 1 
mg of histone H4 peptides were coupled to a 1-ml bed volume of SulfoLink beads (Pierce, 
Cat. #20402).  Coupling efficiency was carefully monitored by running uncoupled 
peptides through reverse chromatography.  Fifty l of Tudor protein (50 M) was 
incubated with 50 l of histone H4 peptide-coupled SulfoLink beads.  After removal of 
unbound Tudor proteins, the bound Tudor proteins were resolved by 15% SDS-PAGE 
and visualized by immunoblotting. 
Cell culture and treatments 
Human tissue-derived cell lines, including HeLa (cervical carcinoma), U2OS 
(osteosarcoma), MCF-7 (breast adenocarcinoma) and HepG2 (hepatocellular liver 
carcinoma) were obtained from the American Type Culture Collection and maintained in 
Dulbecco's Modified Eagle's Medium (DMEM) with 10% fetal bovine serum in a 
humidified atmosphere of 5% CO2 and 95% air at 37°C.  All media used were pre-
warmed to 37°C.  Cells were cultured in T-75 flasks with 20 ml medium.  Medium was 
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changed every 2 days until confluence was reached, then subculture was performed with 
0.25% trypsin.  Cells were seeded in 40%-50% confluence.  After 48 hours, the 
confluence reached 80%-90%, and desired treatments were preformed.  To induce DNA 
damage, bleocin was typically used at 10 g/ml for 1 hour.  Acetate treatment (NaOAc, 
pH 7.5) was performed for 48 hours with the containers sealed with parafilm to minimize 
acetate vaporization. 
siRNA transfection 
Transfection was conducted according to the manufacturer's instructions 
(Oligofectamine Cat. #12252, Invitrogen).  Cells were seeded in 24-well plates at 50% 
confluence one day prior to transfection.  100 nM dsRNA diluted in Opti-MEM I was 
mixed with Oligofectamine.  After incubation at room temperature for 20 min, the 
mixtures were added to wells.  After 48 h, bleocin treatment was performed. 
Plasmid transfection 
Transfection was conducted according to the manufacturer's instructions (FuGENE 6, 
Roche).  Cells were seeded in 6-well plates at 50-80% confluence one day before 
transfection.  Two g of plasmid diluted in Opti-MEM I (Invitrogen) were mixed with 
FuGENE 6.  After incubation at room temperature for 15 min, the mixtures were added to 
the wells.  After 48 h, bleocin treatment was performed. 
Statistical analyses 
All data are expressed as the mean ± S.E.M. and were analyzed by one-way ANOVA, 
followed by Tukey’s test if significant differences were found.  Differences were 
classified as significant when two-tailed analysis gave p < 0.05. 
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Table 3.1 Primer sequences used in cloning, site-directed mutagenesis and quantitative PCR 
Gene Gene Symbol Access# Primer sequence 
53BP1 TP53BP1 ENST00000263801 (F)GCTTAGATGCCTCCCATATGGGAAATAGCTTTGTAGG 
   (R)AGAGGGGATCCGGATCCTTAGGGGCCAAGCCCATAC 
53BP1 W1495A N/A N/A (F)CCGTGTTGTAGCCAAGGCCTCATCCAATGGCTAC 
   (R)GTAGCCATTGGATGAGGCCTTGGCTACAACACGG 
JMJD2A KDM4A ENST00000372396 (F)CGTGCCAAGGGAAGCTTGCAAAGCATCACTGC 
   (R)CAGTCTGGATCCGGATCCTTAGGGAAGCTCTTCATCCAGTG 
PHF20 PHF20 ENST00000374000 (F)CCTAACAGAAGCTTGATCAGCTTTGAAGTGGGAG 
   (R)TTAGGCCTGGATCCGGATCCTTAATTCTGATCTTTGGAAAAGGCTTTGACATG 
histone H4 HIST2H4A ENST00000369165 (F)CGACAATTGCAATTGAGAGGGACCTGAGCAGAGTGGAGGAGGAGG 
   (R)GGGCCGCGGTAGCTTTCCGTTAACTTCGGATCCGATTGTCGC 
histone H4 K16A N/A N/A (F)CTTAGGCAAAGGGGGCGCTGCTCGCCACCGCAAGGTCTTG 
   (R)CAAGACCTTGCGGTGGCGAGCAGCGCCCCCTTTGCCTAAG 
histone H4 K16Q N/A N/A (F)CTTAGGCAAAGGGGGCGCTCAGCGCCACCGCAAGGTCTTG 
   (R)CAAGACCTTGCGGTGGCGCTGAGCGCCCCCTTTGCCTAAG 
histone H4 K16R N/A N/A (F)TTAGGCAAAGGGGGCGCTCGGCGCCACCGCAAGGTCTT 
   (R)AAGACCTTGCGGTGGCGCCGAGCGCCCCCTTTGCCTAA 
MOFq MYST1 ENST00000219797 (F)GATCCACATCGGGAACTAC 
   (R)GGACGAGTGGGTAGACAAG 
53BP1q TP53BP1 ENST00000263801 (F)ACCCATGATCCCATACTTG 
   (R)GGCAACAGACTCAGCAAC 
DNA-PKcsq PRKDC ENST00000314191 (F)ATGTCCCAAGAGGAGAAGG 
   (R)GCCACCATAAAGTTGTTCAG 
18S rRNAq RN18S1 X03205 (F)GTGTGCCTACCCTACG 
   (R)TGACCCGCACTTACTG 
 
q:for quantitative PCR 
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Table 3.2 Histone H4 peptides 
 
Peptide Corresponding Sequence Molecular 
 region & modifications weight 
No Modification (No Mod) 15-22 CAK RHRK VL 1110.4 
K20me1 15-22 CAK RHRK(me1) VL 1124.4 
K20me2 15-22 CAK RHRK(me2) VL 1138.4 
K20me3 15-22 CAK RHRK(me3) VL 1152.5 
K16ac/K20me1 15-22 CAK(ac) RHRK(me1) VL 1166.5 
K16ac/K20me2 15-22 CAK(ac) RHRK(me2) VL 1180.5 
K16ac/K20me3 15-22 CAK(ac) RHRK(me3) VL 1194.5 
 
Peptide sequences are written from N to C terminus.  Lysines 16 and 20 are bold, with 
modifications shown in parentheses (ac for acetylation; me1, me2, and me3 for mono-, di-, and 
trimethylation, respectively).  Shaded amino acid is extra residue added to facilitate coupling to 
supports. 
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3.3 Results 
Histone H4 K16 acetylation antagonizes recognition of methyl K20 by the 53BP1 
Tudor domains in vitro 
Based on the negative correlation between K16 acetylation and 53BP1 foci formation 
described in Chapter 2, I hypothesized that acetyl K16 may antagonize the recognition of 
methyl K20 by 53BP1.  To test this idea, the most direct evidence is to measure the 
interaction between these two molecules.  To this end, an in vitro binding assay was 
performed.  The conditions for induction of tandem Tudor domain of 53BP1 (53BP1-TT) 
were tested including induction temperature and culture medium for E.coli strain BL21 
(DE3).  53BP1-TT was expressed well in either LB or 2X YT medium, whereas H4 was 
expressed well only in 2X YT media.  A lower induction temperature of 18°C increased 
the yield of soluble 53BP1-TT (Fig. 3.1A).  The attachment of 6X His-tag to 53BP1-TT 
allowed convenient purification by immobilized metal affinity chromatography (IMAC).  
A single IMAC step was sufficient to isolate highly purified 53BP1-TT from crude 
bacterial lysates (Fig. 3.1B). 
Peptides corresponding to the N-terminal tail of histone H4 were synthesized with 
different combinations of acetyl K16 and methyl K20 (Table 3.2).  The wild-type Tudor 
domain from 53BP1 showed relatively high affinity for both monomethyl and dimethyl 
K20 peptides, while it had lower affinity for peptides with any methyl K20 combined 
with acetyl K16 (Fig. 3.2A).  Results from pull-down assays confirmed this antagonism, 
in which adjacent acetyl K16 disrupted binding of 53BP1 to mono-/di-methyl K20 (Fig. 
3.2D).  A point mutant of 53BP1-TT, 53BP1-TT(W1495A) which does not bind K20 
me1/me2 was also included as a negative control (Botuyan, et al. 2006) (Fig. 3.2B).  In  
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A. 
 
B. 
 
Fig. 3.1 Expression and purification of Tudor domain 
(A) T7 promoter-driven expression of 53BP1-TT was induced by 1 mM IPTG at either 
37°C or 18°C.  Two media, LB and 2X YT(YT) were also tested for induction efficiency.  
Supernatant (S) and pellet (P) made from sonicated bacterial lysate were used to examine 
the solubility of 53BP1-TT.  (B) The soluble fraction of 53BP1-TT was further purified 
by IMAC.  Pre-purified crude lysate served as positive control (+); unbound fraction and 
washes showed no 53BP1-TT.  The elutant from 1st and 2nd elution showed an intense 
band of 53BP-TT (indicated by an asterisk).  Numbers labeled on the top of gel indicate 
the lysate-to-beads ratio in IMAC. 
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Fig. 3.2 Acetyl-K16 hinders methyl-K20 recognition by 53BP1 Tudor domain 
(Continued on next page) 
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D. 
 
 
 
Fig. 3.2 Acetyl-K16 hinders methyl-K20 recognition by 53BP1 Tudor domain 
(continued) 
Histone H4 peptides with combinations of modifications were coated on 96-well plates 
(100 pmol/well) and then incubated with bacterial-expressed 6X-His tagged Tudor 
proteins, (A) 53BP1-wild-type, (B) 53BP1-W1495A, and  (C) JMJD2A, followed by 
detection of anti-His tag antibody.  (D) The pull-down assay was conducted in a similar 
manner.  Histone H4 peptides were first coupled to sepharose beads and then incubated 
with 53BP1-TT protein.  After removal of unbound proteins, elutants were resolved by 
15% SDS-PAGE and probed by anti-His tag antibody. 
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addition to binding of methyl lysine, Tudor-containing proteins have also been shown to 
bind methyl arginine (Cote and Richard 2005) and RNA (Ponting 1997).  Among these 
proteins, JMJD2A and PHF20 have also been suggested to bind to methyl K20 of histone 
H4 (Kim, et al. 2006).  I attempted to purify tandem Tudor domains of JMJD2A and 
PHF20 to test if acetyl K16 antagonized methyl K20 recognition by these other Tudor 
containing proteins.  However, I found that PHF20-TT was insoluble in bacteria and 
further experiments were not pursued.  On the other hand, the JMJD2A-TT was soluble, 
but purified protein showed an unexpectedly high affinity for unmodified and 
monomethyl K20 peptides (Fig. 3.2C), contradicting a previous report that suggested a 
binding preference for trimethyl K20 (Lee, et al. 2008).  This discrepancy may result 
from different folding of the fragments expressed in these cases.  Regardless of this 
potential folding issue, the binding of JMJD2A-TT to monomethyl K20 was suppressed 
by the adjacent acetyl K16 (Fig. 3.2C). 
Taken together, these results support the notion that acetyl K16 hinders the 
recognition of methyl K20 by 53BP1-TT, and suggest a possible common regulatory 
mechanism for regulating the interaction of Tudor-containing proteins with methylated 
proteins.  Moreover, it provides a possible mechanism for the negative correlation 
between 53BP1 foci formation and K16 acetylation I observed in vivo. 
DNA damage-induced 53BP1 foci formation is impaired by K16 acetylation in vivo 
The levels of H4 K16 acetylation and K20 dimethylation varies markedly among 
different cell lines (Pesavento, et al. 2008).  While most of the cell lines tested had 80% 
of histone H4 with K20 dimethylation, the histone H4 with K16 acetylation ranged 
approximately from 25% to 60%.  Intriguingly, K16ac almost accompany K20me2, 
ranged 20% to 50% of total molecules.  This observation raised the question of whether 
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cells with different K16 acetylation would have different 53BP1 recruitment upon DNA 
damage.  I demonstrated in Chapter 2 (Fig. 2.8) that this does appear to the case, but 
arguments may be raised that other factors are responsible for this difference of 53BP1 
foci formation.  To answer this question in an isogenic background, I added acetate to 
increase the production of acetyl-coA (which is the donor of acetyl groups for histone 
acetyltransferases) and thereby to enhance K16 acetylation ((Wilhelm and McCarty 1970) 
and Pesavento, J. J., unpublished data).  Assessment by either immunoblot or 
immunofluorescence staining showed the dose-dependent effect of acetate on K16 
acetylation (Fig. 3.3).  After 48 h of treatment with acetate, bleocin was applied to induce 
DNA damage.  Individual U2OS cells were analyzed to determine the number of 53BP1 
foci formed and the intensity of K16 acetylation; cells with higher pre-damage K16 
acetylation formed fewer 53BP1 foci (Fig. 3.3C and D).  These results support my 
hypothesis that adjacent K16 acetylation regulates K20 accessibility to 53BP1, and also 
imply that cells/tissues with different basal levels of K16 acetylation may have different 
responses/sensitivities to DNA damage. 
Altering epigenetic markers (such as histone acetylation) has gained attention as a 
possible cancer therapy.  Various kinds of compounds are used to modulate the activities 
of enzymes involved in epigenetic modifications.  One group of these compounds are 
histone deacetylase inhibitors (HDACi).  It has been reported that HDACi can sensitize 
tumor cells to DNA-damaging agents (Chen, et al. 2007, Lin, et al. 2008, Munshi, et al. 
2005).  Given that 53BP1 is one of the key mediators of the DDR, and given the 
antagonistic effect of acetyl K16 on the accessibility of dimethyl K20 to 53BP1, HDACi  
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Fig. 3.3 Upregulated K16 acetylation by metabolic treatment suppresses DNA 
damage-induced 53BP1 foci formation 
(Continued on next page) 
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Fig. 3.3 Elevated K16 acetylation by metabolic treatment suppresses DNA damage-
induced 53BP1 foci formation (continued) 
(A) Sodium acetate (NaOAc) and sodium chloride (NaCl) were administrated to increase 
acetate and to balance osmotic pressure respectively, at indicated concentrations shown.  
After 48 h, cells were processed for immunoblotting with K16ac antibody; histone H3 
served as loading control.  (B) Bleocin (10 g/ml) was applied to acetate-pretreated 
U2OS cells for 1 h.  Then cells were stained for K16ac and 53BP1.  53BP1 foci number 
(C) and K16ac intensity (D) were quantified from more than 100 cells in multiple 
randomly-selected regions.  All numbers are expressed as mean ± SEM. 
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may exert its sensitizing effect in part by repressing recruitment of 53BP1.  To test this 
hypothesis, cells were treated with either class I/II [butyrate (NaB) & trichostatin A 
 (TSA)] or class III HDAC [nicotinamide (NAM) and salermide (SLM)] inhibitors.  
Bleocin was applied following 16 hours of pretreatment with HDAC inhibitors.  
Consistent with the results of the metabolic treatment using acetate, class I/II HDAC 
inhibitors decreased the bleocin-induced 53BP1 foci number (Fig. 3.4).  To exclude the 
possibility that the metabolic or HDAC-mediated treatment affected 53BP1 recruitment 
by altering the acetylation of proteins other than H4,  I used siRNA to knock down the 
K16-specific histone acetyltransferase MOF (Fig. 3.5A) and showed that 53BP1 foci 
number was increased by this treatment (Fig. 3.5B). 
Although only a few substrates of MOF are known, I wanted to get more direct 
evidence that K16ac regulated 53BP1 foci formation.  FLAG-tagged histone H4 with 
different Q or R substitutions for K16 were expressed in HeLa cells and the effect on 
53BP1 foci formation was analyzed.  The data indicate that K16Q suppressed 53BP1 foci 
formation, while K16R had little or no effect (Fig. 3.6).  To further confirm that the result 
that butyrate treatment suppressed 53BP1 foci formation (Fig. 3.4) was attributable to 
K16 hyperacetylation, cells expressing exogenous FLAG-H4 were treated with butyrate, 
followed by bleocin treatment.  The results demonstrated that butyrate attenuated 53BP1 
foci formation in cells expressing wild-type histone H4, but not in K16R cells, 
confirming the pivotal role of K16 in 53BP1 recruitment (Fig. 3.7).  Taken together, these 
data demonstrate that K16 deacetylation facilitates 53BP1 recruitment during the DDR. 
Acetylation at lysine 16 is the major acetylation site of histone H4 (Thorne, et al. 
1990) and is thought to precede acetylation of K5, K8 and K12 in histone H4 (Fig. 1.2A).   
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A. 
 
B. 
 
Fig. 3.4 HDAC inhibitors suppress 53BP1 foci formation 
(A) U2OS cells were pretreated with HDACi – 10 mM butyrate (NaB), 250 nM TSA, 20 
mM nicotinamide (NAM) or 25 M salermide (SLM) – for 16-18 hours followed by 1 h 
of bleocin treatment (10 g/ml). Cells were stained for 53BP1.  (B) Quantification of 
53BP1 foci number expressed as mean ± SEM. 
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Fig. 3.5 MOF knockdown potentiates 53BP1 foci formation 
HeLa cells were transfected with siRNA against luciferase (suLuc, control) or the K16-
specific acetyltransferase MOF (siMOF).  72 hours after transfection, cells were pulse-
treated with bleocin (10 g/ml) for 10 min and harvested for staining with antisera to 
53BP1 at the times indicated (B, C).  Knockdown efficiency was checked by RT-PCR (A) 
and the effect of MOF-knockdown on K16ac evaluated by immunoblotting (B).  All 
numbers are expressed as mean ± SEM. 
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Fig. 3.6 53BP1 foci formation is suppressed by H4K16 mutation that mimic 
acetylation 
(A) HeLa cells transfected for 48 h with wild-type FLAG-H4 (WT), K16Q or K16R point 
mutants (16Q, 16R) were treated with bleocin (10 g/ml) for 1 hr and then stained with 
antisera to 53BP1 and the FLAG-tag.  More than 30 cells were analyzed to determine the 
mean number of 53BP1 foci per cell plotted in the lower panel (B).  All numbers are 
expressed as mean ± SEM.  Lettering in the bar graphs in panels designates values not 
significantly different (identical letters) versus those which are significantly different 
(p<0.05) (different letters).  
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A. 
 
B. 
 
Fig. 3.7 H4K16 mutation that mimics deacetylation alleviates suppression of 53BP1 
foci by sodium butyrate 
HeLa cells were transfected for 48 h with wild-type FLAG-H4 (WT) or the K16R point 
mutant and butyrate (10 mM) was applied for the last 16 h.  Bleocin (10 g/ml) was then 
added and after 1 h cells were harvested for staining with antisera to 53BP1 and the 
FLAG-tag.  All numbers are expressed as mean ± SEM.  Lettering in the bar graphs in 
panels designates values not significantly different (identical letters) versus those which 
are significantly different (p<0.05) (different letters). 
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To better understand this DNA damage-induced deacetylation process, I also evaluated 
K5, K8 and K12 acetylation levels to see if K16 is the only residue affected.  Bleocin-
treated cells showed decreased acetylation at both K8 and K12 residues.  Data for K5 was 
not available due to the poor sensitivity of antisera available (Fig. 3.8A).  Interestingly, 
replacement of either K12 or K16 residue to glutamine (Q), which mimics the 
constitutive acetylated lysine, attenuated the 53BP1 recruitment (Fig. 3.8B), whereas 
replacement of K5 or K8 had no effect, indicating that the interaction surface of 53BP1-
TT may be large enough to involve K12. 
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Fig. 3.8 Differential impact of H4 acetylation sites on 53BP1 foci formation 
(A) U2OS cells were treated with bleocin (10 g/ml) for 1 h prior to immunoblotting 
with antisera to K8ac and K12ac.  (Continued on next page) 
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Fig. 3.8 Differential impact of H4 acetylation sites on 53BP1 foci formation 
(continued) 
(B) & (C) HeLa cells were transfected for 48 h with either wild type (WT) Flag-H4 or the 
acetylation site point mutants shown.  Cells were then mock-treated or treated with 
bleocin (10 g/ml) for 1 h and stained with antisera to 53BP1 and the Flag tag. All values 
represent mean ± SEM.  Lettering in the bar graphs in panels designates values not 
significantly different (identical letters) versus those which are significantly different 
(p<0.05) (different letters). 
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3.4 Discussion 
K16 deacetylation facilitates 53BP1 foci formation 
The recruitment of 53BP1 through the K20me2 and its importance has been well 
demonstrated.  However, what prevents 53BP1 from recognizing K20me2 occurring 
without K16ac in the absence of DNA damage is still not known.  The role played by 
K20me2 in the DDR contrasts sharply with that of other histone modifications which are 
either induced or reduced following DNA damage.  Proteomic analyses have established 
that nearly all H4 molecules in human cells acquire K20me1 or K20me2 within the first 
cell cycle after their initial synthesis, and that progressive methylation proceeds during 
the next cell cycle such that approximately 98% of all H4 molecules acquire K20me2 
(Pesavento, et al. 2008).  Once acquired, K20me2 is extremely stable with the only 
detectable change in abundance of H4K20me2 molecules accounted for by progressive 
methylation of a minor fraction to the K20me3 form.  Although evidence suggesting that 
the MMSET methyltransferase methylates K20 locally at sites of DNA damage to 
facilitate 53BP1 foci formation has been described (Pei, et al. 2011), previous results 
from our group imply that this can involve only a minor fraction of H4 (Pesavento, et al. 
2008).  The approach used by Lou and colleagues (induced expression of I-SceI nuclease 
to generate DSBs), does not account for how rapidly K16 deacetylation facilitates 53BP1 
binding to pre-existing K20me2, as demonstrated here.  Moreover, their experimental 
designs did not account for the possibility that K16 deacetylation was a likely explanation 
for why the antisera they used detected increases in the levels of all three states of K20 
methylation rather than a specific increase in K20me2 as expected given the apparent 
product specificity of MMSET.  Along with other lines of evidence, knockdown of the 
major methyltransferase for K20me2, SUV4-20h1, dramatically decreases K20me2 and 
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attenuates the formation of 53BP1 foci as well (Yang, et al. 2008).  Nevertheless, in 
support of the role of suv4-20 in 53BP1 function, B lymphocytes derived from Suv4-20 
null mice were deficient in immunoglobulin class-switch recombination (Schotta, et al. 
2008), which is required for 53BP1-mediated DNA repair (Bothmer, et al. 2010).  These 
observations support the notion that SUV4-20h1-mediated pre-establishment of K20me2 
is critical for 53BP1 foci formation.  Taken together, the evidence currently available 
indicates that K16 deacetylation is a more significant regulator of 53BP1 foci dynamics 
in the DDR compared to possible de novo K20 methylation by MMSET or other enzymes, 
and that the role of MMSET in the DDR is limited to the minor fraction of H4 which is 
either unmethylated or monomethylated at K20, or may involve the methylation of 
proteins other than H4. 
Although the structural basis for selective recognition of K20me2 by the tandem 
Tudor domains of 53BP1 and Crb2 has been described (Botuyan, et al. 2006), how K16ac 
attenuates their binding to K20me2 remains to be determined since residues N-terminal to 
Arg19 of H4 were not accounted for in the structure.  However, the role proposed here 
for facilitation of  53BP1 foci formation by K16 deacetylation is consistent with prior 
evidence that K16 is initially deacetylated following DNA damage (Jazayeri, et al. 2004, 
Miller, et al. 2010), that expression of the H4K16Q reduces cell survival after ultraviolet-
induced DNA damage (Bird, et al. 2002, Megee, et al. 1995), and that HDAC activity is 
required for 53BP1 foci formation (Kao, et al. 2003).  The importance of K16ac 
dynamics is further supported by studies showing that perturbation of either HDAC or 
HAT activity postpones the disassembly of H2A.X-containing complexes during later 
stages of the DDR (Geng, et al. 2006, Ikura, et al. 2007, Kusch, et al. 2004).  Intriguingly, 
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hypoacetylation of other proteins including p53 (Liu, et al. 1999, Luo, et al. 2001), Ku70 
(Cohen, et al. 2004, Jeong, et al. 2007, Sundaresan, et al. 2008) and NBS1 (Yuan, et al. 
2007) is associated with facilitating DNA repair and cell survival, suggesting the 
possibility that coordinated deacetylation of multiple proteins may represent a major 
component of the DDR. 
HDAC inhibitors have been used with chemotherapeutic agents and radiotherapy 
against cancer in clinical settings (Cerna, et al. 2006).  Early work demonstrated that 
HDAC inhibitors can promote the relaxation of the chromatin conformation, making 
DNA more susceptible to DNA damage by biochemical compounds and endonucleases 
(Marchion, et al. 2005, Sankaranarayanan, et al. 1990, Smith 1986).  In addition to the 
conformational change of chromatin induced by HDAC inhibitors, other effects are also 
possible.  It has been reported that modulating the expression of genes involved in DNA 
damage responses can sensitize cells to DNA damage (Kurz, et al. 2001, Zhang, et al. 
2007).  My current observation, attenuation of 53BP1 foci formation by acetyl K16, 
reveals additional aspects of the modulatory role of HDAC inhibitors.  Increased 
acetylation by metabolic treatment with acetate may be an attractive application for 
cancer therapy.  Whether circulating levels of acetate can be a prediagnostic marker, and 
whether metabolic pathways involved in acetate utilization can be a therapeutic target, 
are interesting issues and need further investigation. 
3.5 Conclusion 
In this study, I demonstrated that K16 deacetylation promotes 53BP1 foci formation, 
as revealed by the impaired 53BP1 recruitment to DNA damage sites when deacetylation 
is blocked.  This observation potentially explains why 53BP1 is not recruited to extant 
methyl K20 without DNA damage.  However, it remains unclear how DNA damage 
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triggers K16 deacetylation.  ATM, ATR and DNA-PKcs of PI3KK family responding to 
various forms of DNA damage are all possible candidate factors that could activate 
HDACs to deacetylate K16.  Involvement of several HDACs in DNA damage responses 
also has been reported.  Intriguingly, it also has been demonstrated that oxidative stress 
induced by inhibition of glutathione reductase, consumption of reduced glutathione, or 
NADPH depletion trigger histone deacetylation in oligodendrocyte precursor cells 
(French, et al. 2009), suggesting that K16 deacetylation can be activated via ATM-
independent mechanisms also.  To find the links between these molecules definitely will 
help us discover the underlying mechanisms of how K16 deacetylation coordinates with 
other repair processes and ultimately may provide new insight into development of new 
treatments against cancer. 
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Chapter 4 – Characterization of biological functions for DNA damage-
induced K16 deacetylation 
4.1 Introduction 
DNA damage, one of the most challenging stresses to cells, takes place several ten 
thousands of times daily per cell (Ciccia and Elledge 2010).  To sense this kind of stress, 
cells have evolved several machineries including the ATM, ATR and DNA-PKcs 
enzymes of the PI3KK family (Lovejoy and Cortez 2009).  Due to its central role in 
sensing DNA damage, ATM has been investigated more than ATR and DNA-PKcs.  
ATM is present in the nucleus as an inactive dimer.  Upon DNA damage, ATM 
autophosphorylates and disassociates to form active monomers (Bakkenist and Kastan 
2003).  Many proteins involved in multiple pathways have been identified as ATM 
substrates, including histone H2A.X, NBS1, CHK1, CHK2, BRCA2 and TP53.  These 
different proteins coordinate and compete with each other to achieve cell cycle arrest and 
DNA repair to promote cell survival following DNA damage. 
Post-translational modifications of histones play important roles in the DNA damage 
pathways.  ATM/ATR-mediated H2A.X phosphorylation provides a platform for the 
assembly of BRCT-containing proteins to assemble on DNA damage sites (Stucki, et al. 
2005).  H2A.X acetylation and ubiquitination promote the disassembly of repair proteins 
during the later stages of the DNA repair process (Ikura, et al. 2007, Mizuguchi, et al. 
2004).  Histone H3 K56 acetylation is required for chromatin reassembly after DNA 
repair (Chen, et al. 2008).  The Abovementioned DNA damage-induced histone 
modifications are made either directly by ATM or by downstream effectors of the ATM 
pathway.  However, in sharp contrast to these DNA damage-induced modifications, 
histone H4 K20 methylation is acquired during normal cell cycle progression and shows 
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little or no turnover rate (Yang and Mizzen 2009).  Upon DNA damage, 53BP1 
associates with DNA damage sites through recognition of dimethyl K20 residues.  In the 
previous chapter, the significance of DNA damage-induced K16 deacetylation for 53BP1 
foci formation was demonstrated, but how deacetylation is triggered is unclear.  What 
factor(s) are involved and how they mediate deacetylation became my great interest. 
Both histone acetyltransferases (HATs) and deacetylases (HDACs) have been 
implicated in DNA damage responses.  Members of the PI3KK family – including ATM, 
ATR, DNA-PKcs, and Trrap – can form complexes with Tip60 (Cai, et al. 2003, Jiang, et 
al. 2006, Sun, et al. 2005).  Tip60, like other DDR mediators, forms irradiation-induced 
foci (IRIF) upon DNA damage, indicating its recruitment to DNA damage sites.  ATM 
itself is a substrate of Tip60, and Tip60 is able to regulate ATM activation through 
acetylation (Sun, et al. 2005).  Nevertheless, MOF, another HAT of the MYST family, 
can interact with ATM and regulate its activation as well (Gupta, et al. 2005).  However, 
it appears that ATM is not the only target of HATs during DNA damage responses—
histones H2A.X (Ikura, et al. 2007), H2A (Murr, et al. 2006), H3 (Das, et al. 2009), and 
H4 (Bird, et al. 2002) are also targets.  In addition to HATs, HDACs are also involved in 
DNA damage responses.  NBS1, a component of the MRN complex, physically interacts 
with SIRT1, and deacetylation of NBS1 by SIRT1 is required for activation of MRN 
complexes (Yuan, et al. 2007).  It has also been demonstrated that HDAC4 associates 
with 53BP1 and forms IRIF upon DNA damage.  Knock-down of HDAC4 decreases 
53BP1 protein levels, suggesting that HDAC4 is required for 53BP1 stability (Kao, et al. 
2003).  Another physiological free end of DNA is the telomere.  It has been noted that a 
number of proteins are common to telomeres and DSBs (Maser and DePinho 2004, Misri, 
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et al. 2008).  TRF2, a telomere binding protein, which can form complexes with HDAC1 
and HDAC2 (Zhou, et al. 2009) transiently associates with DSB sites independently of 
MRN complexes (Bradshaw, et al. 2005).  Interestingly, ATM activates protein 
phosphatase 1 following irradiation, which in turn dephosphorylates HDAC1, allowing 
dissociation of HDAC1 from Rb to unharness its enzyme activity (Guo, et al. 2007).  This 
is consistent with earlier evidence that global HDAC activity increases and that HDAC1 
associates with ATM following irradiation (Kim, et al. 1999).  Similarly, it has also been 
reported that ATR associates with HDAC2 (Schmidt and Schreiber 1999).  The 
importance of HDAC1 and HDAC2 in promoting nonhomologous end-joining has been 
demonstrated recently (Miller, et al. 2010).  The involvement of multiple HATs and 
HDACs at various stages of DNA damage responses suggests it will be challenging to 
elucidate which factors are critical for K16 deacetylation and the recruitment of 53BP1.  
However, given the importance of 53BP1 for NHEJ (Dimitrova, et al. 2008), 
understanding how this process is regulated by acetylation will provide critical insight 
into this fundamental aspect of DNA damage response. 
K16 acetylation has been implicated in regulating transcription and chromatin 
conformation.  Hyperacetylation of K16 promotes transcription presumably through 
chromatin decondensation.  In response to DNA damage, K16 acetylation was decreased 
which allows the recruitment of 53BP1.  In my current working hypothesis, 
deacetylation-regulated 53BP1 recruitment is expected to correlate with its biological 
function in the nonhomologous end-joining process.  It also raises a very interesting and 
critical question ― if K16 deacetylation favors chromatin condensation, how does this fit 
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within the model that histone acetylation-driven increases of chromatin accessibility are 
required for DNA repair? 
In this present study, I demonstrate that K16 deacetylation is mediated by the ATM 
pathway and a subset of HDACs which are insensitive to butyrate treatment.  The 
significance of K16 deacetylation for 53BP1-dependent end-joining and transcriptional 
repression upon DNA damage are also analyzed.  Surprisingly when K16 acetylation 
levels are lowered, the chromatin became more accessible, suggesting that the loss of this 
histone modification itself is not sufficient to cause chromatin condensation. 
4.2 Material and Methods 
Cell culture and treatments 
Human tissue-derived cell lines, including HeLa (cervical carcinoma), U2OS 
(osteosarcoma) and WI-38/VA-13 ( lung fibroblast) were obtained from the American 
Type Culture Collection and maintained in Dulbecco's Modified Eagle's Medium 
(DMEM) with 10% fetal bovine serum.  An ATM-deficient cell line, GM05849, derived 
from a patient with Ataxia Telangiectasia (AT), was obtained from the Coriell Cell 
Repositories and maintained in Eagle's Minimum Essential Medium (MEM) with 10% 
fetal bovine serum.  All cells were kept in a humidified atmosphere of 5% CO2 and 95% 
air at 37°C.  All media used were pre-warmed to 37°C.  Cells were routinely maintained 
in T-75 flasks with 20 ml media.  Media were changed every 2 days until confluence was 
reached, and then subcultured with 0.25% trypsin.  Cells were seeded at 40%-50% 
confluence.  After 48 h, the confluence reached 80%-90%, and desired treatments were 
performed.  To induce DNA damage, cells were treated with 10 g/ml bleocin for the 
time indicated.  Pretreatment with an ATM inhibitor, KU-55933 (EMD, Cat# 118500), 
prepared in DMSO was performed 1 hour prior to bleocin treatment.  For more 
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complicated treatments, e.g. combination of KU-55933 and end-joining assay, see text 
and figure legends for details and visual illustration. 
Transfection 
Transfection was conducted according to the manufacturer's instructions (FuGENE 6, 
Roche).  Cells were seeded in 6-well plates at 50-80% confluence one day before 
transfection.  Two g of plasmid diluted in Opti-MEM I (Invitrogen) were mixed with 
FuGENE 6.  After incubation at room temperature for 15 min, the mixtures were added to 
the wells.  After 48 h, further treatments were performed. 
Labeling of nascent RNA with 5-bromouridine 5’-triphosphate (BrUTP) 
Protocols were adapted from a previous study (Kanestrom, et al. 1998) with slight 
modifications.  Briefly, FuGENE 6 was used to deliver BrUTP into cells.  FuGENE 6 
was diluted 10 times in 1X HEPES buffered saline (HeBS, 140 mM NaCl, 25 mM 
HEPES, 0.75 mM Na2HPO4) and then mixed with BrUTP at a final concentration of 5 
mM.  After 15 min of incubation, to allow the BrUTP/FuGENE 6 complexes to form, 
cells grown on coverslips were pulse-labeled with this BrUTP/FuGENE 6 mixture at 
room temperature in a humidified chamber for 15 min. 
Plasmid preparation and linearization 
Plasmid preparation was done by following the manufacturer’s instructions 
(QIAprep® Spin Miniprep, Cat# 27106, Qiagen) with minor modifications.  Briefly, 
bacterial lysate made from buffers P1, P2 and N3 was treated with RNase (50 ng/l) at 
37°C for 20 min before loading on a spin column.  To linearize plasmid DNA, 10-20 g 
of eluted plasmid was digested with 10-20 units of SacI (NEB, R0156) in a 10 l of 
reaction volume at 37°C for 16-18 hours, and then purified using QIAquick Gel 
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Extraction kit (Qiagen, Cat# 28704).  The efficiency of plasmid linearization was 
checked on a 0.7% agarose gel. 
End-joining assay 
Sequences encoding the Cerulean and Venus fluorescent proteins were made as 
described previously (Nagai, et al. 2002, Rizzo, et al. 2004) and subcloned into pFLAG-
CMV-2 (Sigma) and pCMV-HA (Clontech), respectively.  A nuclear localization signal 
(NLS) (Fieck, et al. 1992) was fused to the N-terminus of each fluorescent protein.  Two 
forms of the Venus vector were created to enable linearization prior to use in the assay 
(Fig. 4.5A).  Plasmid Vl1 contains a SacI site between the CMV promoter and the Venus 
start codon.  Plasmid Vl2 contains a MfeI site 3' to the SV40 polyadenylation sequence.  
Cells growing on coverslips were transfected with circular Cerulean plasmid (Cc) plus 
one of Vc, Vl1 or Vl2.  Forty-eight hours later, cells were fixed in 4% PFA/PBS for 10 
min., permeabilized in 0.2% Triton X-100/PBS for 20 min., and Venus expression among 
Cerulean-positive cells quantitated by fluorescence microscopy.  50 or more Cerulean-
positive cells were analyzed for each sample.  End-joining activity is expressed as the 
percentage of Cerulean-positive cells which were also Venus-positive.  For experiments 
involving expression of FLAG-H4, the mutagenic PCR was used to remove the FLAG 
sequence from the pFLAG-CMV-Cerulean vector. 
Chromatin accessibility assay on slide 
Cells were fixed and permeabilized in 4% PFA, 0.25% Triton X-100 in PBS at room 
temperature for 15 min.  Coverslips were washed 3 times in PBS, and then equilibrated in 
1X micrococcal endonuclease reaction buffer (50 mM Tris-Cl pH 8.0, 40 mM NaCl and 1 
mM CaCl2).  Micrococcal endonuclease (0.05U/ml, Wellington) was applied to 
coverslips at 30°C for 30 min.  Reactions were terminated in stop solution (5 mM EDTA 
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in 1x TBST) for at least 5 min at RT.  Following 2 washes with 5mM EDTA/PBS and 3 
washes with TBST, coverslips were immersed in terminal deoxynucleotidyl transferase 
(TdT) buffer (20 mM Tris-acetate, potassium acetate, 10 mM magnesium acetate and 1 
mM CoCl2, pH 7.9) for at least 10 min on ice.  The TdT reaction was set up by mixing 
vial 1(TdT) and vial 2 (dNTPs and buffer) according to the manufacturer’s instruction 
(Roche, Cat. No. 1 684 795).  Reactions were performed at 37°C for 2 hours, and stopped 
by adding 2 ml of stop solution (5 mM EDTA in 1x TBST), followed by 2 washes of 
TBST.  Samples were then processed for immunofluorescence staining (for proteins) or 
directly observed by confocal microscopy for fluorochrome-conjugated dUTP. 
Statistical analyses 
All data are expressed as the mean ± S.E.M. and were analyzed by one-way ANOVA, 
followed by Tukey’s test if significant differences were found.  Differences were 
classified as significant when two-tailed analysis gave p < 0.05. 
4.3 Results 
ATM-dependent DNA damage-induced K16 deacetylation 
How DNA damage is sensed has been heavily studied, but remains poorly understood.  
One of earliest responding molecules is ATM kinase.  Once ATM binds to MRN 
complexes, its kinase domain is de-repressed via autophosphorylation.  Various factors 
including reactive oxygen species, DNA free ends, and chromatin conformation changes, 
can stimulate ATM activation.  Therefore it is critical to investigate how the DNA 
damage-induced K16 deacetylation I observed relates to ATM activation.  A set of 
samples harvested from a time course of DNA damage demonstrated that ATM activation 
can be observed after just 15 min of bleocin treatment using phosphorylated ATM and 
H2A.X as markers (Fig. 4.1).  Note that the detection of H2A.X was more sensitive  
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Fig. 4.1 ATM-dependent K16 deacetylation 
U2OS cells treated with 10 g/ml bleocin were harvested at the indicated times (h) and 
immunoblotted for ATM-pS1981 (pATM), p53-pS15, H2A.X-pS139 (H2A.X) and 
H4K16ac.  Ponceau S staining of core histones serves as a loading control. 
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than that of ATM autophosphorylation since considerable signal amplification occurs in 
this pathway due to the abundance of H2A.X molecules.  Compared to ATM and H2A.X 
phosphorylation, changes in p53 phosphorylation and K16 deacetylation were detected 
more slowly becoming evident at 1 hour of treatment.  This time course suggested that 
K16 deacetylation was likely to downstream of ATM.  To test this hypothesis, cells were 
treated with an ATM-specific inhibitor, KU-55933, and then treated with bleocin to 
induce DNA damage.  The compound KU-55933 blocked both ATM 
autophosphorylation and H2A.X.  It also blocked K16 deacetylation, indicating that 
ATM is upstream in the pathway mediates K16 deacetylation (Fig. 4.2).  To exclude the 
potential that these results due to off-target effects of KU-55933, a pair of ATM-
proficient and ATM-deficient cell lines, WI-38/VA-13 (referred to as VA-13) and 
GM05849 respectively, were used to validate the ATM-dependency of these observations.  
Bleocin-induced DNA damage triggered ATM autophosphorylation in VA-13 at 1 h, 
while it was undetectable in GM05849 cells (Fig. 4.3).  More importantly, K16 
acetylation was retained after DNA damage in GM05849 cells, suggesting that DNA 
damage-induced K16 deacetylation depends on ATM kinase.  
Specific members of the HDAC family mediate DNA damage-induced K16 
deacetylation 
To understand how ATM regulates DNA damage-induced K16 deacetylation became one 
of my great interests.  Identifying of HDACs that are substrates of ATM or which are 
recruited to DNA damage sites, is a feasible approach to this issue.  There are at least 18 
different HDACs in human genome.  Based on homology to their orthologs in yeast, they 
can be grouped into four classes, each of which has distinct sensitivity to different HDAC 
inhibitors.  To utilize these differences and narrow down the HDAC candidates 
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Fig. 4.2 A PI3KK inhibitor suppresses K16 deacetylation following DNA damage 
U2OS cells were pretreated with an ATM inhibitor, KU-55933 (KU, 2 M), for 1 h 
followed by treatment with 10 g/ml bleocin for another 1 h.  Samples were 
immunoblotted for ATM-pS1981 (pATM), H2A.X-pS139 (H2A.X) and H4K16ac.  
Ponceau S staining of core histones serves as a loading control. 
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Fig. 4.3 ATM-deficient cells fail to induce K16 deacetylation 
ATM-proficient (VA-13) and deficient (GM05849; GM49) cells were treated with 
bleocin (10 g/ml) for 1 h and harvested for immunoblot.  Samples were probed for 
ATM-pS1981 (pATM), ATM and H4K16ac.  Ponceau S staining of core histones serves 
as a loading control. 
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responsible for K16 deacetylation in DNA damage responses, cells were pretreated with 
four HDAC inhibitors for 30 min prior to UV exposure.  The inhibitors against class III 
HDAC had no effect either on the basal K16ac or UV-induced K16 deacetylation.  In 
contrast, butyrate increased the basal level of K16ac in this short period of treatment but 
was unable to suppress UV-induced deacetylation, implying that butyrate-insensitive 
HDAC(s) are involved in the responses to UV.  Intriguingly, TSA was able to repress 
UV-induced K16 deacetylation (Fig. 4.4), narrowing down the possible HDACs to 6, 10 
and 11.  Identification of HDACs using this approach in combination with other 
strategies (i.e. siRNA knockdown) is ongoing.  Additionally, an immuno-depletion 
coupled HDAC assay currently under development has yielded promising initial results. 
K16 deacetylation facilitates 53BP1-mediated NHEJ 
Along with the issue of what regulates or mediates K16 deacetylation, it is equally 
important to know how K16 deacetylation contributes to the DNA damage responses, and 
more specifically, to the function of 53BP1.  In Chapter 3, I demonstrated that 
hyperacetylated H4 or substitutions that mimic K16 acetylation compromised 53BP1 foci 
formation, but whether K16 hyperacetylation affects the function of 53BP1 remains 
unclear.  53BP1 has been shown to promote joining of DNA ends (Dimitrova, et al. 2008).  
To develop an assay for measuring this end-joining (EJ) process, I began by transfecting 
cells with a mixture of plasmids encoding cyan and yellow fluorescent proteins (CFP and 
YFP).  One plasmid was linearized using a unique restriction site in the 5’ untranslated 
region (5’-UTR) while the other one intact (circular) plasmid served as a control to 
identify transfected cells.  Expression of the fluorescent protein encoded by the linear 
plasmid could then provide a measure of NHEJ activity.  Since the EJ process is an error-
prone and unfaithful repair mechanism, using a restriction site in the 5’-UTR provided a  
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Fig. 4.4 DNA damage-induced K16 deacetylation responds differently to HDAC 
inhibitors 
U2OS cells were pretreated with various HDACi in indicated concentrations for 30 min, 
followed UV exposure (125 J/m2).  Samples were probed for H4K16ac.  Ponceau S 
staining of core histones serves as a loading control.   
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buffer region to prevent a frame-shift in the fluorescent protein caused by the error-prone 
EJ repair.  During the early development of this assay, the expressed CFP and YFP 
localized to both cytoplasm and nucleus, causing two problems.  First, the irregular shape 
of the cells made image processing more difficult.  Another problem was the weak signal 
for CFP.  To improve these two issues, Cerulean (Rizzo, et al. 2004) and Venus (Nagai, 
et al. 2002), two brighter fluorescent proteins, were substituted for the assay (Shaner, et al. 
2005).  Additionally, a nuclear localization signal (NLS) was added to the proteins to 
enhance their nuclear localization and facilitate image processing.  Venus was linearized 
to serve as the substrate for EJ process, while Cerulean served as the transfection control 
(see Fig. 4.5A for plasmid illustration).  The ratio of the number of Venus-positive cells 
over the number of Cerulean-positive (V/C) was calculated.  Butyrate-treated cells 
showed a lower V/C ratio, indicating that the EJ process was inhibited (Fig. 4.5E).  Two 
control experiments indicated this inhibitory effect was specific to the EJ process.  
Butyrate treatment had no effect on V/C ratio in cells transfected with either intact 
plasmid or linear plasmid digested on the 3’-end downstream of the polyadenylation 
signal of Venus (Vl2 in Fig. 4.5A and C).  Further validating this in vivo EJ assay, PI3KK 
inhibitors and siRNA knockdown of DDR proteins was both able to suppress this EJ 
process (Fig. 4.5D), indicating that this exogenous DNA free end-based EJ assay is an 
appropriate surrogate for measuring the EJ process of endogenous native free ends.  
Acetylation, like other post-translational modifications, can affect many proteins, and 
thus the decreased EJ activity after butyrate treatment was not necessarily mediated 
through K16 acetylation.  In order to clarify this issue, the EJ assay was performed in  
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Fig. 4.5 Development of an in vivo end-joining assay 
(Continued on next page) 
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Fig. 4.5 Development of an in vivo end-joining assay (continued) 
(A) Schematic diagrams of the plasmids used to assess end-joining in vivo.  Circular 
Venus plasmid Vc was used to provide a positive control for Venus expression.  
Linearized Venus plasmid Vl1, cut at a single SacI site between the CMV promoter and 
the Venus coding region, was used to measure end-joining.  Linearized Venus plasmid 
Vl2, cut at a single MfeI site near the end of the polyadenylation signal, was used to 
monitor the transfection efficiency of linear plasmids.  Circular Cerulean plasmid Cc was 
(Continued on next page)
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Fig. 4.5 Development of an in vivo end-joining assay (continued) 
added to all transfections to provide an internal control for transfection.  (B) Diagram for 
EJ-related experiments.  Pretreatments, including siRNA, FLAG-H4 transfection, HDACi 
and PI3KKi, were performed as indicated.  Six hours after transfection of the EJ plasmids, 
media were changed to conditioned media containing the same pretreatment (if any).  
After 48 h of EJ transfection, cells were harvested.  (C) U2OS cells were treated with 
sodium butyrate (10 mM) for 16 h and then co-transfected with different pairs of Venus 
and Cerulean plasmids.  The percentage of Venus-positive cells among cells that were 
Cerulean-positive was determined 48 h post-transfection.  (D) The assay was validated by 
pretreating U2OS with PI3KK inhibitors (Caffeine 2 mM; KU-55933 2 M) for 1 h or by 
transfecting cells with siRNA (50 nM) against 53BP1 or DNA-PKcs for 48 h prior to co-
transfection of EJ constructs (Vl1 and Cc).  (E) U2OS cells were maintained in the 
presence or absence of sodium butyrate (10 mM) for 16 h prior to transfection with 
linearized pCMV-HA-Venus (Vl1) for measuring end-joining activity.  Transfections also 
contained intact circular pCMV-Cerulean (Cc) as an internal control.  Cells were 
harvested 48 h post-transfection and the percentage of Venus-positive cells relative to 
Cerulean-positive cells was determined and plotted as end-joining activity after 
normalization to the control (no butyrate) group.  All values represent mean ± SEM.  
Asterisks indicate values which differ significantly from the respective controls (p<0.05). 
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cells transfected with FLAG-tagged human histone H4 wild-type or K16 mutants.  
Intriguingly, not only the K16 mutant mimicking acetylated-lysine (Q) demonstrated 
lower EJ activity, but also the non-acetylatable substitutions (R and A) demonstrated 
lower EJ activity compared to wild-type (Fig. 4.6), suggesting that K16 plays a pivotal 
role in regulating DNA repair process through its proper deacetylation and acetylation. 
DNA damage-induced transcriptional repression and conformation change of 
chromatin 
It has been suggested that K16 is involved in transcriptional regulation and the higher 
order folding of chromatin (Akhtar and Becker 2000, Shogren-Knaak, et al. 2006).  It is 
reasonable to ask if these two functions of K16ac are significant for DNA damage 
responses.  Instead of measuring specific transcripts, BrUTP was used to label newly 
synthesized nascent RNA.  Consistent with early reports, global transcription was 
repressed to approximately 30% of control upon DNA damage (Fig. 4.7B).  To measure 
chromatin accessibility, a limited micrococcal nuclease (MNase) digestion-based assay 
was developed.  The assay was based on the traditional assumption that the more 
accessible the chromatin is, the more rapidly it is digested by nucleases.  In my earliest 
experiments, cells were fixed after bleocin treatment followed by MNase digestion.  
Crosslinks were reversed and the fragmented chromatin was resolved on agarose gel.  
This procedure involved too many steps that introduced variation in the results.  To 
improve the assay, I introduced end-terminal labeling of DNA ends as a more reliable 
alternative to measure the extent of digestion.  In brief, bleocin-treated cells cultured on 
glass coverslips were fixed by paraformaldehyde followed by MNase digestion in situ.  
The DNA free ends generated by MNase digestion were then labeled using terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay (Fig. 4.8A).  The  
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Fig. 4.6 H4K16 mutations impair in vivo end-joining 
HeLa cells transfected with the FLAG-H4 constructs for 48 h were transfected again with 
linearized pCMV-HA-Venus to assay end-joining activity (also see Fig. 4.5B for 
experiment timeline).  All values represent mean ± SEM.  Asterisks indicate values 
which differ significantly from the respective controls (p<0.05). 
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Fig. 4.7 BrUTP labeling of nascent transcripts 
(A) Diagram for the BrUTP labeling process.  (B) U2OS cells were incubated in control 
media or media containing bleocin (10 g/ml) for 45 minutes.  Both control and bleocin-
treated BrUTP were then labeled with BrUTP for 30 min and then stained with antisera to 
53BP1 and BrdU.  All values represent mean ± SEM.  Asterisks indicate values which 
differ significantly from the respective controls (p<0.05). 
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Fig. 4.8 Chromatin accessibility is enhanced after DNA damage 
(Continued on next page)
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Fig. 4.8 Chromatin accessibility is enhanced after DNA damage (continued) 
(A) Diagram illustrating the in situ chromatin accessibility assay.  (B) U2OS cells were 
treated with bleocin (10 g/ml) for 1 h, fixed and permeabilized, incubated with or 
without MNase (0, 0.05 or 0.5 U/ml) for 30 minutes at 30 oC, and DNA free ends were 
detected with the TUNEL assay. 
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results demonstrated that bleocin-treated cells had more end labeling, reflecting that more 
extensive digestion by MNase was the consequence of chromatin structure becoming 
more accessible after DNA damage (Fig. 4.8B, central panel).  This increased end-
labeling was not due to bleocin-induced DNA damage itself, since samples without 
MNase digestion showed no difference (Fig. 4.8B, left panel).  It is worthwhile to 
mention that over-digestion by MNase caused a serious loss of end-labeling signal (Fig. 
4.8B, right panel), which could be misinterpreted.  Thus, a serial dose of MNase 
digestion is strongly recommended when performing this assay.  Taken together, DDR 
induced K16 deacetylation is not sufficient for chromatin decondensation. 
4.4 Discussion 
This chapter raised several distinct but highly related issues, attempting to shed light 
on the significance of K16 deacetylation for the DNA damage response.  These issues 
can be conveniently divided to two parts – events upstream and events downstream of 
K16 deacetylation.  In the first part, I attempted to fit K16 deacetylation into the known 
signaling network that regulate DNA damage responses, while in the latter, I explored the 
impact of K16 deacetylation on DNA repair and chromatin folding. 
DNA damage-induced K16 deacetylation involves ATM activation and class IIb 
HDACs 
DNA double stranded breaks, one of the most dangerous types of DNA damage 
causes genome instability through processes including chromosomal deletions and 
insertions.  ATM is one of the proteins shown to be involved in the early sensing of DSB.  
Kinase activity of ATM can be stimulated by the presence of DNA free ends, ROS (Guo, 
et al. 2010), hypertonic stress (Dmitrieva and Burg 2005) and heat shock (Kaneko, et al. 
2005).  Upon ATM activation, various kinds of proteins get phosphorylated and thus 
trigger signal amplification that leads to DNA repair, cell cycle arrest (Reinhardt and 
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Yaffe 2009) and metabolic shift (Armata, et al. 2010).  The master role of ATM is to 
initiate and control the progress of DNA damage responses.  Among these, one of the 
most important substrates of ATM kinase is H2A.X, one of the histone H2A variants.  
DNA damage-induced ATM-dependent phosphorylated H2A.X rapidly provides a 
platform for protein assembly at DNA damage sites.  Since the discovery of H2A.X 
phosphorylation, numerous post-translational modifying factors have been implicated in 
DNA damage responses.  In a recently discovered pathway, MDC1 binds to H2A.X and 
recruits RNF8 (Huen, et al. 2007, Kolas, et al. 2007, Mailand, et al. 2007, Stucki, et al. 
2005), an ubiquitin ligase, which ubiquitinates H2A.X, and in turn ubiquitinated H2A.X 
further recruits another ubiquitin ligase, RNF168, to ubiquitinate H2A (Doil, et al. 2009).  
This type of mechanism does not require de novo protein synthesis and guarantees fast 
responses and amplification of signals. 
My preliminary study indicated that DNA damage-induced K16 deacetylation 
depends on ATM activation.  Should this be considered to be part of the ATM signal 
transduction cascade?  Indeed, it has been reported that ATM is directly associated with 
HDAC1 and promotes its activity through phosphorylation (Guo, et al. 2007, Kim, et al. 
1999) and that ATR is associated with HDAC2 (Schmidt and Schreiber 1999).  This 
association and increased HDAC activity has not drawn much attention due to the lack of 
demonstrated biological functions, together with the main stream theory for DNA 
damage repair that histone acetylation promotes chromatin accessibility to facilitate the 
binding of DNA repair factors to DNA.  While several studies have reported that HATs 
are involved in DNA damage responses (Hejna, et al. 2008, Li, et al. 2010, Sharma, et al. 
2010), several HDACs have also been to be involved (Bhaskara, et al. 2008, Bhaskara, et 
 115
al. 2010, Kaidi, et al. 2010, Kao, et al. 2003, Kotian, et al. 2011, Namdar, et al. 2010, 
Yuan, et al. 2007).  Little is known regarding regulation of HDAC activity through 
phosphorylation or other PTMs.  Only a few scattered have reported on the regulation of 
HDAC1 by phosphorylation (Guo, et al. 2007, Pflum, et al. 2001).  However, in my study 
DNA damage-induced K16 deacetylation was not repressed by butyrate, a HDAC 
inhibitor suppressing class I and class IIa HDACs, implying HDAC1 is not likely to be 
the HDAC responsible for this deacetylation.  Intriguingly, TSA, a HDAC inhibitor 
suppressing class I, IIa, IIb and IV HDACs (Bolden, et al. 2006), was able to block this 
deacetylation.  This TSA-sensitive characteristic suggests that class IIb and IV HDACs, 
which include HDAC6, 10 and 11, may be involved.  Although individual HDACs may 
only have been partially inhibited by these treatments, this result clearly demonstrates the 
possibility that a little set of specific HDACs are responsible for this deacetylation.  Other 
lines of evidence indicate that other HDACs may be involved.  HDAC4 physically 
interacts with 53BP1 and knockdown of HDAC4 represses 53BP1 foci formation (Kao, 
et al. 2003).  Nevertheless, HDAC4 accumulates in the nucleus upon DNA damage 
(Basile, et al. 2006, Geng, et al. 2006), and suppressing this translocation prolongs the 
duration of H2A.X foci (Geng, et al. 2006), which could possibly reflect deficient 
recruitment or disassembly of repair proteins.  Proper post-translational modification 
dynamics are very important for the assembly and disassembly of repair proteins with 
precise timing (Chowdhury, et al. 2005, Ikura, et al. 2007, Kusch, et al. 2004).  My data 
shows that K16 acetylation ultimately returns to the basal levels (Fig. 4.1), and the timing 
of this re-acetylation matches the timing for 53BP1 foci disassembly (Fig. 3.5B).  It is 
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still unclear if the DNA damage-induced nuclear accumulation of HDAC4 is ATM-
dependent or not and should be investigated further. 
As mentioned earlier, class IIb and IV HDACs includes HDAC6, 10 and 11, and 
there are a few reports suggesting any or a relationship to DNA damage responses.  One 
report showed that HDAC6-specific inhibitor treatment caused DNA damage and 
triggered apoptosis (Namdar, et al. 2010), while another reported that knockdown of 
either HDAC9 or HDAC10 impaired homology-mediated recombination (Kotian, et al. 
2011).  It remains unknown whether this HDAC inactivation-induced genomic instability 
is related to altered levels of K16 acetylation.  However, these reports demonstrate that 
multiple HDACs are involved in the network of DNA damage responses, and that 
acetylation/deacetylation is a prominent regulatory mechanism like phosphorylation/de-
phosphorylation.  Different HDACs and HATs could be confined to distinct cellular 
compartments to regulate the progress of this pathway. 
One of the more formidable challenges remaining for this project is the need to 
measure HDAC activity from each individual HDACs.  Commercially available HDAC 
assays are based on the use of acetylated substrate for either HRP or luciferase, which 
these enzyme can use only after it has been deacetylated by HDACs.  In general, these 
assays measure global/total HDAC activity, and are not selective for individual HDACs.  
One way to make these assays more selective is to immunoprecipitate individual HDACs 
and then assay these immunoprecipitates.  However, it has been known that several of the 
antisera available are not compatible with this strategy since they inhibit HDAC activity 
in vitro.  Thus I am investigating an alternative strategy which uses antisera to immuno-
deplete individual HDAC(s) from samples and then assays are performed to compare the 
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activity of samples with or without immuno-depletion.  The development of this assay for 
DNA damage-induced K16 deacetylation is ongoing and needs further investigation. 
K16 deacetylation serves in a fundamental mechanism to protect against the 
consequences of DNA damage 
Besides the role of K16 deacetylation in facilitating 53BP1 foci formation and NHEJ 
as discussed above, my data suggests that loss of acetylation also contribute to the 
repression of global transcription.  This represent an independent mechanism for limiting 
potential deleterious consequence of DNA damage –the transcription of mutated genes. 
Histone H4 K16 acetylation plays pivotal roles in transcriptional regulation and 
modulation of chromatin conformation, presumably through disrupting the interaction 
between histone and DNA molecules (Akhtar and Becker 2000, Shogren-Knaak, et al. 
2006).  Histone acetylation has also been suggested to facilitate DNA repair by increasing 
the accessibility of DNA lesions to repair proteins (Hejna, et al. 2008, Li, et al. 2010, 
Sharma, et al. 2010), suggesting that the K16 deacetylation we observed early in DDR 
might be associated with chromatin condensation.  However, the novel in situ 
accessibility assay I developed clearly indicates that chromatin accessibility is enhanced 
during the interval in which K16 deacetylation is prevalent, arguing that K16 
deacetylation alone is not sufficient to mediate chromatin condensation during the DDR.  
EXPAND1, a protein implicated in chromatin decondensation, physically interacts with 
53BP1 (Huen, et al. 2010, Sy, et al. 2010).  Thus, a possible mechanism for this 
chromatin decondensation during DDR could be K16 deacetylation resulting in 53BP1 
foci formation and recruitment of EXPAND1 to DSBs to facilitate chromatin 
decondensation.  The notion that the outcome mediated by the presence or absence of a 
specific histone modification is dependent on the nature of the factor(s) which interact 
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with it is not uncommon as H2A.X, a post-translational modification expected to 
promote decondensation of chromatin, can be associated with chromatin condensation 
(Fernandez-Capetillo, et al. 2003, Rogakou, et al. 2000). 
Because DSBs that occur within coding regions can potentially give rise to truncated 
gene products that are hazardous for normal cell physiology, I speculate that the K16 
deacetylation component of the DDR has evolved to down-regulate transcription as a 
protective mechanism.  Several independent lines of evidence show that transcriptional 
activity is down-regulated upon genotoxic stress.  Transcriptional activity of nuclear 
receptors is repressed (de Leseleuc and Denis 2006, Mantoni, et al. 2006) and an ATM-
dependent transcriptional repression is also demonstrated upon DNA damage (Kruhlak, 
et al. 2007, Shanbhag, et al. 2010).  Also, UV treatment induces CTD phosphorylation of 
RNA polymerase II, which suppresses the RNA elongation process and promotes RNA 
polII degradation (Luo, et al. 2001, Munoz, et al. 2009).  In addition, genome-wide 
analyses demonstrated that the number of down-regulated genes induced by DNA 
damage is more than the number of up-regulated genes (Cloos, et al. 2006, Tachiiri, et al. 
2006). 
4.5 Conclusion 
This chapter attempted to blend two major issues of K16 deacetylation ― the 
upstream regulators and downstream effectors.  The DNA damage-induced K16 
deacetylation depends on ATM kinase activity, based on the evidence that ATM-deficient 
or ATM inhibitor-treated cells showed impaired K16 deacetylation.  K16 deacetylation 
also facilitated 53BP1-mediated DNA rejoining as demonstrated by an in vivo end-
joining assay.  FLAG-histone H4 with K16 mutants indicated that either deacetylation or 
acetylation is important for proper end-joining repair.  In addition to DNA repair, K16 
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deacetylation may also contribute to DNA damage-induced transcriptional repression: 
How K16 deacetylation is related to DNA damage-induced chromatin decondensation 
remains unclear, although it is possible that a 53BP1-mediated mechanism is involved.  
Taken together, this study situates K16 deacetylation in the knowledge base for DNA 
damage responses and extends the view of the function of acetylation in regulating 
protein interactions.  This in turn may help the development of better therapeutic strategy 
against cancer. 
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Chapter 5 – Outlook and future directions 
5.1 A quick summary 
In this study (summarized in Fig. 5.1), I originally aimed to demonstrate that affinity 
of a specific protein for an individual post-translational modification can be greatly 
altered by an additional modification at an adjacent site.  53BP1, an important mediator 
in DNA damage responses, displays less binding efficiency to dimethyl K20 of histone 
H4 when acetylation is present at K16 compared to when it is absent.  Furthermore, I 
have shown that K16 acetylation is lost in cells following DNA damage.  These 
observations were further supported by HDAC inhibitors, HAT-knockdown and 
metabolic treatment-mediated K16 acetylation.  Most importantly, the DNA damage-
induced K16 deacetylation was shown to facilitate nonhomologous end-joining, a process 
mediated by 53BP1 signaling.  In the following sections, I will focus on related issues 
that need further clarification. 
5.2 Structural basis for the K16ac/53BP1 Tudor domain interaction 
The interaction of the 53BP1 tandem Tudor domain and dimethyl K20 of H4 has been 
solved by X-ray crystallography (Botuyan, et al. 2006); however, interactions involving 
residues distal to R19, including K16, were not visualized due to the highly dynamic 
nature of histone H4 tail.  In contrast, NMR (nuclear magnetic resonance) spectroscopy 
can provide high resolution information on the conformation of flexible proteins.  A 
typical NMR structure includes an ensemble of protein structures.  The structures in this 
ensemble are similar to each other in regions which are strong constrained, and very 
different in less constrained portions (flexible portions) of the chain.  Furthermore, a 
major advantage of NMR spectroscopy is that it provides information on proteins in  
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Fig. 5.1 A quick review for K16 deacetylation in DDR 
Characterization of roles of K16 deacetylation in DDR were divided into three major 
directions – upstream factors mediating deacetylation, differential binding to different 
acetylation level and downstream effectors.  Four PTMs are labeled on nucleosomes: P: 
H2A.X phosphorylated S139, M: H4 dimethyl K20, A: H4 acetyl K16 and U: H2A.X and 
H2A ubiquitinated lysines. 
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solution, which may provide more insight into the interaction between the tandem Tudor 
domain and histone H4 tail. 
Why is this structural information so important?  Currently, it is unknown how K16 
interacts with the Tudor domains or how acetyl K16 interrupts these interactions.  There 
are a few possibilities.  First, it can result from the bulky effect of the acetyl group.  
Second of all, incorporation of an acetyl group neutralizes positive charge of lysine 
groups, abolishing electrostatic interactions.  Third, the acetyl group increases the 
hydrophobicity and could disrupt polar interaction between proteins.  Fourth, the 
acetylation of K16 may change the orientation of histone H4 tail.  In Fig. 2.10, I indicated 
a surface patch, which possibly accounts for interaction with K16 residue of histone H4.  
Based on the abovementioned four possible models of the interaction, residues residing in 
this patch can be mutated to investigate their roles in stabilizing H4:53BP1 interactions 
(Table 5.1).  In addition to elucidating how the Tudor domain interacts with K16, this 
work could potentially inform the development of an acetyl K16-insensitive 53BP1 
Tudor domain mutant that could be used to stimulate DNA repair pathway in the 
presence of K16 hyperacetylation as occurs during cancer therapy with HDACi or could 
be used as an exogenous source Tudor protein to block 53BP1 function (Xie, et al. 2007). 
5.3 Decision to homologous recombination and nonhomologous end-joining 
There are two major pathways, homologous recombination (HR) and nonhomologous 
end-joining (NHEJ), responsible for repair of DNA double stranded damages in 
eukaryotes.  These two pathways compete with each other and balance the tradeoff 
between genome fidelity and cell survival.  It has been shown that template availability in 
part determines the decision to use HR or NHEJ.  In this study, by characterizing the 
roles of K16ac in recruitment of 53BP1, HR/NHEJ preference in the cell cycle can be  
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Table 5.1 Proposed site mutations to compensate for acetyl K16 
 
 Target residues Proposed Effect of mutation on 
  mutation length of side-chain and/or charge 
 1543 Glutamate (E) Asp (D) shorter side chain 
   Gln (Q) less negative 
   Asn (N) shorter and less negative 
 1545 Threonine (T) Gly (G) shorter 
 1591 Glutamate (E) Asp (D) shorter side chain 
   Gln (Q) less negative 
   Asn (N) shorter and less negative 
 1592 Glutamine (Q) Asn (N) shorter 
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interpreted differently than in the model of template availability (see section 1.7).  Earlier  
 works in our group (Pesavento, et al. 2008) showed that newly synthesized histone H4 
does not get dimethylated until G2/M, and thus through early S to mid S phase, the net 
levels of K20 dimethylation are relatively low (still around 60%), and this relatively low 
K20 dimethylation may less favor NHEJ because of reduced 53BP1.  On the other hand, 
successively K20 methylation begins to burst around the G2/M boundary, favoring 53BP1 
binding in the later G1 phase. 
To fairly evaluate how K16/K20 status modulates DNA repair activities, one of the 
most important requirements is being able to measure these repair processes.  Although I 
previously simplified the DNA repair pathways as NHEJ and HR, there are minor 
alternative repair pathways that are less well understood.  The EJ assay I used in this 
study measures only classical-NHEJ (c-NHEJ), which is DNA-PK-dependent.  
Alternative NHEJ pathway are also known as microhomology-mediated EJ (MMEJ), 
which requires microhomologous sequences (5-25 bp) around the DSB sites and single-
stranded annealing (SSA), which uses homologous sequences longer than 30 bp for end-
joining (McVey and Lee 2008).  To measure MMEJ activity, a pair of microhomologous 
sequences could be placed around the DSB site while a pair of longer homologous 
sequences could be placed around the DSB site for measuring SSA.  To measure HR, two 
copies of reporter gene (e.g., GFP), one containing a digestion site in coding region and 
the other lacking a start codon, are separated by a long sequence (> 1 Kbp).  The non-
expressing version can be used as template to repair the damaged copy during HR 
process.  Instead of direct measurement of HR activity, two other alternative markers 
may provide some indirect information.  Phosphorylated RPA binds to resected DNA in 
 125
an early step during HR (Treuner, et al. 1999), while Rad51 subsequently displaces RPA 
to promote strand exchange with a homologous sequence (Stauffer and Chazin 2004).  
Thus RPA phosphorylation and Rad51 foci number can serve as reporter for the HR 
activity.  53BP1 represses resection activity, which is required for and promotes MMEJ, 
SSA and HR.  It will be worthwhile to further clarify whether K16ac-mediated 53BP1 
recruitment can modulate these three different repair processes. 
The role of the K16/K20 regulatory module may provide an additional control for the 
decision between HR or NHEJ.  It has been demonstrated that HR is the dominant 
pathways in mouse embryonic stem (ES) cells whereas NHEJ is predominant in 
differentiated embryonic fibroblasts (Serrano, et al. 2011).  The K16/K20 regulatory 
module may also play a role in the HR/NHEJ decision in stem/differentiated cells and ES 
cells may be an excellent model for addressing this issue.  K16ac levels in ES or 
differentiated cells can be measured and manipulated to see how the preference toward 
HR/NHEJ changes.  Reliance upon NHEJ in differentiated cells is associated with an 
increase in the probability of increased accumulation of mutations that eventually lead to 
senescence or quiescent status.  Mutations which dysregulate the cell cycle can 
potentially lead to carcinogenesis. 
5.4 Clinical implications 
Mutations in proteins responsible for DNA damage responses cause several diseases, 
e.g., severe combined immunodeficiency, ataxia telangiectasia and Bloom's syndrome.  
These diseases share features such as high sensitivity to irradiation, predisposition for 
cancer and immunodeficiency.  Although 53BP1 is an important mediator in DDR, 
mutation or deficiency of 53BP1 has not been linked to any human diseases.  53BP1-
knockout(KO) in mice is not lethal, but causes high sensitivity to irradiation and 
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immunodeficiency (Ward, et al. 2003).  53BP1 has been implicated in both V(D)J 
recombination and class switch recombination (CSR) (Bothmer, et al. 2010, 
Difilippantonio, et al. 2008) and the compromised immune system in 53BP1-KO mice is 
presumably caused by the deficiency of these two important events in the immune system.  
Antibody class (isotype) is determined by the heavy chain constant (CH) region, which is 
important for determining the effector function of antibody.  B cells undergo CSR in vivo 
after immunization or infection.  Since 53BP1 is important in this process, factors that 
have negative effects on NHEJ that is promoted by 53BP1 may also compromise CSR.  
Many single-nucleotide polymorphisms (SNPs) reported in 53BP1 gene (Ensembl, 
human build GRCh37) and some of these SNPs are linked to tumorigenesis (He, et al. 
2010).  However, the impact of these individual SNPs remains unclear and how they may 
affect 53BP1 function and further reflect individual immune responses to immune 
challenge i.e., infection, needs further investigation.  To explore this possibility, the effect 
on EJ activity could be investigated by overexpressing 53BP1 carrying these SNP in cells.  
Also, it is technically feasible to immunologically challenge mice, expressing either 
major or minor forms of 53BP1, with pathogens and monitor the recovery time and even 
immunoglobulin (antibody) production to evaluate immune function of these animals.  
These studies may ultimately open an avenue for modulating or promoting immune 
function and may provide some clues about individual susceptibility to pathogen 
infections (e.g., seasonal influenza). 
Another interesting observation about 53BP1 is that deficiency of 53BP1 rescues 
BRCA1-deficient mice from embryonic lethality and from high sensitivity to DNA 
damage (Bouwman, et al. 2010, Cao, et al. 2009, Kass, et al. 2010).  In the absence of 
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BRCA1, 53BP1 inhibits BRCA1-independent HR, causing massive cell death since HR 
is dominant in stem cells (Serrano, et al. 2011).  However, in the mice carrying a double 
deficiency of BRCA1/53BP1, the loss of 53BP1 de-represses the HR process. Noticeably 
this rescue does not appear to be due to a decrease in the NHEJ activity since the loss of 
DNA ligase IV or DNA-PK activity does not rescue BRCA1-deficient cells (Bunting, et 
al. 2010).  In this mouse model, the rescued BRCA1-deficient mice only show a slight 
increase in tumorigenesis (Cao, et al. 2009).  In contrast, loss of 53BP1 in human is often 
associated with tumorigenesis: 90% of 53BP1-negative breast tumors are triple negative, 
i.e., lacking estrogen and progesterone receptors and epidermal growth factor receptor 2 
(ER, PR and HER2) (Bouwman, et al. 2010).  Current chemotherapeutic agents such as 
platinum compounds (cisplatin) and PARP inhibitor rely on the deficiency of HR to 
induce massive cell death in BRCA1/BRCA2-negative tumors.  However, the loss of 
53BP1 makes such tumor more resistant to this treatment strategy.  By better 
understanding the mechanism how 53BP1 and possible K16 acetylation suppresses HR, 
more efficient combinations of treatments against tumor development/growth may be 
developed. 
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Appendix 
Protein induction in E.coli 
Notes: 
 Beware of what strain of bacteria you use: BL21(DE3), BL21(DE3) pLys, Tuner 
(DE3) 
1. Initial culture in small scale (in test tube): 
 1) Pick up colonies from LB plates: 
 • Pick up 1 colony per tube for 3-5 tubes v.s. 3-5 colonies per tube (3 ml/tube) 
  Take your own tradeoff!  
 • Determine if LB or 2X YT is best for your experiment 
 
2) Incubate at 37°C with shaking (225 rpm) until OD600 reach 0.4~0.6 (1 O.D. = 
1x109 E.coli)  
  (DON’T go above 0.6) 
 •  for Tudor protein, usually take 2~2.5 hr to reach 0.6 
 •  for core histones, 3~4 hr 
 
2. Based on the OD, set up large scale culture (60~100 ml in 225 ml flask)  
 1) Adjust initial OD ~ 0.02-0.05 
 2) Incubate at 37°C with shaking (225 rpm) until OD600 reach 0.4~0.6 
  (DON’T go above 0.6) 
 •  for Tudor protein, usually take 1.5~2 hr to reach 0.6 
 •  for core histones, 7~8 hr 
 
 3) When OD is close to 0.6, add IPTG (stock 1M) to desired concentration 
 •  for Tudor protein, use 1 mM IPTG 
 •  for core histones, use 0.1 mM IPTG 
 
 4) Specific conditions for induction 
 •  for Tudor protein, incubate at 14°C with lower speed shaking (175 rpm) for 
overnight (14-16 hr) 
 •  for core histones, incubate at 37°C with shaking (225 rpm) for 3~4 hr  
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 IMAC for 6x His-tagged Tudor proteins 
This protocol is based on the instruction for Chelating Sepharose Fast Flow (GE, 
17-0575-01) 
1. Prepare beads: beads bed (referred to as bed volume (BV), the actual volume for 
beads, not the slurry) = 300 ul; 700~800 xg, RT, for 2~3 min; remove solution. 
 Calculate how many beads you need, typically 50 ul BV per tube 
 Thus 5 Rx needs 50 x 5 = 250 ul → prepare 300 ul (6 Rx) (one more Rx for spare) 
2. Milli-Q water wash x 2 times (> 2 BV), use 1500 ul x 2 
3. Load 0.2 M NiCl2 to beads (> 0.2 BV), use 1.5 BV (300 x 1.5 = 450 ul) 
 RT with rotation for 1 h 
4. Milli-Q water wash (> 5 BV), 1500 x 2 
5. Acid buffer wash (> 5 BV), 1500 x 2 
 Check pH of the supernatant = 4.0 
6. His-binding buffer wash (> 5 BV), 1000 x 2 
7. Resuspend beads in  
 Aliquot beads, 50 ul BV per tube; remove excess solution after centrifugation 
8. Load sonicated lysate into beads 
 Lysate conc.: 50 OD/ml 
 Lysate-to-beads ratio: 30 : 1, means 50 ul BV of beads is capable to purify all Tudor 
from 1500 ul of bacterial lysate.  The volume of bacterial lysate loaded is referred to 
as LV. 
 If the lysate is prepared in PB/NaCl (20 mM sodium phosphate, 150 mM NaCl), 
adjust conc. for NaCl to 300 mM and imidazole to 5 mM BEFORE LOADING 
LYSATE TO BEADS 
 Incubate at RT for 1 h with rotation 
9. 3000 rpm, 5 min ; collect supernatant as unbound control 
10. Add 1 LV of His-washing buffer 
 3000 rpm, 5 min; collect supernatant as wash control 
11. His-washing buffer wash x 1 (1 LV) 
12. Elute proteins in 1/5 LV of His-elution buffer (5 times concentrated, decide this factor 
based on induction levels), RT with rotation for 1 hr. 
13. Centrifuge to collect supernatant as Elutant 1 (E1); add 1/5 LV of His-elution buffer 
to beads again, store at 4°C. 
14. Next day, collect the supernatant as Elutant 2 (E2) 
15. Run SDS-PAGE with BSA to estimate concentration and to check purity. 
IMAC for 6x His-tagged Tudor proteins 
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IMAC for 6x His-tagged Tudor proteins (continued – 2/3) 
 
Acid buffer (50 ml) 
 2 M NaOAc pH 4.0 500 ul 0.02 M 
 5 M NaCl 5.0 ml 0.5 M 
 
His-binding buffer (50 ml) 
 0.2 M sodium phosphate pH 7.5 12.5 ml 50 mM 
 5 M NaCl 3.0 ml 200 mM# 
 2 M imidazole 125 ul 5 mM 
 
His-washing buffer (50 ml) 
 0.2 M sodium phosphate pH 7.5 12.5 ml 50 mM 
 5 M NaCl 3.0 ml 200 mM# 
 2 M imidazole 500 ul 20 mM 
 
His-elution buffer (50 ml) 
 0.2 M sodium phosphate pH 7.5 12.5 ml 50 mM 
 5 M NaCl 3.0 ml 200 mM# 
 2 M imidazole 12.5 ml 500 mM 
#: in later sets of purification, this NaCl concentration was increased to 300 mM to 
decrease nonspecific binding based on Craig’s recommendation. 
 
2 M imidazole 
Always prepare small scale (don’t use solution if older than 2 weeks); not stable in 
solution! 
Take 6.8 g of imidazole (M.W.=68.08) dissolve in 40 ml autoclaved Milli-Q water, 
pH to 7.4 with HCl and fill up to 50 ml 
Before adjust pH, pH ~= 10.8xx; take ~ 116 drops (~4.4 ml) of 12.1 M HCl to get pH 
7.4.  Store at 4°C. 
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IMAC for 6x His-tagged Tudor proteins (continued – 3/3) 
 
0.2 M Sodium phosphate pH 7.5 
1. To make 0.2 M sodium phosphate at desired pH, first prepare the following two 
stock buffers separately, 
0.2 M monobasic stock 
13.9 g sodium phosphate monobasic (NaH2PO4) in 500 ml Milli-Q water (pH ~ 
4.3)  
0.2 M dibasic stock 
53.65 g sodium phosphate dibasic heptahydrate (Na2HPO4·7H2O) in 1 L Milli-Q 
water (pH ~ 8.9) 
2. Combine quantities of each stock and add water to bring up to 50 ml. 
 
monobasic (ml) dibasic (ml) pH 
 46.75 3.25 5.7 
 46.00 4.00 5.8 
 45.00 5.00 5.9 
 43.85 6.15 6.0 
 42.50 7.50 6.1 
 40.75 9.25 6.2 
 38.75 11.25 6.3 
 36.75 13.25 6.4 
 34.25 15.75 6.5 
 31.25 18.75 6.6 
 28.25 21.75 6.7 
 25.50 24.50 6.8 
 22.50 27.50 6.9 
 19.50 30.50 7.0 
 16.50 33.50 7.1 
 14.00 36.00 7.2 
 11.50 38.50 7.3 
 9.50 40.50 7.4 
 8.00 42.00 7.5 
 6.50 43.50 7.6 
 5.25 45.25 7.7 
 4.25 45.75 7.8 
 3.50 46.50 7.9 
 2.65 47.35 8.0 
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Peptide Coupling to SulfoLink Sepharose & pull-down assay 
Part I – Preparation of DTT-reduced peptides 
1. Spin-vacuum dry 100 ug (~50 nmol) (small scale) of histone H4 peptides; for 
scale-up, use 1 mg 
2. Dissolve dried peptides in 50 ul of 100 mM DTT and incubate at room temperature 
for 4 hours and store at 4 at 4°C overnight. 
 100 ug peptide in 50 ul of 100 mM DTT 
 1 mg peptide in 500 ul of 100 mM DTT 
3. Run reverse phrase HPLC (RP-HPLC) to purify peptides (desalt and remove DTT) 
4. Spin-vacuum dry the collected fractions corresponding to H4 peptides 
5. Keep the dried peptides at -20°C until ready to do coupling (Part II – Step 5) 
6. Dissolve peptides in 200 ul of coupling buffer (optional: pH to 8-9 with Tris 
powder and check pH with pH stripe).  Save 1/100 as uncoupled control▲ 
 
Part II – Coupling peptides to sepharose beads 
1. Take 1200 ul (for 3 Rx) of SulfoLink beads (PIERCE, SulfoLink® Coupling Gel, 
20402) to proper tubes.  
 The ratio of peptide(mg)-to-beads(ml) is usually 1(mg)-to-1(ml), but for capturing 
most of peptides, begin with 1(mg)-to-2(ml). 
 50% slurry, thus 1200 ul = 600 ul beads ; 200 ul of beads is for 100 ug peptide. 
2. Wash with at least equal volume of coupling buffer 
 Use 1 ml to wash x 3 (1000 xg, 5 min to collect beads) 
3. Resuspend beads in desired volume and aliquot to 3 tubes (3 Rx) 
4. Drain the beads (remove excess buffer) (NOW 200ul beads/tube) 
5. Load the reduced peptides from Part I to the beads (becomes 100 ug of peptide in 
400 ul of 50% slurry); incubate at room temperature for > 4 hours and then leave at 
4°C overnight  
6. 1000 xg, 5 min to collect beads; save supernatant for coupled control 
7. Add at least equal volume of 50 mM cysteine to beads for blocking the uncoupled 
beads; incubate at room temperature for 4 hours and then move to 4°C (store in 
this condition until finishing the RP-HPLC for estimating coupling efficiency) 
8. Remove buffer and wash with equal volume of 1X TBST with 0.02% NaN3 and 1 
mM AEBSF. 
 1 ml per wash, 3 times 
9. Resuspend in desired volume (based on molecular weight and coupling efficiency) 
of 1X TBST with 0.02% NaN3 and 1 mM AEBSF, and store at 4°C.  The beads are 
ready for pull-down assay.  The final concentration of peptide in this 50% 
slurry should be around 250 M (50 nmol in ~200 l of 50% slurry). 
Peptide Coupling to SulfoLink Sepharose 
& ull-down ass y
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Peptide Coupling to SulfoLink Sepharose & pull-down assay (Continued – 2/3) 
 
Part III – Evaluation of coupling efficiency by RP-HPLC 
1. Run RP-HPLC for uncoupled and coupled controls 
2. Compare the area under the peak corresponding to H4 peptides. 
 Ideally there should be no peak for the coupled control (all peptides are 
conjugated to beads); however, the efficiency ranges 70-100%. 
 
R
)O'(R' - O)(R
couplingEfficiency
  
Before coupling: Peak area from Reduced peptide (R) 
 Peak area from Oxidized peptide (O) 
After coupling: Peak area from Reduced peptide (R') 
 Peak area from Oxidized peptide (O') 
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Peptide Coupling to SulfoLink Sepharose & pull-down assay (Continued – 3/3) 
 
Part IV – Set up pull-down assay based on concentration-calibrated peptides 
1. Calibrate the molar number of each peptides/beads based on the molecular weight 
of peptide and the coupling efficiency and then balance the beads amount in the 
end. 
 For example: 
 WT K20me2 
M.W. 2022 2038 
Before coupling 100 ug 100 ug 
Coupling Efficiency 85% 95% 
How many peptides coupled to beads (nmol) 42.03 46.61 
100 ug/2022 x 0.85 = 42.03 nmol 
 Two factors need to be balanced:  
1) molar number of peptides 
2) amount of beads 
 
To balance peptides, simply take different amount of beads 
 WT K20me2 
Take x l of peptide-coupled slurry 100 l 90 l 
 
To balance the beads amount: 
 WT K20me2 
Volumes of peptide-coupled slurry 100 l 90 l 
Add MOCK slurry - 10 l 
The mock slurry is made by mixing beads with 50 mM cysteine; remove excess 
cysteine and wash with TBST. (See PartII – Step 7 & 8) 
 
2. Remove the excess buffer from the balanced  beads 
3. Load IMAC-purified Tudor protein to the beads 
 Incubate at room temperature for 1 hour and then move to 4°C overnight 
4. 1X TBST wash x 3 times 
5. Add 100 l of 2X sample buffer; 95°C for 5 min 
6. Load 20-30 l for 15% SDS-PAGE 
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2X Sample buffer and preparation of whole cell extract for immunoblotting 
1. After desired treatment, place cells (plates, dishes) on ice 
2. Remove medium 
3. Add 500 ul of cold-“TBS (PBS)+Ai” (Ai for all inhibitors) per 10 cm dish 
4. Scrape cells from surface by using cell lifter/scraper 
5. Transfer cells to eppendorf (on ice) 
6. Pellet the cells by centrifugation at 700xg, 4°C for 10 min 
7. Remove liquid and disrupt the cell pellet 
8. Heat “2X Sample Buffer (SB)+Ai” on 95C heatblock for 1~2 min.  When disrupted 
cell pellet is ready on ice, add AEBSF to heated 2X SB at final conc. of 1 mM 
9. Add ~150 ul heating 2X SB to eppendorf and immediately vortex the tube 
10. Place tubes on heatblock for another 2 min 
11. Samples can be snap-frozen in dry ice/ethanol bath or go forward for sonication 
12. Sonication usually is done by 25~30 pulses at 4~5 of power output, 50% duty cycle. 
13. After sonication, briefly heat the samples again on 95C heatblock for 2 min 
 
 
2X Sample Buffer with all inhibitors† (2X SB+Ai) 
For making 50 ml Final conc. 
 1 M Tris·Cl pH 7.5 1 ml 20 mM 
 0.5 M EDTA 2 ml 20 mM 
 SDS 1 g 2 % 
 Glycerol (d=1.26g/ml) 10 ml=12.6 g 20 % (v/v) 
 Bromophenol Blue 0.002 g 0.004 % 
 Dithiothreitol (DTT) 1.542 g 200 mM 
 5 M NaB† 100 l 10 mM 
 250 uM TSA† 100 l 500 nM 
 2 M Nicotinamide† 250 l 10 mM 
 5 M Microcystin LR† 50 l 5 nM 
 1 M NaF† 50 l  1 mM 
 200 mM activated Na3VO4† 250 l 1 mM 
Fill up to 50 ml, aliquot and store at -80°C 
†: choose appropriate inhibitors for your specific application 
 
AEBSF 
To prepare 500 mM 4-(2-Aminoethyl)-benzenesulfonylfluoride hydrochloride 
(BIOSYNTH, A-5440) M.W.= 239.5, 
Dissolve 1.2 g in a final volume of 10 ml autoclaved Milli-Q water; aliquot and store 
at -80°C. 
2X Sample buffer and 
pre aratio of wh le cel  extract r i munoblotting
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2X Sample buffer and 
preparation of whole cell extract for immunoblotting 
(Continued – 2/2) 
 
NaB (Sodium Butyrate) 
 To prepare 5 M NaB stock (store at -20°C), 
1. Pipette 23 ml of butyric acid into 150 ml beaker containing a stir bar. 
2. Add 20.5 ml of 10 N NaOH slowly with stirring to avoid excess heat generated. 
3. Cool to room temperature, and adjust pH to 7.0 (general purpose in cell harvest) or 
to 7.4 (cell culture) by adding NaOH dropwise. 
4. Adjust final volume to 50 ml (by autoclaved milli-Q water). 
 
TSA 
To prepare 5 mM Trichostatin A (TOCRIS, 1406) M.W.= 306.88,  
Dissolve 1 mg (whole bottle) in 652 ul of DMSO or ethanol (EtOH). 
This 5 mM is super-stock!  Store at -20°C. 
Dilute to 250 or 500 M for working stock. 
 
Nicotinamide (NAM) 
2 M as stock, store at -20°C. 
 
Microcystin LR (CalBiochem, Cat# 475815) 
5 M as working stock, store at -20°C. 
 
NaF 
1 M NaF as stock, store at room temperature. 
 
Na3VO4 
This procedure depolymerizes the vanadate, converting it into a more potent inhibitor 
of protein tyrosine phosphatases. 
1. Dissolve 1.84 g of sodium vanadate in 45 ml autoclaved water in a small beaker 
with a stir bar.  
2. Adjust the pH to 10 using either 1 N NaOH or 1 N HCl, with stirring.  The starting 
pH of the sodium orthovanadate may vary with lots of the chemical.  At pH 10, 
solution will be yellow. 
3. Boil solution until it turns colorless.  All of the crystals should dissolve. 
4. Cool to room temperature. 
5. Readjust the pH to 10 and repeat steps 3 and 4 until solution remains colorless and 
pH stabilizes at 10.  Adjust the final volume to 50 ml with autoclaved water. 
6. Aliquot the activated sodium orthovanadate in 1.5 ml eppendorf and store at -20°C. 
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Reagents for SDS-PAGE & Immunoblotting 
Few reagents have been introduced‡ and are NOT identical to those in Craig’s lab.  
You should understand what you’re doing and the purposes for certain reagents! 
 
4X Tris-HCl/SDS (pH 8.8) for separating gel‡ (for 400 ml) 
 Tris·base 72.8 g 1.5 M 
 SDS 1.6 g 0.4 % 
1. Place 72.8 g of Tris·base in ~300 ml autoclaved Milli-Q water 
2. Before adjust pH, pH ~= 11.0 
 Adjust pH to 8.8 by adding 12.1 M HCl (take ~10 ml) 
3. Fill up to 400 ml 
4. Filter the solution via 0.22 m filter 
5. Add 1.6 g SDS 
 
4X Tris-HCl/SDS (pH 6.8) for stacking gel‡ (for 400 ml) 
 Tris·base 24.2 g 0.5 M 
 SDS 1.6 g 0.4 % 
Do same procedures as in 4X Tris·HCl/SDS (pH 8.8), except adjust pH to 6.8 
 
30:0.8 acrylamide 30% liquid gel (for 500 ml) 
Beware of both acrylamide and bis-acrylamide are light-weight powder and also toxic.  
Wear N95 respirator mask if necessary. 
1. Add 4 g bis-acrylamide to 250 ml of autoclaved milli-Q water while stirring. 
 Bis-acrylamide is hydrophobic and will float on the surface! 
2. Add 146 g acrylamide to submerge these floating bis-acrylamide crystals. 
3. Add water up to ~450 ml. 
4. Cover the beaker and stir for at least 2 h. 
5. Filter the solution via 0.22 um filter, wrap bottle in aluminum foil and store at 4°C. 
 
10% APS 
Add 1 g of ammonium peroxydisulfate (APS, (NH4)2S2O4) to 8 ml autoclaved Milli-Q 
water in 15 ml conical tube.  Fill up to 10 ml and store at 4°C. 
 
Reagents for SDS-PAGE & Immunoblotting 
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Reagents for SDS-PAGE & immunoblotting (continued – 2/4) 
 
Prepared for 2 thick (1.5 mm) gels 
Separating gel‡ 5% 15% 
30% liquid gel 2.64 ml 8.00 ml 
4X Tris·HCl/SDS, pH 8.8 4.00 ml 4.00 ml 
Milli-Q water 9.28 ml 3.92 ml 
10% APS 80 l 80 l 
TEMED 12.5 l 10 l 
 16 ml 16 ml 
 
Quick Table for separating gel 
Separating gel‡ 15% 15% 15% 15% 5% 5% 
30% liquid gel 6.00 ml 8.00 ml 10.00 ml 12.00 ml 1.65 ml 2.64 ml 
4X Tris·HCl/SDS, pH 8.8 3.00 ml 4.00 ml 5.00 ml 6.00  ml 2.50 ml 4.00 ml 
Milli-Q water 2.90 ml 3.92 ml 4.90 ml 5.88  ml 5.80 ml 9.28 ml 
10% APS 60 l 80 l 100 l 120 l 100 l 100 l 
TEMED 10 l 10 l 12.5 l 15 l 12.5 l 12.5 l 
 12 ml 16 ml 20 ml 24 ml 10 ml 16 ml 
 
Volume required for short gel (8.5 cm x 6.0 cm) ~= 7.0 ml/gel 
 long gel (8.5 cm x 7.5 cm) ~= 9.5 ml/gel 
 
4% Stacking gel‡ 1 gel 2 gel 3 gels 
30% liquid gel 333 666 999 ul 
4X Tris-HCl/SDS, pH 6.8 635 1250 1875 ul 
Milli-Q water 1.5 3.0 4.5 ml 
10% APS 25 50 75 l 
TEMED 10 10 10 l 
 2.5 5.0 7.5 ml 
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Reagents for SDS-PAGE & immunoblotting (continued – 3/4) 
10X Running buffer (Res buffer in CM Lab) (for 2.5 L) 
 Tris-base 75.5 g 0.25 M 
 glycine 360.0 g 2 M 
 SDS 25.0 g 1 % 
Adjust pH to 8.3 
Dilute to 1X for routine usage. 
 
10X Transferring buffer (for 3.0 L)‡ 
 Tris-base 90.9 g 0.25 M 
 glycine 432.0 g 2 M 
 SDS★ 12.0 g 0.4 % 
After preparation, pH ~= 8.7x, DON’T adjust pH. 
In CM Lab, this buffer is NOT used to be prepared in 10X. 
★: quick comparison – 0.4% SDS in CM Lab, 1% SDS in SJT Lab; both have been 
tested, okay for histone works. 
 
1X Transferring buffer (Towbin’s buffer) (for 1.0 L)‡ 
 10X Transferring buffer 100 ml 1X 
 methanol☆ 150 ml 15% 
If desired, adjust pH to 8.3 
☆: 10% in CM Lab; adjustable range: 10~20% 
 
10X TBST (for 1.0 L) 
 Tris-base 24.22 g 0.2 M 
 NaCl 90.00 g 1.5 M 
 Tween-20 (d=1.1g/ml) 10 ml=11.0 g 1 % (v/v) 
 
Ponceau S (for 500 ml) 
 Ponceau S 2 g 0.4% 
 TCA 40 g 8.0% 
 Acetic acid 10 ml 2.0% 
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Reagents for SDS-PAGE & immunoblotting (continued – 4/4) 
Coomassie blue 
 CBR-250▽  0.05 % 
 Methanol (CH3OH, MeOH)  50 % 
 Acetic acid (CH3COOH)  10 % 
▽: CBR-250, Coomassie brilliant blue R-250 
 
Coomassie blue destaining buffer 
 Methanol (CH3OH, MeOH)  10 % 
 Acetic acid (CH3COOH)  5 % 
 168
SDS-PAGE & Immunoblotting 
1. Cells are used to be harvested in 2X SB.  Typically 150 ul for cells from 10 cm dish, 
loading 10~20 ul /well is enough (depends on the affinity of specific antibody). 
2. Mark wells and interface on glass-plate if necessary. 
3. Conditions for Electrophoresis & Transfer※, 
  Short gel Long gel 
E
le
ct
ro
ph
or
es
is Fast-Run 
(larger proteins) 
Upper 
200 V•15 min 200 V•15 min 
until all proteins enter lower gel 
Lower 
160 V•50 min 160 V•70 min 
run until dye-front reaches bottom
Slow-Run (for histone proteins, 
especially H4) 
Upper 60 V•50 min 
 
Lower 150 V•60 min 
T
ra
ns
fe
r 
Cutting 3M papers & PVDF membranes in 
following sizes 
9 x 6 cm2 9 x 7.5 cm2 
Determine the current needed (area in cm2 x 0.95): 
1 gel:  9 x 6 x 0.95 = 51 mA →still use 105 mA for 100 min 
2 gels:  9 x 6 x 2 x 0.95 = 102 mA for 100 min 
※: If this gel is for Coomassie blue or sliver staining, skip transfer procedures and go 
ahead for Coomassie blue or sliver staining! 
4. After transferring, briefly check how efficient the transfer is; place membranes in 
deionized water for 1~2 min, and then stain in Ponceau S (PS) solution for 2~5 min. 
5. Destain membranes in deionized water and scan the membranes in lab scanner. 
6. Blocking in 5% non-fat milk for 1 h at room temperature (RT). 
7. Incubate with primary antibody (1⁰ Ab), at RT for 1 h or at 4°C for overnight with 
agitation. 
8. 1X TBST wash x 3 times. 
9. Incubate with secondary antibody (2⁰ Ab), at RT for 1 h with agitation (NEVER do 
overnight incubation). 
10. 1X TBST wash x 3~5 times. 
11. Prepare ECL (equal volume from each bottle) in 50 ml conical tube (re-used tube) 
 Be careful! DON’T cross-contaminate these two reagents. 
 Incubate membranes with ECL (0.5~1.0 ml/membrane) for 1 min; DON’T LET 
MEMBRANES DRY! 
12. X-film exposure & development. 
SDS-PAGE & Immunoblotting 
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SDS-PAGE & Immunoblotting (Continued – 2/2) 
 
Notes for transferring 
1. Wet PVDF membranes in methanol for exact 1 min. 
 For nitrocellulose membrane, wet in 1X transferring buffer. 
2. Incubate membrane in 1X transferring buffer for 3~5 min 
3. Equilibrate gel in 1X transferring buffer at least for 5 min (NOT longer) 
4. Wet 3M papers in 1X transferring buffer; remove air from the paper as much as you 
can. 
5. Casting sandwich for semi-dry: 
 How are the proteins charged in 1X transferring buffer?  (negative or positive?!) 
 
 
 
 
 
 
 
 
 
 
 
6. Set up constant current based on the area (cm2) of your sandwiches, maximize the 
voltage and run for 100 min 
 
 
3 pieces of 3M paper 
3 pieces of 3M paper 
Gel 
Methanol wetted membrane 
Cathode 
Anode 
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 Micrococcal Nuclease (MNase) digestion on coverslips 
1. Cells grown on glass coverslips were subjected to desired treatment, for example, 
bleocin (10 ug/ml for 1 h) 
2. Fixed and permeabilized in 4% PFA/0.25% Triton X-100 in PBS, at room 
temperature for 15 min (do step 4 during the period of 
waiting) 
3. PBS wash x 3 (to remove any residual PFA)  
4. Prepare MNase Rx on ice 
 
  Final  Example 
 1 Rx conc 250 ul x 5 U/ml = 1.25 U (total) 
 5X MN Buffer 16 ul 1 x 50 ul 
 0.5 U/ul MNase x ul 5 U/ml 2.5 ul 
 Water 64 ul - 200 ul 
 Vol/Rx 80 ul 
5. Aliquot MNase Rx (80 ul/well) onto individual wells in clean 6 well-plate on ice 
 Place coverslips (from step 3) to individual wells (cell side faced down) 
6. Incubate plates at 37°C (the incubator for bacteria culture) for 30 min 
7. STOP reaction: Prepare STOP solution: 5 mM EDTA in 1X TBST (500 ul 0.5M 
EDTA + 49.5 ml 1X TBST) 
 a) on ice and then add 2 ml of STOP solution/well; wait for 3~5 min on ice 
 b) wash cvs with STOP solution x 2; then sit on ice for another 5 min 
8. Immerse cvs in 1x TdT buffer at least 10 min on ice 
9. Prepare TdT Rx 
 1 Rx 
Roche Vial 1(TdT) 5 ul 
 Vial 2 (dNTP) 45 ul 
 Vol/Rx 50 ul 
10. Aliquot TdT Rx (50 ul/well) onto individual wells in clean 6 well-plate on ice 
11. Incubate plates at 37°C (the incubator for bacteria culture) for 2 hr 
MNase stock conc. 50 U/ul 
dilute 100x in 1X MN buffer (2 
ul MNase + 198 ul 1X MN 
buffer) to get 0.5 U /ul 
ul 2.5
 U/ul0.5
 U1.25 
Micrococcal Nuclease (MNase) digestion on coverslips 
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Micrococcal Nuclease (MNase) digestion on coverslips (Continued – 2/2) 
12. STOP TUNEL assay: 
 a) on ice and then add 2 ml of STOP solution/well 
 b) wash cvs with TBST x 2 
13. After step 12: 
 a) samples can be proceeded to confocal microscopy for FdT (Fluorescein-labeled dTTP) 
or b) proceeded to IF protocols: Do blocking NOW (see IF protocol for detail) 
Reagents & Buffers 
TdT Kit 
In Situ Cell Death Detection Kit, Fluorescein (Roche, 11 684 795 910) 
2 kinds of vial – one for TdT and the other for dNTP 
 
5X MN Buffer (for 50 ml) 
 Tris·Cl pH 8.0  250 mM 
 5 M NaCl  200 mM 
 2 M CaCl2  5 mM 
 
STOP solution (for 50 ml) 
 0.5 M EDTA 0.5 ml 5 mM 
 1X TBST 49.5 ml ~ 1X 
 
5X TdT buffer (for 100 ml) 
 Tris·Acetate 1.211 g 100 mM 
 KOAc 2.454 g 250 mM 
 Mg(OAc)2 1.072 g 50 mM 
1. Dissolve above reagents in ~ 70 ml autoclaved Milli-Q water 
2. Adjust pH to 7.9 with acetic acid 
3. Fill up to 100 ml with autoclaved Milli-Q water 
4. Filter via 0.22 m membrane 
 
1X TdT buffer (prepared from 5X TdT buffer) 
 5X TdT buffer  1 X 
 0.5 M CoCl2  5 mM 
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BrUTP labeling for nascent RNA 
Day 0 
 Seeding cells on glass coverslips in 6 well-plates (50-70% confluence) 
Day 2 
 Do desired treatment on cells; take bleocin treatment as example:  
1) Reschedule time point for BrUTP uptake 
Original desired time to harvest is at 1 hr (bleocin treatment for 1 hr) 
1 hr - 15 min (time for BrUTP intake) = 45min 
2) After beginning treatment, 7~10 min before time is up (the 45 min time point): prepare 
the FuGENE 6 (FG6)/BrUTP mixture as following:  
  1Rx 
 2X HeBS 67.5 ul 
 water 67.5 ul 
 FG6 15.0 ul 
 Let this FG6 solution sit at room temperature for 5 min 
3) add 10 ul of 500 mM BrUTP into the FG6 solution (final conc. of BrUTP is 5 mM)  
 Let the FG6/BrUTP mixture sit at room temperature for 15 min 
4) During the waiting time of 15 min, set up a clean parafilm wrapped on the tile surface 
(in Lab not Cell culture room).  When 15 min is up, take whole 6 well-plate back in 
lab. 
5) Aliquot 140 ul of FG6/BrUTP onto parafilm surface in a proper spacing 
6) Pick up coverslips from 6 well-plate by a pair of tweezers, and then directly place on a 
drop of FG6/BrUTP (cell side faces down). 
7) Room temperature for 15 min (for BrUTP uptake)  
 During this peroid of time, DON’T throw out the 6 well-plate yet! Put them back in 
37°C cell incubator 
8) When 15 min is up, place coverslips back to the well when it came out 
9) Place 6 well-plate back in 37°C cell incubator for another 30 min (allowed for BrUTP 
incorporation); this incubation time can be adjusted.  Shorter time (15 min) has been 
tested, and the signal is much lower.  
10) Do fixation and permeabilization procedures based on your target protein 
 In the case of 53BP1, 2 or 4% PFA/0.25% Triton X-100 in PBS, room temperature 
for 15 min (See IF protocol) 
2X HEPES-buffered Saline (2X HeBS) 
(2X HeBS, recipe from Invitrogen) 
For making 200 ml Final conc. 
 NaCl 3.28 g 280 mM 
 HEPES 2.38 g 50 mM 
 Na2HPO4·7H2O 0.0804 g 1.5 mM 
pH with NaOH to 7.05; then store at -20°C, avoid from light 
BrUTP labeling for nascent RNA 
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General protocol for immunofluorescence staining (IF) 
1. Fix & permeabilize cells on coverslips (22 mm sq; Corning, 2870-22) 
 1) Take coverslips out of medium and do PBS wash x 3 times 
  DON'T use TBS before/after any procedures involved PFA! 
 2) Choose one of three protocols best to your experiment (See Fig. 2.6A for 
illustration; for 53BP1, use F/P) 
•Fixed and then permeabilized (F→P): 
Fixed in 4% PFA/4% sucrose/PBS, RT 12 min →  PBS wash x 3 → 
Permeabilized in 0.2% TX-100/PBS, RT 20 min → TBST wash x 3 
•Fixed and permeabilized simultaneously (F/P): 
Fixed & permeabilized in 4% PFA/4% sucrose/0.25% TX-100/PBS, RT 15 min 
→ PBS wash x 3 
•Permeabilized and then fixed (P→F): 
Permeabilized in 0.2% TX-100/PBS, RT 15 min → PBS wash x 3 → Fixed in 4% 
PFA/4% sucrose/PBS, RT 12 min → PBS wash x 3 
2. Blocking in IF blocking buffer at RT for 1 hr or at 4°C overnight 
3. Prepare primary antibody (1° Ab) in IF blocking buffer 
 1) Make proper dilution for 1° Ab (1:100 ~ 1:1000, see Table 2.1) 
 2) Place coverslips (cells face up) on the tile (~ 6” x 8”) wrapped with parafilm and 
add 50~200 ul diluted primary antibody onto the coverslip 
 3) Incubate at RT for 2 hr in a humidified chamber 
4. 1x TBST wash x 3 times 
5. Prepare secondary antibody (2° Ab) & TO-PRO-3 (optional) 
 1) Use 2° Ab in 1:500 dilution 
  Use TO-PRO-3 in 1:1000 dilution 
 2) 150 ul/coverslip 
 3) Incubate at RT for 1 hr in a dark and humidified chamber 
6. 1x TBST wash x 3 times 
General protocol for im unofluorescence staining (IF) 
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General protocol for immunofluorescence staining (IF) (Continued – 2/3) 
 
7. Mount coverslips on the slide 
 1) Add one drop of VECTASHIELD® Mounting Media for each coverslips 
  Usually mount 2 coverslips on a single slide (3” x 1” x 1mm; Fisher 12-544-3) 
 2) Carefully and gently remove excess mounting media from the edges of coverslips 
by placing Kimwipes papers on the slide with proper pressure 
8. Seal 4 edges of coverslips with nail polish 
9. Allow nail polish to be dry at RT for 10~15 min in a dark environment (box, drawer 
or wrapped with aluminum foil) 
10. Briefly wash slides with water by using a squirt bottle to remove salts on the surface 
11. Store slides at 4°C and go confocal as soon as you can!!!!  Signals can have 
noticeable decrease just for an overnight storage 
 
Reagents & Buffers 
4% PFA/(4% sucrose) in PBS 
IF done with 2% or 4% PFA shows no difference, and 4% PFA with or without 
sucrose has no difference either. 
1. Weight 2 g of paraformaldehyde (PFA) and 2 g sucrose (optional) in 40 ml PBS; 
add 50 l of 10N NaOH to facilitate PFA dissolved 
2.  Heat at 60°C for 1-2 hours and then leave on shaker at room temperature 
overnight.  (It is normal to see some insoluble particles after overnight shaking) 
3. Fill up to 50 ml with 1X PBS 
4. Filter by syringe/filter; check pH by pH stripe! (Don't use pH meter, most probe is 
NOT compatible with PFA) 
6. a. Aliquot in 15 ml conical tubes (14 ml/tube) and store at -20°C 
 b. For preparing 4% PFA/(4% sucrose)/0.25% Triton X-100, add 175 l of 20% 
Triton X-100 to 14 ml of aliquoted solution, and then store at -20°C 
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General protocol for immunofluorescence staining (IF) (Continued – 3/3) 
 
Permeabilizing buffer 
To make 0.2% Triton X-100 in PBS, add 140 l of 20% Triton X-
100 to 14 ml PBS, and then store at room temperature 
 
IF Blocking buffer (for 50 ml) 
 BSA 1 g 2 % 
Fetal Bovine Serum (FBS) 1 ml 2 % 
 20% Tween 20 500 l 0.1 % 
 6.5% NaN3 150 l 0.02 % 
 
10X PBS (for 1L) 
 NaCl 80.05 g 1370 mM 
 KCl 2.01 g 27 mM 
 Na2HPO4·7H2O 26.81 g 100 mM 
 KH2PO4 2.72 g 20 mM 
DON'T adjust pH!  pH should be ~7.4 
 
10X TBST (for 1L) 
 Tris·Cl 24.22 g 0.2 M 
 NaCl 90.00 g 1.5 M 
 Tween-20 (d=1.100 g/ml) 11.00 g 1.0 % 
DON'T adjust pH!  pH should be ~7.5 
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 Site-directed Mutagenesis 
1. Set up and run PCR 
 1 Rx (l) 
 10X Pfu Buffer 2.0 
50 mM MgCl2 (for Taq buffer only) 0.6 
 10 mM dNTP 0.4 
 20 M primer F 0.4 
 20 M primer R 0.4 
 DNA template (-) plasmid 50-100 ng/Rx 
 DNA polymerase (-) 1.5 l 2.5U/l Pfu or 0.1 l 5U/l Taq 
 H2O (-) 
 Total 20.0 
 
Standard Pfu thermo program for mutagenesis: 
95°C, 6 min (if using Taq, omit this step) 
[95°C, 30 sec; 55°C†, 30 sec; 68°C, 11 min‡] x 18 cycles 
68°C, 10 min 
4°C, ∞ 
†: adjust temperature based on your sequence and results 
‡: 11 min is the default; for longer template, adjust to 13 min 
2. DpnI digestion 
 Add 1 l DpnI/Rx, 37°C incubation for overnight 
3. Take 5 l for transformation.  Usually spreading 100 l is good enough to get 
reasonable amount of single colonies (See transformation protocol) 
 
Quick trouble shooting: 
 Few colonies: check your transformation protocol for heatshock time, DH5 
efficiency, low PCR amplification (annealing T is too high) 
 Too many colonies or clones identical to WT: dead DpnI or improper PCR conditions 
(mispriming) 
 High mutation rate, especially multiple inserts:  annealing T is too low or bad primer 
design (primer dimer) 
 
Site-directed Mutagenesis 
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Restriction Enzyme digestion and DNA ligation 
 
Restriction Enzyme digestion 
  1 Rx 
 10X Buffer† 1.0 l 
 10X BSA 1.0 l prepare 10X from 100X 
 Restriction enzyme (RE) 10-20 U 
 plasmid DNA 1-2 g 
 H2O (-) 
 Total 10.0 
Incubate at 37°C overnight 
†: When doing double digestion, always choose the buffer giving maximal activity for 
both enzymes and also avoid the buffer which may cause star activity 
 
 
Ligation 
  1 Rx 
 5X Buffer 2.0 l 
 T4 DNA ligase (1U/l) 1.0 l 
 vector 10-20 U 15-30 fmol/Rx 
 insert 1-2 g 3-5 time of vector (range 100-150 fmol/Rx) 
 H2O (-) 
 Total 10.0 
Incubate at 14°C overnight 
 
Restriction E zyme digestion and DNA ligation 
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E.coli Transformation 
1. Mix the following materials ON ICE!!! 
  1 Rx 
 Competent cells† 50 l 
 0.5 M -ME (optional) 2 l 
 DNA(1) (-) 
 
†: Thaw competent cells ON ICE!  NEVER use your body temperature (hand) to warm 
it!  
 Use appropriate cells for your experiment and have records for what strain and batch 
you use! 
 DH5 for plasmid preparation and clone checking etc. 
 BL21(DE3) or BL21(DE3) pLys for protein expression 
 
2. On ice 30 min 
3. 42°C for 1 min; this time may vary and affect transforming efficiency a lot! 
4. On ice 10-15 min 
5. Add LB (no antibiotics) 250 l(2) to transformed cells 
6. Incubate at 37°C for  1 hour(3) 
7. Spread 100 l(4) on LB-plate with appropriate antibiotic 
 (add 50 l of 50 mg/ml carbenicillin to one LB plate and evenly spread it!) 
8. Incubate LB plates at 37°C overnight (16-18 hours) 
Use (1)-(4) well to control colony number: 
  Step.1 Step.5 Step.6 Step.7 
 Intact plasmid 2 l (0.1-1.0 ng/Rx) 250 1 hr 50-100 l 
 TA cloning 2-5 l 250 1 hr 50-100 l 
 Site-directed mutagenesis 5 l 200 1 hr 100-200 l 
 General cloning 10 l 200 2-3 hr 200-250 l 
 (gel-purified vector/insert) 
 
 
E.coli Transformation 
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Preparation of Competent cells for transformation 
 
1. Pick up single colony and grow in 3 ml SOB overnight (LB is an okay substitute for 
SOB, same for the following steps) 
2. Inoculate cells into flask containing SOB and culture at 37°C until OD600 = 1.00; 
 the volume corresponding to culture at density of 1 OD600 is “V”. 
3. Pellet cells by centrifugation at 750-1000 xg for 12-15 min at 4°C 
4. Resuspend the pellet in 1/3 V of RF1, disrupt the pellets gently (DON’T vortex!) on 
ice! 
 incubate for 15 min for DH5 & JM101; do 2-4 hours for BL21(DE3) & Tuner (DE3) 
5. Pellet the cells again and resuspend in 1/12.5 V of RF2; incubate on ice for 15 min 
6. Aliquot to pre-colded eppendorf in 500, 200, 50 ul per tube; snap freeze in dry 
ice/ethanol bath (or liquid N2) and store at -80°C 
 
RF1 (500 ml) final conc 
RbCl 6.00 g 100 mM 
MnCl2 4.95 g 50 mM 
KOAc 1.47 g 30 mM 
CaCl2·2H2O 2.5 ml of 2 M stock 10 mM 
Glycerol 75 g 15% (W/V) 
Adjust pH to 5.8 with 0.2M acetic acid and sterilized by filtration through 0.22 m 
membrane 
 
RF2 (200 ml) final conc 
MOPS 0.418 g 10 mM 
RbCl 0.241 g 10 mM 
CaCl2·2H2O 7.5 ml of 2 M stock 75 mM 
Glycerol 30 g 15% (W/V) 
Adjust pH to 6.8 with NaOH and sterilized by filtration through 0.22 m membrane 
 
 
Preparation of Competent cells for transformation 
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Maps for expression vectors 
pcDNA3.1-hyg-FLAG-histone H4 
Backbone: pcDNA3.1/hyg (Invitrogen) 
pcDNA3.1/hyg/FLAG-hH4
5904 bp
FLAG-hH4 CDS
Hygro(R)
Amp(R)
Kozak seq
SV40 pA
BGH pA
CMV promoter
SV40 early promoter
bla promoter
f1 origin
pUC origin
 
Sequences around CDS: 
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pET3m-Tudor/53BP1 
Backbone: pET3 (EMD Chemicals) 
pET3-m-HT-53BP1/Tudor-WT
4985 bp
Amp(R)His-TEV-Tudor CDS
TEV cleav age site
bla promoter
T7 promoter
pUC origin
T7 terminator
W1495
 
Sequences around CDS: 
 
Notes: 
1. W1495A mutant: change W(TGG) to A(GCC) (highlight in red) 
2. pET3m backbone was modified to pET3n by introducing a HindIII site in the end of 
TEV-cleavage site (highlight in green) 
'm' version: 
=E==D==L==Y==F==Q==G= 
gaggatctgtactttcaggga 
 
'n' version: 
=E==D==L==Y==F==Q==S==L= 
gaggatctgtactttcaaagcttg 
                 ^^^^^^ HindIII site 
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pFLAG-Cerulean-NLS 
Backbone: pFLAG-CMV™-2 (Sigma, E7033) 
pFLAG-CMV2-Cerulean-NLS
5435 bp
Amp(R)
Cerulean (A206K) - NLS
FLAG+Lineker seq
CAG enhancer
SV40 enhancer
FLAG
NLS
hGH polyA signal
CMV promoter
SV40 promoter
T7 promoter
lac promoter
bla promoter
SV40 origin
pBR322 origin
f1 origin
 
 
Sequences around CDS: 
 
  
 183
pFLAG-Cerulean-NLS (continued) 
Notes: 
 1. Nuclear localization signal was introduced to C terminus (highlight in green). 
 2. The original Cerulean construct was FLAG-tagged; to compatible with FLAG-hH4, 
the FLAG on Cerulean construct was removed by mutagenic PCR. 
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pHA-Venus-NLS 
Backbone: pCMV-HA (Clontech, 631604) 
 
pCMV-HA-Venus-NLS
4568 bp
Amp(R)
Venus
HA & Linker
Enhancer
SV40 late 19s mRNA intron
Modified SV40 late 16s mRNA intro
HA tag w ith start codon ATG
MCS
NLS
SV40 Polyadenylation signal
SV40pA
CMVbla promoter
Ribosome binding site
pUC origin
TATA box
-10 region for Amp
-35 region for Amp
β-lactamase mature polypeptide
β-lactamase signal peptide
MfeI (1851)
SacI (535)
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pHA-Venus-NLS (continued) 
Sequences around CDS 
 
 
Notes: 
1. Digestion sites used for preparing substrates for EJ assay are highlighted in red. 
2. Nuclear localization signal was introduced to C terminus (highlight in green). 
